id	sid	tid	token	lemma	pos
ajlm-2505	1	1	abstract	abstract	ADJ
ajlm-2505	1	2	introduction	introduction	NOUN
ajlm-2505	1	3	methods	method	NOUN
ajlm-2505	1	4	results	result	VERB
ajlm-2505	1	5	discussion	discussion	NOUN
ajlm-2505	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2505	1	7	references	reference	NOUN
ajlm-2505	1	8	about	about	ADP
ajlm-2505	1	9	the	the	DET
ajlm-2505	1	10	author(s	author(s	NOUN
ajlm-2505	1	11	)	)	PUNCT
ajlm-2505	1	12	njabulo	njabulo	PROPN
ajlm-2505	1	13	khumalo	khumalo	PROPN
ajlm-2505	1	14	department	department	PROPN
ajlm-2505	1	15	of	of	ADP
ajlm-2505	1	16	chemical	chemical	PROPN
ajlm-2505	1	17	pathology	pathology	PROPN
ajlm-2505	1	18	,	,	PUNCT
ajlm-2505	1	19	national	national	PROPN
ajlm-2505	1	20	health	health	PROPN
ajlm-2505	1	21	laboratory	laboratory	PROPN
ajlm-2505	1	22	service	service	PROPN
ajlm-2505	1	23	,	,	PUNCT
ajlm-2505	1	24	cape	cape	NOUN
ajlm-2505	1	25	town	town	NOUN
ajlm-2505	1	26	,	,	PUNCT
ajlm-2505	1	27	south	south	PROPN
ajlm-2505	1	28	africa	africa	PROPN
ajlm-2505	1	29	division	division	NOUN
ajlm-2505	1	30	of	of	ADP
ajlm-2505	1	31	chemical	chemical	PROPN
ajlm-2505	1	32	pathology	pathology	NOUN
ajlm-2505	1	33	,	,	PUNCT
ajlm-2505	1	34	faculty	faculty	NOUN
ajlm-2505	1	35	of	of	ADP
ajlm-2505	1	36	health	health	NOUN
ajlm-2505	1	37	sciences	sciences	PROPN
ajlm-2505	1	38	,	,	PUNCT
ajlm-2505	1	39	university	university	NOUN
ajlm-2505	1	40	of	of	ADP
ajlm-2505	1	41	cape	cape	PROPN
ajlm-2505	1	42	town	town	NOUN
ajlm-2505	1	43	,	,	PUNCT
ajlm-2505	1	44	cape	cape	NOUN
ajlm-2505	1	45	town	town	NOUN
ajlm-2505	1	46	,	,	PUNCT
ajlm-2505	1	47	south	south	PROPN
ajlm-2505	1	48	africa	africa	PROPN
ajlm-2505	1	49	cameron	cameron	PROPN
ajlm-2505	1	50	a.	a.	PROPN
ajlm-2505	1	51	francis	francis	PROPN
ajlm-2505	1	52	department	department	PROPN
ajlm-2505	1	53	of	of	ADP
ajlm-2505	1	54	chemical	chemical	PROPN
ajlm-2505	1	55	pathology	pathology	PROPN
ajlm-2505	1	56	,	,	PUNCT
ajlm-2505	1	57	national	national	PROPN
ajlm-2505	1	58	health	health	PROPN
ajlm-2505	1	59	laboratory	laboratory	PROPN
ajlm-2505	1	60	service	service	PROPN
ajlm-2505	1	61	,	,	PUNCT
ajlm-2505	1	62	cape	cape	NOUN
ajlm-2505	1	63	town	town	NOUN
ajlm-2505	1	64	,	,	PUNCT
ajlm-2505	1	65	south	south	PROPN
ajlm-2505	1	66	africa	africa	PROPN
ajlm-2505	1	67	division	division	NOUN
ajlm-2505	1	68	of	of	ADP
ajlm-2505	1	69	chemical	chemical	PROPN
ajlm-2505	1	70	pathology	pathology	NOUN
ajlm-2505	1	71	,	,	PUNCT
ajlm-2505	1	72	faculty	faculty	NOUN
ajlm-2505	1	73	of	of	ADP
ajlm-2505	1	74	health	health	NOUN
ajlm-2505	1	75	sciences	sciences	PROPN
ajlm-2505	1	76	,	,	PUNCT
ajlm-2505	1	77	university	university	NOUN
ajlm-2505	1	78	of	of	ADP
ajlm-2505	1	79	cape	cape	PROPN
ajlm-2505	1	80	town	town	NOUN
ajlm-2505	1	81	,	,	PUNCT
ajlm-2505	1	82	cape	cape	NOUN
ajlm-2505	1	83	town	town	NOUN
ajlm-2505	1	84	,	,	PUNCT
ajlm-2505	1	85	south	south	PROPN
ajlm-2505	1	86	africa	africa	PROPN
ajlm-2505	1	87	siphiwe	siphiwe	PROPN
ajlm-2505	1	88	m.	m.	PROPN
ajlm-2505	1	89	baloyi	baloyi	PROPN
ajlm-2505	1	90	department	department	PROPN
ajlm-2505	1	91	of	of	ADP
ajlm-2505	1	92	haematology	haematology	PROPN
ajlm-2505	1	93	,	,	PUNCT
ajlm-2505	1	94	national	national	PROPN
ajlm-2505	1	95	health	health	PROPN
ajlm-2505	1	96	laboratory	laboratory	PROPN
ajlm-2505	1	97	service	service	PROPN
ajlm-2505	1	98	,	,	PUNCT
ajlm-2505	1	99	cape	cape	NOUN
ajlm-2505	1	100	town	town	NOUN
ajlm-2505	1	101	,	,	PUNCT
ajlm-2505	1	102	south	south	PROPN
ajlm-2505	1	103	africa	africa	PROPN
ajlm-2505	1	104	division	division	NOUN
ajlm-2505	1	105	of	of	ADP
ajlm-2505	1	106	clinical	clinical	ADJ
ajlm-2505	1	107	haematology	haematology	NOUN
ajlm-2505	1	108	,	,	PUNCT
ajlm-2505	1	109	faculty	faculty	NOUN
ajlm-2505	1	110	of	of	ADP
ajlm-2505	1	111	health	health	NOUN
ajlm-2505	1	112	sciences	sciences	PROPN
ajlm-2505	1	113	,	,	PUNCT
ajlm-2505	1	114	university	university	NOUN
ajlm-2505	1	115	of	of	ADP
ajlm-2505	1	116	cape	cape	PROPN
ajlm-2505	1	117	town	town	NOUN
ajlm-2505	1	118	,	,	PUNCT
ajlm-2505	1	119	cape	cape	NOUN
ajlm-2505	1	120	town	town	NOUN
ajlm-2505	1	121	,	,	PUNCT
ajlm-2505	1	122	south	south	PROPN
ajlm-2505	1	123	africa	africa	PROPN
ajlm-2505	1	124	jody	jody	PROPN
ajlm-2505	1	125	a.	a.	PROPN
ajlm-2505	1	126	rusch	rusch	PROPN
ajlm-2505	1	127	department	department	PROPN
ajlm-2505	1	128	of	of	ADP
ajlm-2505	1	129	chemical	chemical	PROPN
ajlm-2505	1	130	pathology	pathology	PROPN
ajlm-2505	1	131	,	,	PUNCT
ajlm-2505	1	132	national	national	PROPN
ajlm-2505	1	133	health	health	PROPN
ajlm-2505	1	134	laboratory	laboratory	PROPN
ajlm-2505	1	135	service	service	PROPN
ajlm-2505	1	136	,	,	PUNCT
ajlm-2505	1	137	cape	cape	NOUN
ajlm-2505	1	138	town	town	NOUN
ajlm-2505	1	139	,	,	PUNCT
ajlm-2505	1	140	south	south	PROPN
ajlm-2505	1	141	africa	africa	PROPN
ajlm-2505	1	142	division	division	NOUN
ajlm-2505	1	143	of	of	ADP
ajlm-2505	1	144	chemical	chemical	PROPN
ajlm-2505	1	145	pathology	pathology	NOUN
ajlm-2505	1	146	,	,	PUNCT
ajlm-2505	1	147	faculty	faculty	NOUN
ajlm-2505	1	148	of	of	ADP
ajlm-2505	1	149	health	health	NOUN
ajlm-2505	1	150	sciences	sciences	PROPN
ajlm-2505	1	151	,	,	PUNCT
ajlm-2505	1	152	university	university	NOUN
ajlm-2505	1	153	of	of	ADP
ajlm-2505	1	154	cape	cape	PROPN
ajlm-2505	1	155	town	town	NOUN
ajlm-2505	1	156	,	,	PUNCT
ajlm-2505	1	157	cape	cape	NOUN
ajlm-2505	1	158	town	town	NOUN
ajlm-2505	1	159	,	,	PUNCT
ajlm-2505	1	160	south	south	PROPN
ajlm-2505	1	161	africa	africa	PROPN
ajlm-2505	1	162	citation	citation	PROPN
ajlm-2505	1	163	khumalo	khumalo	PROPN
ajlm-2505	1	164	n	n	CCONJ
ajlm-2505	1	165	,	,	PUNCT
ajlm-2505	1	166	francis	francis	PROPN
ajlm-2505	1	167	ca	ca	PROPN
ajlm-2505	1	168	,	,	PUNCT
ajlm-2505	1	169	baloyi	baloyi	PROPN
ajlm-2505	1	170	sm	sm	PROPN
ajlm-2505	1	171	,	,	PUNCT
ajlm-2505	1	172	rusch	rusch	PROPN
ajlm-2505	1	173	ja	ja	PROPN
ajlm-2505	1	174	.	.	PUNCT
ajlm-2505	1	175	gamma	gamma	PROPN
ajlm-2505	1	176	gap	gap	NOUN
ajlm-2505	1	177	and	and	CCONJ
ajlm-2505	1	178	albumin	albumin	NOUN
ajlm-2505	1	179	-	-	PUNCT
ajlm-2505	1	180	globulin	globulin	NOUN
ajlm-2505	1	181	ratio	ratio	NOUN
ajlm-2505	1	182	show	show	VERB
ajlm-2505	1	183	poor	poor	ADJ
ajlm-2505	1	184	sensitivity	sensitivity	NOUN
ajlm-2505	1	185	for	for	ADP
ajlm-2505	1	186	monoclonal	monoclonal	NOUN
ajlm-2505	1	187	gammopathy	gammopathy	ADJ
ajlm-2505	1	188	screening	screening	NOUN
ajlm-2505	1	189	in	in	ADP
ajlm-2505	1	190	south	south	PROPN
ajlm-2505	1	191	africa	africa	PROPN
ajlm-2505	1	192	.	.	PUNCT
ajlm-2505	2	1	afr	afr	PROPN
ajlm-2505	2	2	j	j	PROPN
ajlm-2505	2	3	lab	lab	PROPN
ajlm-2505	2	4	med	med	PROPN
ajlm-2505	2	5	.	.	PUNCT
ajlm-2505	3	1	2025;14(1	2025;14(1	NUM
ajlm-2505	3	2	)	)	PUNCT
ajlm-2505	3	3	,	,	PUNCT
ajlm-2505	3	4	a2505	a2505	PROPN
ajlm-2505	3	5	.	.	PROPN
ajlm-2505	3	6	https://doi.org/10.4102/ajlm.v14i1.2505	https://doi.org/10.4102/ajlm.v14i1.2505	NUM
ajlm-2505	3	7	note	note	NOUN
ajlm-2505	3	8	:	:	PUNCT
ajlm-2505	3	9	additional	additional	ADJ
ajlm-2505	3	10	supporting	support	VERB
ajlm-2505	3	11	information	information	NOUN
ajlm-2505	3	12	is	be	AUX
ajlm-2505	3	13	available	available	ADJ
ajlm-2505	3	14	for	for	ADP
ajlm-2505	3	15	download	download	NOUN
ajlm-2505	3	16	alongside	alongside	ADP
ajlm-2505	3	17	the	the	DET
ajlm-2505	3	18	online	online	ADJ
ajlm-2505	3	19	version	version	NOUN
ajlm-2505	3	20	of	of	ADP
ajlm-2505	3	21	this	this	DET
ajlm-2505	3	22	article	article	NOUN
ajlm-2505	3	23	as	as	ADP
ajlm-2505	3	24	online	online	ADJ
ajlm-2505	3	25	supplementary	supplementary	ADJ
ajlm-2505	3	26	document	document	NOUN
ajlm-2505	3	27	1	1	NUM
ajlm-2505	3	28	.	.	PUNCT
ajlm-2505	3	29	original	original	ADJ
ajlm-2505	3	30	research	research	NOUN
ajlm-2505	3	31	gamma	gamma	NOUN
ajlm-2505	3	32	gap	gap	NOUN
ajlm-2505	3	33	and	and	CCONJ
ajlm-2505	3	34	albumin	albumin	NOUN
ajlm-2505	3	35	-	-	PUNCT
ajlm-2505	3	36	globulin	globulin	NOUN
ajlm-2505	3	37	ratio	ratio	NOUN
ajlm-2505	3	38	show	show	VERB
ajlm-2505	3	39	poor	poor	ADJ
ajlm-2505	3	40	sensitivity	sensitivity	NOUN
ajlm-2505	3	41	for	for	ADP
ajlm-2505	3	42	monoclonal	monoclonal	NOUN
ajlm-2505	3	43	gammopathy	gammopathy	ADJ
ajlm-2505	3	44	screening	screening	NOUN
ajlm-2505	3	45	in	in	ADP
ajlm-2505	3	46	south	south	PROPN
ajlm-2505	3	47	africa	africa	PROPN
ajlm-2505	3	48	njabulo	njabulo	PROPN
ajlm-2505	3	49	khumalo	khumalo	PROPN
ajlm-2505	3	50	,	,	PUNCT
ajlm-2505	3	51	cameron	cameron	PROPN
ajlm-2505	3	52	a.	a.	PROPN
ajlm-2505	3	53	francis	francis	PROPN
ajlm-2505	3	54	,	,	PUNCT
ajlm-2505	3	55	siphiwe	siphiwe	PROPN
ajlm-2505	3	56	m.	m.	PROPN
ajlm-2505	3	57	baloyi	baloyi	PROPN
ajlm-2505	3	58	,	,	PUNCT
ajlm-2505	3	59	jody	jody	PROPN
ajlm-2505	3	60	a.	a.	PROPN
ajlm-2505	3	61	rusch	rusch	PROPN
ajlm-2505	3	62	received	receive	VERB
ajlm-2505	3	63	:	:	PUNCT
ajlm-2505	3	64	22	22	NUM
ajlm-2505	3	65	may	may	PROPN
ajlm-2505	3	66	2024	2024	NUM
ajlm-2505	3	67	;	;	PUNCT
ajlm-2505	3	68	accepted	accept	VERB
ajlm-2505	3	69	:	:	PUNCT
ajlm-2505	3	70	10	10	NUM
ajlm-2505	3	71	dec	dec	PROPN
ajlm-2505	3	72	.	.	PROPN
ajlm-2505	3	73	2024	2024	NUM
ajlm-2505	3	74	;	;	PUNCT
ajlm-2505	3	75	published	publish	VERB
ajlm-2505	3	76	:	:	PUNCT
ajlm-2505	3	77	26	26	NUM
ajlm-2505	3	78	mar	mar	PROPN
ajlm-2505	3	79	.	.	PROPN
ajlm-2505	4	1	2025	2025	NUM
ajlm-2505	4	2	copyright	copyright	NOUN
ajlm-2505	4	3	:	:	PUNCT
ajlm-2505	4	4	©	©	PROPN
ajlm-2505	4	5	2025	2025	NUM
ajlm-2505	4	6	.	.	PUNCT
ajlm-2505	5	1	the	the	DET
ajlm-2505	5	2	author(s	author(s	PROPN
ajlm-2505	5	3	)	)	PUNCT
ajlm-2505	5	4	.	.	PUNCT
ajlm-2505	6	1	licensee	licensee	NOUN
ajlm-2505	6	2	:	:	PUNCT
ajlm-2505	6	3	aosis	aosis	NOUN
ajlm-2505	6	4	.	.	PUNCT
ajlm-2505	7	1	this	this	PRON
ajlm-2505	7	2	is	be	AUX
ajlm-2505	7	3	an	an	DET
ajlm-2505	7	4	open	open	ADJ
ajlm-2505	7	5	access	access	NOUN
ajlm-2505	7	6	article	article	NOUN
ajlm-2505	7	7	distributed	distribute	VERB
ajlm-2505	7	8	under	under	ADP
ajlm-2505	7	9	the	the	DET
ajlm-2505	7	10	terms	term	NOUN
ajlm-2505	7	11	of	of	ADP
ajlm-2505	7	12	the	the	DET
ajlm-2505	7	13	creative	creative	ADJ
ajlm-2505	7	14	commons	common	NOUN
ajlm-2505	7	15	attribution	attribution	NOUN
ajlm-2505	7	16	license	license	NOUN
ajlm-2505	7	17	,	,	PUNCT
ajlm-2505	7	18	which	which	PRON
ajlm-2505	7	19	permits	permit	VERB
ajlm-2505	7	20	unrestricted	unrestricted	ADJ
ajlm-2505	7	21	use	use	NOUN
ajlm-2505	7	22	,	,	PUNCT
ajlm-2505	7	23	distribution	distribution	NOUN
ajlm-2505	7	24	,	,	PUNCT
ajlm-2505	7	25	and	and	CCONJ
ajlm-2505	7	26	reproduction	reproduction	NOUN
ajlm-2505	7	27	in	in	ADP
ajlm-2505	7	28	any	any	DET
ajlm-2505	7	29	medium	medium	NOUN
ajlm-2505	7	30	,	,	PUNCT
ajlm-2505	7	31	provided	provide	VERB
ajlm-2505	7	32	the	the	DET
ajlm-2505	7	33	original	original	ADJ
ajlm-2505	7	34	work	work	NOUN
ajlm-2505	7	35	is	be	AUX
ajlm-2505	7	36	properly	properly	ADV
ajlm-2505	7	37	cited	cite	VERB
ajlm-2505	7	38	.	.	PUNCT
ajlm-2505	8	1	abstract	abstract	ADJ
ajlm-2505	8	2	background	background	NOUN
ajlm-2505	8	3	:	:	PUNCT
ajlm-2505	8	4	monoclonal	monoclonal	NOUN
ajlm-2505	8	5	gammopathies	gammopathy	NOUN
ajlm-2505	8	6	,	,	PUNCT
ajlm-2505	8	7	including	include	VERB
ajlm-2505	8	8	multiple	multiple	ADJ
ajlm-2505	8	9	myeloma	myeloma	NOUN
ajlm-2505	8	10	,	,	PUNCT
ajlm-2505	8	11	present	present	ADJ
ajlm-2505	8	12	significant	significant	ADJ
ajlm-2505	8	13	challenges	challenge	NOUN
ajlm-2505	8	14	in	in	ADP
ajlm-2505	8	15	sub	sub	ADJ
ajlm-2505	8	16	-	-	ADJ
ajlm-2505	8	17	saharan	saharan	ADJ
ajlm-2505	8	18	africa	africa	PROPN
ajlm-2505	8	19	.	.	PUNCT
ajlm-2505	9	1	diagnosis	diagnosis	NOUN
ajlm-2505	9	2	is	be	AUX
ajlm-2505	9	3	often	often	ADV
ajlm-2505	9	4	missed	miss	VERB
ajlm-2505	9	5	because	because	SCONJ
ajlm-2505	9	6	of	of	ADP
ajlm-2505	9	7	limited	limited	ADJ
ajlm-2505	9	8	screening	screening	NOUN
ajlm-2505	9	9	tools	tool	NOUN
ajlm-2505	9	10	.	.	PUNCT
ajlm-2505	10	1	the	the	DET
ajlm-2505	10	2	gamma	gamma	NOUN
ajlm-2505	10	3	gap	gap	NOUN
ajlm-2505	10	4	and	and	CCONJ
ajlm-2505	10	5	albumin	albumin	NOUN
ajlm-2505	10	6	-	-	PUNCT
ajlm-2505	10	7	globulin	globulin	NOUN
ajlm-2505	10	8	ratio	ratio	NOUN
ajlm-2505	10	9	(	(	PUNCT
ajlm-2505	10	10	agr	agr	NOUN
ajlm-2505	10	11	)	)	PUNCT
ajlm-2505	10	12	have	have	AUX
ajlm-2505	10	13	been	be	AUX
ajlm-2505	10	14	proposed	propose	VERB
ajlm-2505	10	15	as	as	ADP
ajlm-2505	10	16	simple	simple	ADJ
ajlm-2505	10	17	,	,	PUNCT
ajlm-2505	10	18	cost	cost	NOUN
ajlm-2505	10	19	-	-	PUNCT
ajlm-2505	10	20	effective	effective	ADJ
ajlm-2505	10	21	screening	screening	NOUN
ajlm-2505	10	22	methods	method	NOUN
ajlm-2505	10	23	;	;	PUNCT
ajlm-2505	10	24	however	however	ADV
ajlm-2505	10	25	,	,	PUNCT
ajlm-2505	10	26	their	their	PRON
ajlm-2505	10	27	utility	utility	NOUN
ajlm-2505	10	28	in	in	ADP
ajlm-2505	10	29	settings	setting	NOUN
ajlm-2505	10	30	with	with	ADP
ajlm-2505	10	31	prevalent	prevalent	ADJ
ajlm-2505	10	32	infectious	infectious	ADJ
ajlm-2505	10	33	and	and	CCONJ
ajlm-2505	10	34	inflammatory	inflammatory	ADJ
ajlm-2505	10	35	diseases	disease	NOUN
ajlm-2505	10	36	is	be	AUX
ajlm-2505	10	37	unclear	unclear	ADJ
ajlm-2505	10	38	.	.	PUNCT
ajlm-2505	11	1	objective	objective	NOUN
ajlm-2505	11	2	:	:	PUNCT
ajlm-2505	11	3	this	this	DET
ajlm-2505	11	4	study	study	NOUN
ajlm-2505	11	5	evaluated	evaluate	VERB
ajlm-2505	11	6	the	the	DET
ajlm-2505	11	7	diagnostic	diagnostic	ADJ
ajlm-2505	11	8	accuracy	accuracy	NOUN
ajlm-2505	11	9	of	of	ADP
ajlm-2505	11	10	gamma	gamma	NOUN
ajlm-2505	11	11	gap	gap	NOUN
ajlm-2505	11	12	and	and	CCONJ
ajlm-2505	11	13	agr	agr	NOUN
ajlm-2505	11	14	in	in	ADP
ajlm-2505	11	15	identifying	identify	VERB
ajlm-2505	11	16	patients	patient	NOUN
ajlm-2505	11	17	who	who	PRON
ajlm-2505	11	18	require	require	VERB
ajlm-2505	11	19	further	further	ADJ
ajlm-2505	11	20	investigation	investigation	NOUN
ajlm-2505	11	21	for	for	ADP
ajlm-2505	11	22	monoclonal	monoclonal	NOUN
ajlm-2505	11	23	gammopathies	gammopathy	NOUN
ajlm-2505	11	24	in	in	ADP
ajlm-2505	11	25	south	south	PROPN
ajlm-2505	11	26	africa	africa	PROPN
ajlm-2505	11	27	.	.	PUNCT
ajlm-2505	12	1	methods	method	NOUN
ajlm-2505	12	2	:	:	PUNCT
ajlm-2505	12	3	a	a	DET
ajlm-2505	12	4	retrospective	retrospective	ADJ
ajlm-2505	12	5	analysis	analysis	NOUN
ajlm-2505	12	6	of	of	ADP
ajlm-2505	12	7	7946	7946	NUM
ajlm-2505	12	8	patients	patient	NOUN
ajlm-2505	12	9	who	who	PRON
ajlm-2505	12	10	underwent	undergo	VERB
ajlm-2505	12	11	investigations	investigation	NOUN
ajlm-2505	12	12	for	for	ADP
ajlm-2505	12	13	monoclonal	monoclonal	NOUN
ajlm-2505	12	14	gammopathies	gammopathy	NOUN
ajlm-2505	12	15	at	at	ADP
ajlm-2505	12	16	groote	groote	PROPN
ajlm-2505	12	17	schuur	schuur	PROPN
ajlm-2505	12	18	hospital	hospital	PROPN
ajlm-2505	12	19	,	,	PUNCT
ajlm-2505	12	20	south	south	PROPN
ajlm-2505	12	21	africa	africa	PROPN
ajlm-2505	12	22	,	,	PUNCT
ajlm-2505	12	23	between	between	ADP
ajlm-2505	12	24	september	september	PROPN
ajlm-2505	12	25	2015	2015	NUM
ajlm-2505	12	26	and	and	CCONJ
ajlm-2505	12	27	september	september	PROPN
ajlm-2505	12	28	2022	2022	NUM
ajlm-2505	12	29	was	be	AUX
ajlm-2505	12	30	conducted	conduct	VERB
ajlm-2505	12	31	.	.	PUNCT
ajlm-2505	13	1	patients	patient	NOUN
ajlm-2505	13	2	were	be	AUX
ajlm-2505	13	3	classified	classify	VERB
ajlm-2505	13	4	based	base	VERB
ajlm-2505	13	5	on	on	ADP
ajlm-2505	13	6	monoclonal	monoclonal	NOUN
ajlm-2505	13	7	protein	protein	NOUN
ajlm-2505	13	8	detection	detection	NOUN
ajlm-2505	13	9	,	,	PUNCT
ajlm-2505	13	10	and	and	CCONJ
ajlm-2505	13	11	the	the	DET
ajlm-2505	13	12	gamma	gamma	NOUN
ajlm-2505	13	13	gap	gap	PROPN
ajlm-2505	13	14	,	,	PUNCT
ajlm-2505	13	15	agr	agr	NOUN
ajlm-2505	13	16	,	,	PUNCT
ajlm-2505	13	17	and	and	CCONJ
ajlm-2505	13	18	multivariable	multivariable	ADJ
ajlm-2505	13	19	models	model	NOUN
ajlm-2505	13	20	were	be	AUX
ajlm-2505	13	21	evaluated	evaluate	VERB
ajlm-2505	13	22	for	for	ADP
ajlm-2505	13	23	diagnostic	diagnostic	ADJ
ajlm-2505	13	24	performance	performance	NOUN
ajlm-2505	13	25	.	.	PUNCT
ajlm-2505	14	1	results	result	NOUN
ajlm-2505	14	2	:	:	PUNCT
ajlm-2505	14	3	among	among	ADP
ajlm-2505	14	4	the	the	DET
ajlm-2505	14	5	patients	patient	NOUN
ajlm-2505	14	6	(	(	PUNCT
ajlm-2505	14	7	median	median	ADJ
ajlm-2505	14	8	age	age	NOUN
ajlm-2505	14	9	:	:	PUNCT
ajlm-2505	14	10	61	61	NUM
ajlm-2505	14	11	years	year	NOUN
ajlm-2505	14	12	,	,	PUNCT
ajlm-2505	14	13	58	58	NUM
ajlm-2505	14	14	%	%	NOUN
ajlm-2505	14	15	female	female	ADJ
ajlm-2505	14	16	[	[	X
ajlm-2505	14	17	4632/7946	4632/7946	NUM
ajlm-2505	14	18	]	]	PUNCT
ajlm-2505	14	19	and	and	CCONJ
ajlm-2505	15	1	42	42	NUM
ajlm-2505	15	2	%	%	NOUN
ajlm-2505	15	3	[	[	X
ajlm-2505	15	4	3314/7946	3314/7946	NUM
ajlm-2505	15	5	]	]	X
ajlm-2505	15	6	male	male	ADJ
ajlm-2505	15	7	patients	patient	NOUN
ajlm-2505	15	8	)	)	PUNCT
ajlm-2505	15	9	,	,	PUNCT
ajlm-2505	15	10	1231	1231	NUM
ajlm-2505	15	11	had	have	VERB
ajlm-2505	15	12	monoclonal	monoclonal	NOUN
ajlm-2505	15	13	proteins	protein	NOUN
ajlm-2505	15	14	.	.	PUNCT
ajlm-2505	16	1	a	a	DET
ajlm-2505	16	2	gamma	gamma	NOUN
ajlm-2505	16	3	gap	gap	NOUN
ajlm-2505	16	4	cutoff	cutoff	NOUN
ajlm-2505	16	5	of	of	ADP
ajlm-2505	16	6	46	46	NUM
ajlm-2505	16	7	g	g	NOUN
ajlm-2505	16	8	/	/	SYM
ajlm-2505	16	9	l	l	NOUN
ajlm-2505	16	10	identified	identify	VERB
ajlm-2505	16	11	35	35	NUM
ajlm-2505	16	12	%	%	NOUN
ajlm-2505	16	13	of	of	ADP
ajlm-2505	16	14	monoclonal	monoclonal	NOUN
ajlm-2505	16	15	cases	case	NOUN
ajlm-2505	16	16	(	(	PUNCT
ajlm-2505	16	17	sensitivity	sensitivity	NOUN
ajlm-2505	16	18	)	)	PUNCT
ajlm-2505	16	19	,	,	PUNCT
ajlm-2505	16	20	with	with	ADP
ajlm-2505	16	21	91	91	NUM
ajlm-2505	16	22	%	%	NOUN
ajlm-2505	16	23	specificity	specificity	NOUN
ajlm-2505	16	24	and	and	CCONJ
ajlm-2505	16	25	an	an	DET
ajlm-2505	16	26	area	area	NOUN
ajlm-2505	16	27	under	under	ADP
ajlm-2505	16	28	the	the	DET
ajlm-2505	16	29	curve	curve	NOUN
ajlm-2505	16	30	(	(	PUNCT
ajlm-2505	16	31	auc	auc	NOUN
ajlm-2505	16	32	)	)	PUNCT
ajlm-2505	16	33	of	of	ADP
ajlm-2505	16	34	0.60	0.60	NUM
ajlm-2505	16	35	.	.	PUNCT
ajlm-2505	17	1	the	the	DET
ajlm-2505	17	2	agr	agr	NOUN
ajlm-2505	17	3	showed	show	VERB
ajlm-2505	17	4	a	a	DET
ajlm-2505	17	5	slightly	slightly	ADV
ajlm-2505	17	6	better	well	ADJ
ajlm-2505	17	7	auc	auc	NOUN
ajlm-2505	17	8	of	of	ADP
ajlm-2505	17	9	0.63	0.63	NUM
ajlm-2505	17	10	,	,	PUNCT
ajlm-2505	17	11	with	with	ADP
ajlm-2505	17	12	44	44	NUM
ajlm-2505	17	13	%	%	NOUN
ajlm-2505	17	14	sensitivity	sensitivity	NOUN
ajlm-2505	17	15	and	and	CCONJ
ajlm-2505	17	16	80	80	NUM
ajlm-2505	17	17	%	%	NOUN
ajlm-2505	17	18	specificity	specificity	NOUN
ajlm-2505	17	19	at	at	ADP
ajlm-2505	17	20	a	a	DET
ajlm-2505	17	21	0.85	0.85	NUM
ajlm-2505	17	22	cutoff	cutoff	NOUN
ajlm-2505	17	23	.	.	PUNCT
ajlm-2505	18	1	multivariable	multivariable	ADJ
ajlm-2505	18	2	models	model	NOUN
ajlm-2505	18	3	incorporating	incorporate	VERB
ajlm-2505	18	4	age	age	NOUN
ajlm-2505	18	5	,	,	PUNCT
ajlm-2505	18	6	sex	sex	NOUN
ajlm-2505	18	7	,	,	PUNCT
ajlm-2505	18	8	and	and	CCONJ
ajlm-2505	18	9	hypogammaglobulinaemia	hypogammaglobulinaemia	NOUN
ajlm-2505	18	10	improved	improved	ADJ
ajlm-2505	18	11	performance	performance	NOUN
ajlm-2505	18	12	,	,	PUNCT
ajlm-2505	18	13	with	with	ADP
ajlm-2505	18	14	the	the	DET
ajlm-2505	18	15	gamma	gamma	NOUN
ajlm-2505	18	16	gap	gap	NOUN
ajlm-2505	18	17	model	model	NOUN
ajlm-2505	18	18	achieving	achieve	VERB
ajlm-2505	18	19	an	an	DET
ajlm-2505	18	20	auc	auc	NOUN
ajlm-2505	18	21	of	of	ADP
ajlm-2505	18	22	0.73	0.73	NUM
ajlm-2505	18	23	,	,	PUNCT
ajlm-2505	18	24	improving	improve	VERB
ajlm-2505	18	25	the	the	DET
ajlm-2505	18	26	sensitivity	sensitivity	NOUN
ajlm-2505	18	27	to	to	ADP
ajlm-2505	18	28	58	58	NUM
ajlm-2505	18	29	%	%	NOUN
ajlm-2505	18	30	,	,	PUNCT
ajlm-2505	18	31	with	with	ADP
ajlm-2505	18	32	a	a	DET
ajlm-2505	18	33	specificity	specificity	NOUN
ajlm-2505	18	34	of	of	ADP
ajlm-2505	18	35	78	78	NUM
ajlm-2505	18	36	%	%	NOUN
ajlm-2505	18	37	.	.	PUNCT
ajlm-2505	19	1	conclusion	conclusion	NOUN
ajlm-2505	19	2	:	:	PUNCT
ajlm-2505	19	3	the	the	DET
ajlm-2505	19	4	gamma	gamma	NOUN
ajlm-2505	19	5	gap	gap	NOUN
ajlm-2505	19	6	and	and	CCONJ
ajlm-2505	19	7	agr	agr	NOUN
ajlm-2505	19	8	showed	show	VERB
ajlm-2505	19	9	low	low	ADJ
ajlm-2505	19	10	sensitivity	sensitivity	NOUN
ajlm-2505	19	11	and	and	CCONJ
ajlm-2505	19	12	moderate	moderate	ADJ
ajlm-2505	19	13	specificity	specificity	NOUN
ajlm-2505	19	14	in	in	ADP
ajlm-2505	19	15	screening	screen	VERB
ajlm-2505	19	16	for	for	ADP
ajlm-2505	19	17	monoclonal	monoclonal	NOUN
ajlm-2505	19	18	gammopathies	gammopathy	NOUN
ajlm-2505	19	19	,	,	PUNCT
ajlm-2505	19	20	highlighting	highlight	VERB
ajlm-2505	19	21	the	the	DET
ajlm-2505	19	22	need	need	NOUN
ajlm-2505	19	23	for	for	ADP
ajlm-2505	19	24	integrated	integrate	VERB
ajlm-2505	19	25	diagnostic	diagnostic	ADJ
ajlm-2505	19	26	approaches	approach	NOUN
ajlm-2505	19	27	combining	combine	VERB
ajlm-2505	19	28	clinical	clinical	ADJ
ajlm-2505	19	29	,	,	PUNCT
ajlm-2505	19	30	demographic	demographic	ADJ
ajlm-2505	19	31	,	,	PUNCT
ajlm-2505	19	32	and	and	CCONJ
ajlm-2505	19	33	laboratory	laboratory	NOUN
ajlm-2505	19	34	data	datum	NOUN
ajlm-2505	19	35	to	to	PART
ajlm-2505	19	36	improve	improve	VERB
ajlm-2505	19	37	early	early	ADJ
ajlm-2505	19	38	detection	detection	NOUN
ajlm-2505	19	39	in	in	ADP
ajlm-2505	19	40	resource	resource	NOUN
ajlm-2505	19	41	-	-	PUNCT
ajlm-2505	19	42	limited	limit	VERB
ajlm-2505	19	43	settings	setting	NOUN
ajlm-2505	19	44	.	.	PUNCT
ajlm-2505	20	1	what	what	PRON
ajlm-2505	20	2	this	this	DET
ajlm-2505	20	3	study	study	NOUN
ajlm-2505	20	4	adds	add	VERB
ajlm-2505	20	5	:	:	PUNCT
ajlm-2505	20	6	although	although	SCONJ
ajlm-2505	20	7	cost	cost	NOUN
ajlm-2505	20	8	-	-	PUNCT
ajlm-2505	20	9	effective	effective	ADJ
ajlm-2505	20	10	and	and	CCONJ
ajlm-2505	20	11	widely	widely	ADV
ajlm-2505	20	12	available	available	ADJ
ajlm-2505	20	13	,	,	PUNCT
ajlm-2505	20	14	gamma	gamma	NOUN
ajlm-2505	20	15	gap	gap	NOUN
ajlm-2505	20	16	and	and	CCONJ
ajlm-2505	20	17	agr	agr	NOUN
ajlm-2505	20	18	have	have	VERB
ajlm-2505	20	19	limited	limit	VERB
ajlm-2505	20	20	accuracy	accuracy	NOUN
ajlm-2505	20	21	for	for	ADP
ajlm-2505	20	22	screening	screen	VERB
ajlm-2505	20	23	monoclonal	monoclonal	NOUN
ajlm-2505	20	24	gammopathies	gammopathy	NOUN
ajlm-2505	20	25	when	when	SCONJ
ajlm-2505	20	26	used	use	VERB
ajlm-2505	20	27	alone	alone	ADV
ajlm-2505	20	28	in	in	ADP
ajlm-2505	20	29	settings	setting	NOUN
ajlm-2505	20	30	with	with	ADP
ajlm-2505	20	31	prevalent	prevalent	ADJ
ajlm-2505	20	32	infectious	infectious	ADJ
ajlm-2505	20	33	and	and	CCONJ
ajlm-2505	20	34	inflammatory	inflammatory	ADJ
ajlm-2505	20	35	diseases	disease	NOUN
ajlm-2505	20	36	.	.	PUNCT
ajlm-2505	21	1	although	although	SCONJ
ajlm-2505	21	2	the	the	DET
ajlm-2505	21	3	tests	test	NOUN
ajlm-2505	21	4	are	be	AUX
ajlm-2505	21	5	good	good	ADJ
ajlm-2505	21	6	at	at	ADP
ajlm-2505	21	7	ruling	rule	VERB
ajlm-2505	21	8	out	out	ADP
ajlm-2505	21	9	monoclonality	monoclonality	NOUN
ajlm-2505	21	10	,	,	PUNCT
ajlm-2505	21	11	they	they	PRON
ajlm-2505	21	12	risk	risk	VERB
ajlm-2505	21	13	missing	miss	VERB
ajlm-2505	21	14	many	many	ADJ
ajlm-2505	21	15	true	true	ADJ
ajlm-2505	21	16	cases	case	NOUN
ajlm-2505	21	17	,	,	PUNCT
ajlm-2505	21	18	delaying	delay	VERB
ajlm-2505	21	19	diagnosis	diagnosis	NOUN
ajlm-2505	21	20	and	and	CCONJ
ajlm-2505	21	21	treatment	treatment	NOUN
ajlm-2505	21	22	.	.	PUNCT
ajlm-2505	22	1	keywords	keyword	NOUN
ajlm-2505	22	2	:	:	PUNCT
ajlm-2505	22	3	gamma	gamma	NOUN
ajlm-2505	22	4	gap	gap	NOUN
ajlm-2505	22	5	;	;	PUNCT
ajlm-2505	22	6	globulins	globulin	NOUN
ajlm-2505	22	7	;	;	PUNCT
ajlm-2505	22	8	paraproteins	paraprotein	NOUN
ajlm-2505	22	9	;	;	PUNCT
ajlm-2505	22	10	paraproteinaemias	paraproteinaemia	NOUN
ajlm-2505	22	11	;	;	PUNCT
ajlm-2505	22	12	albumin	albumin	ADJ
ajlm-2505	22	13	/	/	SYM
ajlm-2505	22	14	globulin	globulin	NOUN
ajlm-2505	22	15	ratio	ratio	NOUN
ajlm-2505	22	16	;	;	PUNCT
ajlm-2505	22	17	inflammation	inflammation	NOUN
ajlm-2505	22	18	.	.	PUNCT
ajlm-2505	23	1	introduction	introduction	NOUN
ajlm-2505	23	2	monoclonal	monoclonal	NOUN
ajlm-2505	23	3	gammopathies	gammopathy	NOUN
ajlm-2505	23	4	include	include	VERB
ajlm-2505	23	5	both	both	DET
ajlm-2505	23	6	malignant	malignant	ADJ
ajlm-2505	23	7	conditions	condition	NOUN
ajlm-2505	23	8	,	,	PUNCT
ajlm-2505	23	9	such	such	ADJ
ajlm-2505	23	10	as	as	ADP
ajlm-2505	23	11	multiple	multiple	ADJ
ajlm-2505	23	12	myeloma	myeloma	NOUN
ajlm-2505	23	13	,	,	PUNCT
ajlm-2505	23	14	plasmacytoma	plasmacytoma	NOUN
ajlm-2505	23	15	,	,	PUNCT
ajlm-2505	23	16	and	and	CCONJ
ajlm-2505	23	17	waldenström	waldenström	ADV
ajlm-2505	23	18	macroglobulinaemia	macroglobulinaemia	NOUN
ajlm-2505	23	19	,	,	PUNCT
ajlm-2505	23	20	as	as	ADV
ajlm-2505	23	21	well	well	ADV
ajlm-2505	23	22	as	as	ADP
ajlm-2505	23	23	the	the	DET
ajlm-2505	23	24	pre	pre	ADJ
ajlm-2505	23	25	-	-	ADJ
ajlm-2505	23	26	malignant	malignant	ADJ
ajlm-2505	23	27	condition	condition	NOUN
ajlm-2505	23	28	,	,	PUNCT
ajlm-2505	23	29	monoclonal	monoclonal	NOUN
ajlm-2505	23	30	gammopathy	gammopathy	ADJ
ajlm-2505	23	31	of	of	ADP
ajlm-2505	23	32	undetermined	undetermined	ADJ
ajlm-2505	23	33	significance	significance	NOUN
ajlm-2505	23	34	(	(	PUNCT
ajlm-2505	23	35	mgus).1	mgus).1	NOUN
ajlm-2505	23	36	these	these	DET
ajlm-2505	23	37	disorders	disorder	NOUN
ajlm-2505	23	38	are	be	AUX
ajlm-2505	23	39	characterised	characterise	VERB
ajlm-2505	23	40	by	by	ADP
ajlm-2505	23	41	the	the	DET
ajlm-2505	23	42	abnormal	abnormal	ADJ
ajlm-2505	23	43	proliferation	proliferation	NOUN
ajlm-2505	23	44	of	of	ADP
ajlm-2505	23	45	clonal	clonal	ADJ
ajlm-2505	23	46	plasma	plasma	NOUN
ajlm-2505	23	47	cells	cell	NOUN
ajlm-2505	23	48	producing	produce	VERB
ajlm-2505	23	49	monoclonal	monoclonal	NOUN
ajlm-2505	23	50	immunoglobulins	immunoglobulin	NOUN
ajlm-2505	23	51	.	.	PUNCT
ajlm-2505	24	1	multiple	multiple	ADJ
ajlm-2505	24	2	myeloma	myeloma	PROPN
ajlm-2505	24	3	,	,	PUNCT
ajlm-2505	24	4	the	the	DET
ajlm-2505	24	5	most	most	ADV
ajlm-2505	24	6	serious	serious	ADJ
ajlm-2505	24	7	and	and	CCONJ
ajlm-2505	24	8	well	well	ADV
ajlm-2505	24	9	-	-	PUNCT
ajlm-2505	24	10	known	know	VERB
ajlm-2505	24	11	form	form	NOUN
ajlm-2505	24	12	,	,	PUNCT
ajlm-2505	24	13	often	often	ADV
ajlm-2505	24	14	progresses	progress	VERB
ajlm-2505	24	15	from	from	ADP
ajlm-2505	24	16	mgus	mgus	ADJ
ajlm-2505	24	17	and	and	CCONJ
ajlm-2505	24	18	leads	lead	VERB
ajlm-2505	24	19	to	to	ADP
ajlm-2505	24	20	complications	complication	NOUN
ajlm-2505	24	21	such	such	ADJ
ajlm-2505	24	22	as	as	ADP
ajlm-2505	24	23	anaemia	anaemia	NOUN
ajlm-2505	24	24	,	,	PUNCT
ajlm-2505	24	25	renal	renal	ADJ
ajlm-2505	24	26	dysfunction	dysfunction	NOUN
ajlm-2505	24	27	,	,	PUNCT
ajlm-2505	24	28	osteolytic	osteolytic	ADJ
ajlm-2505	24	29	lesions	lesion	NOUN
ajlm-2505	24	30	,	,	PUNCT
ajlm-2505	24	31	and	and	CCONJ
ajlm-2505	24	32	increased	increase	VERB
ajlm-2505	24	33	susceptibility	susceptibility	NOUN
ajlm-2505	24	34	to	to	ADP
ajlm-2505	24	35	infections	infection	NOUN
ajlm-2505	24	36	.	.	PUNCT
ajlm-2505	25	1	despite	despite	SCONJ
ajlm-2505	25	2	advances	advance	NOUN
ajlm-2505	25	3	in	in	ADP
ajlm-2505	25	4	treatment	treatment	NOUN
ajlm-2505	25	5	,	,	PUNCT
ajlm-2505	25	6	multiple	multiple	ADJ
ajlm-2505	25	7	myeloma	myeloma	NOUN
ajlm-2505	25	8	remains	remain	VERB
ajlm-2505	25	9	incurable	incurable	ADJ
ajlm-2505	25	10	but	but	CCONJ
ajlm-2505	25	11	manageable.2	manageable.2	ADJ
ajlm-2505	25	12	multiple	multiple	ADJ
ajlm-2505	25	13	myeloma	myeloma	NOUN
ajlm-2505	25	14	accounts	account	VERB
ajlm-2505	25	15	for	for	ADP
ajlm-2505	25	16	1.3	1.3	NUM
ajlm-2505	25	17	%	%	NOUN
ajlm-2505	25	18	of	of	ADP
ajlm-2505	25	19	all	all	DET
ajlm-2505	25	20	malignancies	malignancy	NOUN
ajlm-2505	25	21	and	and	CCONJ
ajlm-2505	25	22	15	15	NUM
ajlm-2505	25	23	%	%	NOUN
ajlm-2505	25	24	of	of	ADP
ajlm-2505	25	25	haematological	haematological	ADJ
ajlm-2505	25	26	malignancies	malignancy	NOUN
ajlm-2505	25	27	,	,	PUNCT
ajlm-2505	25	28	with	with	ADP
ajlm-2505	25	29	an	an	DET
ajlm-2505	25	30	estimated	estimate	VERB
ajlm-2505	25	31	138	138	NUM
ajlm-2505	25	32	000	000	NUM
ajlm-2505	25	33	new	new	ADJ
ajlm-2505	25	34	cases	case	NOUN
ajlm-2505	25	35	diagnosed	diagnose	VERB
ajlm-2505	25	36	globally	globally	ADV
ajlm-2505	25	37	each	each	DET
ajlm-2505	25	38	year.3	year.3	NOUN
ajlm-2505	25	39	however	however	ADV
ajlm-2505	25	40	,	,	PUNCT
ajlm-2505	25	41	the	the	DET
ajlm-2505	25	42	incidence	incidence	NOUN
ajlm-2505	25	43	and	and	CCONJ
ajlm-2505	25	44	mortality	mortality	NOUN
ajlm-2505	25	45	rates	rate	NOUN
ajlm-2505	25	46	are	be	AUX
ajlm-2505	25	47	significantly	significantly	ADV
ajlm-2505	25	48	higher	high	ADJ
ajlm-2505	25	49	in	in	ADP
ajlm-2505	25	50	affluent	affluent	ADJ
ajlm-2505	25	51	regions	region	NOUN
ajlm-2505	25	52	like	like	ADP
ajlm-2505	25	53	north	north	PROPN
ajlm-2505	25	54	america	america	PROPN
ajlm-2505	25	55	,	,	PUNCT
ajlm-2505	25	56	western	western	PROPN
ajlm-2505	25	57	europe	europe	PROPN
ajlm-2505	25	58	,	,	PUNCT
ajlm-2505	25	59	and	and	CCONJ
ajlm-2505	25	60	australia	australia	PROPN
ajlm-2505	25	61	compared	compare	VERB
ajlm-2505	25	62	to	to	ADP
ajlm-2505	25	63	less	less	ADV
ajlm-2505	25	64	affluent	affluent	ADJ
ajlm-2505	25	65	regions	region	NOUN
ajlm-2505	25	66	such	such	ADJ
ajlm-2505	25	67	as	as	ADP
ajlm-2505	25	68	sub	sub	ADJ
ajlm-2505	25	69	-	-	ADJ
ajlm-2505	25	70	saharan	saharan	ADJ
ajlm-2505	25	71	africa	africa	PROPN
ajlm-2505	25	72	,	,	PUNCT
ajlm-2505	25	73	asia	asia	PROPN
ajlm-2505	25	74	,	,	PUNCT
ajlm-2505	25	75	and	and	CCONJ
ajlm-2505	25	76	oceania.3	oceania.3	PROPN
ajlm-2505	25	77	cowan	cowan	PROPN
ajlm-2505	25	78	et	et	NOUN
ajlm-2505	25	79	al.3	al.3	PROPN
ajlm-2505	25	80	and	and	CCONJ
ajlm-2505	25	81	rebbeck	rebbeck	VERB
ajlm-2505	25	82	et	et	PROPN
ajlm-2505	25	83	al.4	al.4	PROPN
ajlm-2505	25	84	suggest	suggest	VERB
ajlm-2505	25	85	that	that	SCONJ
ajlm-2505	25	86	this	this	DET
ajlm-2505	25	87	disparity	disparity	NOUN
ajlm-2505	25	88	may	may	AUX
ajlm-2505	25	89	result	result	VERB
ajlm-2505	25	90	from	from	ADP
ajlm-2505	25	91	limited	limited	ADJ
ajlm-2505	25	92	access	access	NOUN
ajlm-2505	25	93	to	to	ADP
ajlm-2505	25	94	screening	screening	NOUN
ajlm-2505	25	95	and	and	CCONJ
ajlm-2505	25	96	diagnostic	diagnostic	ADJ
ajlm-2505	25	97	tools	tool	NOUN
ajlm-2505	25	98	in	in	ADP
ajlm-2505	25	99	resource	resource	NOUN
ajlm-2505	25	100	-	-	PUNCT
ajlm-2505	25	101	constrained	constrain	VERB
ajlm-2505	25	102	settings	setting	NOUN
ajlm-2505	25	103	.	.	PUNCT
ajlm-2505	26	1	consequently	consequently	ADV
ajlm-2505	26	2	,	,	PUNCT
ajlm-2505	26	3	many	many	ADJ
ajlm-2505	26	4	cases	case	NOUN
ajlm-2505	26	5	of	of	ADP
ajlm-2505	26	6	multiple	multiple	ADJ
ajlm-2505	26	7	myeloma	myeloma	NOUN
ajlm-2505	26	8	go	go	VERB
ajlm-2505	26	9	undetected	undetected	ADJ
ajlm-2505	26	10	or	or	CCONJ
ajlm-2505	26	11	are	be	AUX
ajlm-2505	26	12	diagnosed	diagnose	VERB
ajlm-2505	26	13	at	at	ADP
ajlm-2505	26	14	advanced	advanced	ADJ
ajlm-2505	26	15	stages	stage	NOUN
ajlm-2505	26	16	,	,	PUNCT
ajlm-2505	26	17	leading	lead	VERB
ajlm-2505	26	18	to	to	ADP
ajlm-2505	26	19	an	an	DET
ajlm-2505	26	20	underestimation	underestimation	NOUN
ajlm-2505	26	21	of	of	ADP
ajlm-2505	26	22	the	the	DET
ajlm-2505	26	23	true	true	ADJ
ajlm-2505	26	24	prevalence	prevalence	NOUN
ajlm-2505	26	25	in	in	ADP
ajlm-2505	26	26	regions	region	NOUN
ajlm-2505	26	27	such	such	ADJ
ajlm-2505	26	28	as	as	ADP
ajlm-2505	26	29	south	south	ADJ
ajlm-2505	26	30	africa.3,4,5	africa.3,4,5	NOUN
ajlm-2505	26	31	screening	screen	VERB
ajlm-2505	26	32	for	for	ADP
ajlm-2505	26	33	monoclonal	monoclonal	NOUN
ajlm-2505	26	34	gammopathies	gammopathy	NOUN
ajlm-2505	26	35	is	be	AUX
ajlm-2505	26	36	critical	critical	ADJ
ajlm-2505	26	37	for	for	ADP
ajlm-2505	26	38	early	early	ADJ
ajlm-2505	26	39	detection	detection	NOUN
ajlm-2505	26	40	,	,	PUNCT
ajlm-2505	26	41	enabling	enable	VERB
ajlm-2505	26	42	timely	timely	ADJ
ajlm-2505	26	43	intervention	intervention	NOUN
ajlm-2505	26	44	and	and	CCONJ
ajlm-2505	26	45	reducing	reduce	VERB
ajlm-2505	26	46	the	the	DET
ajlm-2505	26	47	risk	risk	NOUN
ajlm-2505	26	48	of	of	ADP
ajlm-2505	26	49	complications.6,7	complications.6,7	NOUN
ajlm-2505	26	50	this	this	PRON
ajlm-2505	26	51	is	be	AUX
ajlm-2505	26	52	particularly	particularly	ADV
ajlm-2505	26	53	important	important	ADJ
ajlm-2505	26	54	in	in	ADP
ajlm-2505	26	55	low	low	ADJ
ajlm-2505	26	56	-	-	PUNCT
ajlm-2505	26	57	resource	resource	NOUN
ajlm-2505	26	58	settings	setting	NOUN
ajlm-2505	26	59	,	,	PUNCT
ajlm-2505	26	60	where	where	SCONJ
ajlm-2505	26	61	restricted	restrict	VERB
ajlm-2505	26	62	access	access	NOUN
ajlm-2505	26	63	to	to	ADP
ajlm-2505	26	64	advanced	advanced	ADJ
ajlm-2505	26	65	diagnostic	diagnostic	ADJ
ajlm-2505	26	66	tools	tool	NOUN
ajlm-2505	26	67	contributes	contribute	VERB
ajlm-2505	26	68	to	to	ADP
ajlm-2505	26	69	delayed	delay	VERB
ajlm-2505	26	70	diagnoses	diagnosis	NOUN
ajlm-2505	26	71	and	and	CCONJ
ajlm-2505	26	72	poorer	poor	ADJ
ajlm-2505	26	73	outcomes.3,4	outcomes.3,4	ADJ
ajlm-2505	26	74	current	current	ADJ
ajlm-2505	26	75	screening	screening	NOUN
ajlm-2505	26	76	and	and	CCONJ
ajlm-2505	26	77	diagnostic	diagnostic	ADJ
ajlm-2505	26	78	methods	method	NOUN
ajlm-2505	26	79	,	,	PUNCT
ajlm-2505	26	80	such	such	ADJ
ajlm-2505	26	81	as	as	ADP
ajlm-2505	26	82	serum	serum	NOUN
ajlm-2505	26	83	protein	protein	NOUN
ajlm-2505	26	84	electrophoresis	electrophoresis	NOUN
ajlm-2505	26	85	(	(	PUNCT
ajlm-2505	26	86	spe	spe	PROPN
ajlm-2505	26	87	)	)	PUNCT
ajlm-2505	26	88	,	,	PUNCT
ajlm-2505	26	89	immunofixation	immunofixation	NOUN
ajlm-2505	26	90	,	,	PUNCT
ajlm-2505	26	91	serum	serum	NOUN
ajlm-2505	26	92	-	-	PUNCT
ajlm-2505	26	93	free	free	ADJ
ajlm-2505	26	94	light	light	ADJ
ajlm-2505	26	95	chains	chain	NOUN
ajlm-2505	26	96	(	(	PUNCT
ajlm-2505	26	97	sflc	sflc	VERB
ajlm-2505	26	98	)	)	PUNCT
ajlm-2505	26	99	,	,	PUNCT
ajlm-2505	26	100	urine	urine	NOUN
ajlm-2505	26	101	protein	protein	NOUN
ajlm-2505	26	102	electrophoresis	electrophoresis	NOUN
ajlm-2505	26	103	,	,	PUNCT
ajlm-2505	26	104	and	and	CCONJ
ajlm-2505	26	105	bone	bone	NOUN
ajlm-2505	26	106	marrow	marrow	NOUN
ajlm-2505	26	107	biopsy	biopsy	NOUN
ajlm-2505	26	108	,	,	PUNCT
ajlm-2505	26	109	while	while	SCONJ
ajlm-2505	26	110	effective	effective	ADJ
ajlm-2505	26	111	,	,	PUNCT
ajlm-2505	26	112	are	be	AUX
ajlm-2505	26	113	costly	costly	ADJ
ajlm-2505	26	114	and	and	CCONJ
ajlm-2505	26	115	complex,8	complex,8	NOUN
ajlm-2505	26	116	limiting	limit	VERB
ajlm-2505	26	117	their	their	PRON
ajlm-2505	26	118	accessibility	accessibility	NOUN
ajlm-2505	26	119	in	in	ADP
ajlm-2505	26	120	resource	resource	NOUN
ajlm-2505	26	121	-	-	PUNCT
ajlm-2505	26	122	poor	poor	ADJ
ajlm-2505	26	123	environments.1	environments.1	NOUN
ajlm-2505	26	124	this	this	PRON
ajlm-2505	26	125	underscores	underscore	VERB
ajlm-2505	26	126	the	the	DET
ajlm-2505	26	127	need	need	NOUN
ajlm-2505	26	128	for	for	ADP
ajlm-2505	26	129	simple	simple	ADJ
ajlm-2505	26	130	,	,	PUNCT
ajlm-2505	26	131	affordable	affordable	ADJ
ajlm-2505	26	132	,	,	PUNCT
ajlm-2505	26	133	and	and	CCONJ
ajlm-2505	26	134	reliable	reliable	ADJ
ajlm-2505	26	135	screening	screening	NOUN
ajlm-2505	26	136	tools	tool	NOUN
ajlm-2505	26	137	to	to	PART
ajlm-2505	26	138	determine	determine	VERB
ajlm-2505	26	139	the	the	DET
ajlm-2505	26	140	need	need	NOUN
ajlm-2505	26	141	for	for	ADP
ajlm-2505	26	142	further	further	ADJ
ajlm-2505	26	143	investigation	investigation	NOUN
ajlm-2505	26	144	.	.	PUNCT
ajlm-2505	27	1	the	the	DET
ajlm-2505	27	2	gamma	gamma	NOUN
ajlm-2505	27	3	gap	gap	NOUN
ajlm-2505	27	4	and	and	CCONJ
ajlm-2505	27	5	albumin	albumin	NOUN
ajlm-2505	27	6	-	-	PUNCT
ajlm-2505	27	7	to	to	ADP
ajlm-2505	27	8	-	-	PUNCT
ajlm-2505	27	9	globulin	globulin	NOUN
ajlm-2505	27	10	ratio	ratio	NOUN
ajlm-2505	27	11	(	(	PUNCT
ajlm-2505	27	12	agr	agr	NOUN
ajlm-2505	27	13	)	)	PUNCT
ajlm-2505	27	14	,	,	PUNCT
ajlm-2505	27	15	derived	derive	VERB
ajlm-2505	27	16	from	from	ADP
ajlm-2505	27	17	routinely	routinely	ADV
ajlm-2505	27	18	measured	measure	VERB
ajlm-2505	27	19	total	total	ADJ
ajlm-2505	27	20	protein	protein	NOUN
ajlm-2505	27	21	and	and	CCONJ
ajlm-2505	27	22	albumin	albumin	ADJ
ajlm-2505	27	23	concentrations	concentration	NOUN
ajlm-2505	27	24	,	,	PUNCT
ajlm-2505	27	25	have	have	AUX
ajlm-2505	27	26	been	be	AUX
ajlm-2505	27	27	used	use	VERB
ajlm-2505	27	28	as	as	ADP
ajlm-2505	27	29	clinical	clinical	ADJ
ajlm-2505	27	30	screening	screening	NOUN
ajlm-2505	27	31	tools	tool	NOUN
ajlm-2505	27	32	for	for	ADP
ajlm-2505	27	33	monoclonal	monoclonal	NOUN
ajlm-2505	27	34	gammopathies.9,10,11	gammopathies.9,10,11	NOUN
ajlm-2505	27	35	their	their	PRON
ajlm-2505	27	36	low	low	ADJ
ajlm-2505	27	37	cost	cost	NOUN
ajlm-2505	27	38	and	and	CCONJ
ajlm-2505	27	39	ease	ease	NOUN
ajlm-2505	27	40	of	of	ADP
ajlm-2505	27	41	calculation	calculation	NOUN
ajlm-2505	27	42	make	make	VERB
ajlm-2505	27	43	them	they	PRON
ajlm-2505	27	44	appealing	appealing	ADJ
ajlm-2505	27	45	options	option	NOUN
ajlm-2505	27	46	.	.	PUNCT
ajlm-2505	28	1	however	however	ADV
ajlm-2505	28	2	,	,	PUNCT
ajlm-2505	28	3	their	their	PRON
ajlm-2505	28	4	diagnostic	diagnostic	ADJ
ajlm-2505	28	5	performance	performance	NOUN
ajlm-2505	28	6	,	,	PUNCT
ajlm-2505	28	7	particularly	particularly	ADV
ajlm-2505	28	8	across	across	ADP
ajlm-2505	28	9	diverse	diverse	ADJ
ajlm-2505	28	10	populations	population	NOUN
ajlm-2505	28	11	,	,	PUNCT
ajlm-2505	28	12	remains	remains	AUX
ajlm-2505	28	13	inadequately	inadequately	ADV
ajlm-2505	28	14	established	establish	VERB
ajlm-2505	28	15	.	.	PUNCT
ajlm-2505	29	1	additionally	additionally	ADV
ajlm-2505	29	2	,	,	PUNCT
ajlm-2505	29	3	chronic	chronic	ADJ
ajlm-2505	29	4	infections	infection	NOUN
ajlm-2505	29	5	,	,	PUNCT
ajlm-2505	29	6	inflammatory	inflammatory	ADJ
ajlm-2505	29	7	conditions	condition	NOUN
ajlm-2505	29	8	,	,	PUNCT
ajlm-2505	29	9	and	and	CCONJ
ajlm-2505	29	10	malnutrition	malnutrition	NOUN
ajlm-2505	29	11	can	can	AUX
ajlm-2505	29	12	influence	influence	VERB
ajlm-2505	29	13	the	the	DET
ajlm-2505	29	14	gamma	gamma	NOUN
ajlm-2505	29	15	gap	gap	NOUN
ajlm-2505	29	16	and	and	CCONJ
ajlm-2505	29	17	agr	agr	NOUN
ajlm-2505	29	18	,	,	PUNCT
ajlm-2505	29	19	leading	lead	VERB
ajlm-2505	29	20	to	to	PART
ajlm-2505	29	21	inaccurate	inaccurate	VERB
ajlm-2505	29	22	results.12,13,14	results.12,13,14	ADV
ajlm-2505	29	23	in	in	ADP
ajlm-2505	29	24	regions	region	NOUN
ajlm-2505	29	25	such	such	ADJ
ajlm-2505	29	26	as	as	ADP
ajlm-2505	29	27	sub	sub	ADJ
ajlm-2505	29	28	-	-	ADJ
ajlm-2505	29	29	saharan	saharan	ADJ
ajlm-2505	29	30	africa	africa	PROPN
ajlm-2505	29	31	,	,	PUNCT
ajlm-2505	29	32	where	where	SCONJ
ajlm-2505	29	33	the	the	DET
ajlm-2505	29	34	burden	burden	NOUN
ajlm-2505	29	35	of	of	ADP
ajlm-2505	29	36	infectious	infectious	ADJ
ajlm-2505	29	37	and	and	CCONJ
ajlm-2505	29	38	inflammatory	inflammatory	ADJ
ajlm-2505	29	39	diseases	disease	NOUN
ajlm-2505	29	40	is	be	AUX
ajlm-2505	29	41	high	high	ADJ
ajlm-2505	29	42	,	,	PUNCT
ajlm-2505	29	43	the	the	DET
ajlm-2505	29	44	gamma	gamma	NOUN
ajlm-2505	29	45	gap	gap	NOUN
ajlm-2505	29	46	and	and	CCONJ
ajlm-2505	29	47	agr	agr	NOUN
ajlm-2505	29	48	may	may	AUX
ajlm-2505	29	49	perform	perform	VERB
ajlm-2505	29	50	poorly	poorly	ADV
ajlm-2505	29	51	as	as	ADP
ajlm-2505	29	52	screening	screen	VERB
ajlm-2505	29	53	tools	tool	NOUN
ajlm-2505	29	54	.	.	PUNCT
ajlm-2505	30	1	south	south	PROPN
ajlm-2505	30	2	africa	africa	PROPN
ajlm-2505	30	3	faces	face	VERB
ajlm-2505	30	4	a	a	DET
ajlm-2505	30	5	significant	significant	ADJ
ajlm-2505	30	6	burden	burden	NOUN
ajlm-2505	30	7	of	of	ADP
ajlm-2505	30	8	infectious	infectious	ADJ
ajlm-2505	30	9	and	and	CCONJ
ajlm-2505	30	10	inflammatory	inflammatory	ADJ
ajlm-2505	30	11	diseases	disease	NOUN
ajlm-2505	30	12	,	,	PUNCT
ajlm-2505	30	13	including	include	VERB
ajlm-2505	30	14	high	high	ADJ
ajlm-2505	30	15	rates	rate	NOUN
ajlm-2505	30	16	of	of	ADP
ajlm-2505	30	17	hiv	hiv	PROPN
ajlm-2505	30	18	,	,	PUNCT
ajlm-2505	30	19	tuberculosis	tuberculosis	NOUN
ajlm-2505	30	20	,	,	PUNCT
ajlm-2505	30	21	viral	viral	ADJ
ajlm-2505	30	22	hepatitis	hepatitis	NOUN
ajlm-2505	30	23	,	,	PUNCT
ajlm-2505	30	24	and	and	CCONJ
ajlm-2505	30	25	other	other	ADJ
ajlm-2505	30	26	chronic	chronic	ADJ
ajlm-2505	30	27	infections.15,16	infections.15,16	NOUN
ajlm-2505	30	28	this	this	PRON
ajlm-2505	30	29	can	can	AUX
ajlm-2505	30	30	result	result	VERB
ajlm-2505	30	31	in	in	ADP
ajlm-2505	30	32	missed	miss	VERB
ajlm-2505	30	33	true	true	ADJ
ajlm-2505	30	34	cases	case	NOUN
ajlm-2505	30	35	,	,	PUNCT
ajlm-2505	30	36	delayed	delay	VERB
ajlm-2505	30	37	diagnoses	diagnosis	NOUN
ajlm-2505	30	38	,	,	PUNCT
ajlm-2505	30	39	or	or	CCONJ
ajlm-2505	30	40	wasted	waste	VERB
ajlm-2505	30	41	healthcare	healthcare	NOUN
ajlm-2505	30	42	resources	resource	NOUN
ajlm-2505	30	43	resulting	result	VERB
ajlm-2505	30	44	from	from	ADP
ajlm-2505	30	45	unnecessary	unnecessary	ADJ
ajlm-2505	30	46	investigations	investigation	NOUN
ajlm-2505	30	47	and	and	CCONJ
ajlm-2505	30	48	follow	follow	VERB
ajlm-2505	30	49	-	-	PUNCT
ajlm-2505	30	50	up	up	NOUN
ajlm-2505	30	51	for	for	ADP
ajlm-2505	30	52	false	false	ADJ
ajlm-2505	30	53	positives	positive	NOUN
ajlm-2505	30	54	,	,	PUNCT
ajlm-2505	30	55	limiting	limit	VERB
ajlm-2505	30	56	the	the	DET
ajlm-2505	30	57	tools	tool	NOUN
ajlm-2505	30	58	’	'	PUNCT
ajlm-2505	30	59	effectiveness	effectiveness	NOUN
ajlm-2505	30	60	.	.	PUNCT
ajlm-2505	31	1	understanding	understand	VERB
ajlm-2505	31	2	these	these	DET
ajlm-2505	31	3	limitations	limitation	NOUN
ajlm-2505	31	4	is	be	AUX
ajlm-2505	31	5	crucial	crucial	ADJ
ajlm-2505	31	6	to	to	ADP
ajlm-2505	31	7	avoiding	avoid	VERB
ajlm-2505	31	8	misdiagnoses	misdiagnose	NOUN
ajlm-2505	31	9	and	and	CCONJ
ajlm-2505	31	10	to	to	ADP
ajlm-2505	31	11	optimising	optimise	VERB
ajlm-2505	31	12	healthcare	healthcare	NOUN
ajlm-2505	31	13	resources	resource	NOUN
ajlm-2505	31	14	in	in	ADP
ajlm-2505	31	15	already	already	ADV
ajlm-2505	31	16	overburdened	overburden	VERB
ajlm-2505	31	17	systems	system	NOUN
ajlm-2505	31	18	.	.	PUNCT
ajlm-2505	32	1	assessing	assess	VERB
ajlm-2505	32	2	the	the	DET
ajlm-2505	32	3	performance	performance	NOUN
ajlm-2505	32	4	of	of	ADP
ajlm-2505	32	5	screening	screening	NOUN
ajlm-2505	32	6	and	and	CCONJ
ajlm-2505	32	7	diagnostic	diagnostic	ADJ
ajlm-2505	32	8	tools	tool	NOUN
ajlm-2505	32	9	is	be	AUX
ajlm-2505	32	10	crucial	crucial	ADJ
ajlm-2505	32	11	to	to	ADP
ajlm-2505	32	12	guiding	guide	VERB
ajlm-2505	32	13	their	their	PRON
ajlm-2505	32	14	clinical	clinical	ADJ
ajlm-2505	32	15	use	use	NOUN
ajlm-2505	32	16	and	and	CCONJ
ajlm-2505	32	17	to	to	PART
ajlm-2505	32	18	support	support	VERB
ajlm-2505	32	19	the	the	DET
ajlm-2505	32	20	development	development	NOUN
ajlm-2505	32	21	of	of	ADP
ajlm-2505	32	22	more	more	ADV
ajlm-2505	32	23	reliable	reliable	ADJ
ajlm-2505	32	24	methods	method	NOUN
ajlm-2505	32	25	.	.	PUNCT
ajlm-2505	33	1	this	this	DET
ajlm-2505	33	2	study	study	NOUN
ajlm-2505	33	3	aimed	aim	VERB
ajlm-2505	33	4	to	to	PART
ajlm-2505	33	5	evaluate	evaluate	VERB
ajlm-2505	33	6	the	the	DET
ajlm-2505	33	7	diagnostic	diagnostic	ADJ
ajlm-2505	33	8	accuracy	accuracy	NOUN
ajlm-2505	33	9	of	of	ADP
ajlm-2505	33	10	the	the	DET
ajlm-2505	33	11	gamma	gamma	NOUN
ajlm-2505	33	12	gap	gap	NOUN
ajlm-2505	33	13	and	and	CCONJ
ajlm-2505	33	14	agr	agr	NOUN
ajlm-2505	33	15	in	in	ADP
ajlm-2505	33	16	identifying	identify	VERB
ajlm-2505	33	17	patients	patient	NOUN
ajlm-2505	33	18	who	who	PRON
ajlm-2505	33	19	required	require	VERB
ajlm-2505	33	20	further	further	ADJ
ajlm-2505	33	21	investigation	investigation	NOUN
ajlm-2505	33	22	for	for	ADP
ajlm-2505	33	23	monoclonal	monoclonal	NOUN
ajlm-2505	33	24	gammopathies	gammopathy	NOUN
ajlm-2505	33	25	in	in	ADP
ajlm-2505	33	26	a	a	DET
ajlm-2505	33	27	population	population	NOUN
ajlm-2505	33	28	burdened	burden	VERB
ajlm-2505	33	29	by	by	ADP
ajlm-2505	33	30	inflammatory	inflammatory	ADJ
ajlm-2505	33	31	and	and	CCONJ
ajlm-2505	33	32	infectious	infectious	ADJ
ajlm-2505	33	33	diseases	disease	NOUN
ajlm-2505	33	34	.	.	PUNCT
ajlm-2505	34	1	we	we	PRON
ajlm-2505	34	2	hypothesised	hypothesise	VERB
ajlm-2505	34	3	that	that	SCONJ
ajlm-2505	34	4	the	the	DET
ajlm-2505	34	5	two	two	NUM
ajlm-2505	34	6	metrics	metric	NOUN
ajlm-2505	34	7	would	would	AUX
ajlm-2505	34	8	perform	perform	VERB
ajlm-2505	34	9	poorly	poorly	ADV
ajlm-2505	34	10	within	within	ADP
ajlm-2505	34	11	this	this	DET
ajlm-2505	34	12	population	population	NOUN
ajlm-2505	34	13	.	.	PUNCT
ajlm-2505	35	1	methods	method	NOUN
ajlm-2505	35	2	ethical	ethical	ADJ
ajlm-2505	35	3	considerations	consideration	NOUN
ajlm-2505	35	4	ethical	ethical	ADJ
ajlm-2505	35	5	approval	approval	NOUN
ajlm-2505	35	6	was	be	AUX
ajlm-2505	35	7	obtained	obtain	VERB
ajlm-2505	35	8	from	from	ADP
ajlm-2505	35	9	the	the	DET
ajlm-2505	35	10	human	human	ADJ
ajlm-2505	35	11	research	research	PROPN
ajlm-2505	35	12	ethics	ethic	NOUN
ajlm-2505	35	13	committee	committee	PROPN
ajlm-2505	35	14	of	of	ADP
ajlm-2505	35	15	the	the	DET
ajlm-2505	35	16	university	university	PROPN
ajlm-2505	35	17	of	of	ADP
ajlm-2505	35	18	cape	cape	NOUN
ajlm-2505	35	19	town	town	NOUN
ajlm-2505	35	20	(	(	PUNCT
ajlm-2505	35	21	reference	reference	NOUN
ajlm-2505	35	22	no	no	INTJ
ajlm-2505	35	23	.	.	PUNCT
ajlm-2505	36	1	hrec	hrec	NOUN
ajlm-2505	36	2	:	:	PUNCT
ajlm-2505	36	3	589/2023	589/2023	NUM
ajlm-2505	36	4	)	)	PUNCT
ajlm-2505	36	5	.	.	PUNCT
ajlm-2505	37	1	data	datum	NOUN
ajlm-2505	37	2	for	for	ADP
ajlm-2505	37	3	this	this	DET
ajlm-2505	37	4	study	study	NOUN
ajlm-2505	37	5	were	be	AUX
ajlm-2505	37	6	managed	manage	VERB
ajlm-2505	37	7	in	in	ADP
ajlm-2505	37	8	accordance	accordance	NOUN
ajlm-2505	37	9	with	with	ADP
ajlm-2505	37	10	the	the	DET
ajlm-2505	37	11	data	data	NOUN
ajlm-2505	37	12	management	management	NOUN
ajlm-2505	37	13	plan	plan	NOUN
ajlm-2505	37	14	,	,	PUNCT
ajlm-2505	37	15	adhering	adhere	VERB
ajlm-2505	37	16	to	to	ADP
ajlm-2505	37	17	data	data	NOUN
ajlm-2505	37	18	protection	protection	NOUN
ajlm-2505	37	19	and	and	CCONJ
ajlm-2505	37	20	privacy	privacy	NOUN
ajlm-2505	37	21	regulations	regulation	NOUN
ajlm-2505	37	22	.	.	PUNCT
ajlm-2505	38	1	only	only	ADV
ajlm-2505	38	2	data	datum	NOUN
ajlm-2505	38	3	required	require	VERB
ajlm-2505	38	4	for	for	ADP
ajlm-2505	38	5	analysis	analysis	NOUN
ajlm-2505	38	6	were	be	AUX
ajlm-2505	38	7	extracted	extract	VERB
ajlm-2505	38	8	and	and	CCONJ
ajlm-2505	38	9	securely	securely	ADV
ajlm-2505	38	10	stored	store	VERB
ajlm-2505	38	11	,	,	PUNCT
ajlm-2505	38	12	and	and	CCONJ
ajlm-2505	38	13	access	access	NOUN
ajlm-2505	38	14	was	be	AUX
ajlm-2505	38	15	limited	limit	VERB
ajlm-2505	38	16	to	to	ADP
ajlm-2505	38	17	authors	author	NOUN
ajlm-2505	38	18	.	.	PUNCT
ajlm-2505	39	1	informed	inform	VERB
ajlm-2505	39	2	consent	consent	NOUN
ajlm-2505	39	3	for	for	ADP
ajlm-2505	39	4	individual	individual	ADJ
ajlm-2505	39	5	inclusion	inclusion	NOUN
ajlm-2505	39	6	was	be	AUX
ajlm-2505	39	7	waived	waive	VERB
ajlm-2505	39	8	because	because	SCONJ
ajlm-2505	39	9	of	of	ADP
ajlm-2505	39	10	the	the	DET
ajlm-2505	39	11	use	use	NOUN
ajlm-2505	39	12	of	of	ADP
ajlm-2505	39	13	data	datum	NOUN
ajlm-2505	39	14	for	for	ADP
ajlm-2505	39	15	secondary	secondary	ADJ
ajlm-2505	39	16	research	research	NOUN
ajlm-2505	39	17	purposes.17	purposes.17	PROPN
ajlm-2505	39	18	the	the	DET
ajlm-2505	39	19	study	study	NOUN
ajlm-2505	39	20	adhered	adhere	VERB
ajlm-2505	39	21	to	to	ADP
ajlm-2505	39	22	international	international	ADJ
ajlm-2505	39	23	ethical	ethical	ADJ
ajlm-2505	39	24	standards	standard	NOUN
ajlm-2505	39	25	,	,	PUNCT
ajlm-2505	39	26	including	include	VERB
ajlm-2505	39	27	the	the	DET
ajlm-2505	39	28	declaration	declaration	NOUN
ajlm-2505	39	29	of	of	ADP
ajlm-2505	39	30	helsinki	helsinki	PROPN
ajlm-2505	39	31	.	.	PUNCT
ajlm-2505	40	1	study	study	NOUN
ajlm-2505	40	2	design	design	VERB
ajlm-2505	40	3	this	this	DET
ajlm-2505	40	4	retrospective	retrospective	ADJ
ajlm-2505	40	5	,	,	PUNCT
ajlm-2505	40	6	observational	observational	ADJ
ajlm-2505	40	7	study	study	NOUN
ajlm-2505	40	8	evaluated	evaluate	VERB
ajlm-2505	40	9	the	the	DET
ajlm-2505	40	10	diagnostic	diagnostic	ADJ
ajlm-2505	40	11	accuracy	accuracy	NOUN
ajlm-2505	40	12	of	of	ADP
ajlm-2505	40	13	the	the	DET
ajlm-2505	40	14	gamma	gamma	NOUN
ajlm-2505	40	15	gap	gap	NOUN
ajlm-2505	40	16	and	and	CCONJ
ajlm-2505	40	17	agr	agr	NOUN
ajlm-2505	40	18	in	in	ADP
ajlm-2505	40	19	classifying	classify	VERB
ajlm-2505	40	20	patients	patient	NOUN
ajlm-2505	40	21	with	with	ADP
ajlm-2505	40	22	suspected	suspect	VERB
ajlm-2505	40	23	monoclonal	monoclonal	NOUN
ajlm-2505	40	24	gammopathies	gammopathy	NOUN
ajlm-2505	40	25	,	,	PUNCT
ajlm-2505	40	26	with	with	ADP
ajlm-2505	40	27	the	the	DET
ajlm-2505	40	28	goal	goal	NOUN
ajlm-2505	40	29	of	of	ADP
ajlm-2505	40	30	determining	determine	VERB
ajlm-2505	40	31	their	their	PRON
ajlm-2505	40	32	effectiveness	effectiveness	NOUN
ajlm-2505	40	33	as	as	ADP
ajlm-2505	40	34	screening	screen	VERB
ajlm-2505	40	35	tools	tool	NOUN
ajlm-2505	40	36	in	in	ADP
ajlm-2505	40	37	a	a	DET
ajlm-2505	40	38	real	real	ADJ
ajlm-2505	40	39	-	-	PUNCT
ajlm-2505	40	40	world	world	NOUN
ajlm-2505	40	41	clinical	clinical	ADJ
ajlm-2505	40	42	setting	setting	NOUN
ajlm-2505	40	43	.	.	PUNCT
ajlm-2505	41	1	setting	set	VERB
ajlm-2505	41	2	groote	groote	PROPN
ajlm-2505	41	3	schuur	schuur	PROPN
ajlm-2505	41	4	hospital	hospital	NOUN
ajlm-2505	41	5	is	be	AUX
ajlm-2505	41	6	an	an	DET
ajlm-2505	41	7	893	893	NUM
ajlm-2505	41	8	-	-	PUNCT
ajlm-2505	41	9	bed	bed	NOUN
ajlm-2505	41	10	tertiary	tertiary	ADJ
ajlm-2505	41	11	teaching	teaching	NOUN
ajlm-2505	41	12	hospital	hospital	NOUN
ajlm-2505	41	13	in	in	ADP
ajlm-2505	41	14	cape	cape	NOUN
ajlm-2505	41	15	town	town	NOUN
ajlm-2505	41	16	,	,	PUNCT
ajlm-2505	41	17	south	south	PROPN
ajlm-2505	41	18	africa	africa	PROPN
ajlm-2505	41	19	.	.	PUNCT
ajlm-2505	42	1	the	the	DET
ajlm-2505	42	2	hospital	hospital	NOUN
ajlm-2505	42	3	’s	’s	PART
ajlm-2505	42	4	national	national	PROPN
ajlm-2505	42	5	health	health	PROPN
ajlm-2505	42	6	laboratory	laboratory	PROPN
ajlm-2505	42	7	service	service	PROPN
ajlm-2505	42	8	laboratory	laboratory	NOUN
ajlm-2505	42	9	is	be	AUX
ajlm-2505	42	10	accredited	accredit	VERB
ajlm-2505	42	11	to	to	ADP
ajlm-2505	42	12	the	the	DET
ajlm-2505	42	13	iso	iso	PROPN
ajlm-2505	42	14	15189	15189	NUM
ajlm-2505	42	15	standard	standard	NOUN
ajlm-2505	42	16	,	,	PUNCT
ajlm-2505	42	17	affiliated	affiliate	VERB
ajlm-2505	42	18	with	with	ADP
ajlm-2505	42	19	the	the	DET
ajlm-2505	42	20	university	university	PROPN
ajlm-2505	42	21	of	of	ADP
ajlm-2505	42	22	cape	cape	NOUN
ajlm-2505	42	23	town	town	NOUN
ajlm-2505	42	24	,	,	PUNCT
ajlm-2505	42	25	and	and	CCONJ
ajlm-2505	42	26	provides	provide	VERB
ajlm-2505	42	27	extensive	extensive	ADJ
ajlm-2505	42	28	testing	testing	NOUN
ajlm-2505	42	29	for	for	ADP
ajlm-2505	42	30	monoclonal	monoclonal	NOUN
ajlm-2505	42	31	gammopathies	gammopathy	NOUN
ajlm-2505	42	32	for	for	ADP
ajlm-2505	42	33	the	the	DET
ajlm-2505	42	34	public	public	ADJ
ajlm-2505	42	35	sector	sector	NOUN
ajlm-2505	42	36	.	.	PUNCT
ajlm-2505	43	1	data	datum	NOUN
ajlm-2505	43	2	collection	collection	NOUN
ajlm-2505	43	3	the	the	DET
ajlm-2505	43	4	data	datum	NOUN
ajlm-2505	43	5	used	use	VERB
ajlm-2505	43	6	in	in	ADP
ajlm-2505	43	7	this	this	DET
ajlm-2505	43	8	study	study	NOUN
ajlm-2505	43	9	were	be	AUX
ajlm-2505	43	10	extracted	extract	VERB
ajlm-2505	43	11	from	from	ADP
ajlm-2505	43	12	the	the	DET
ajlm-2505	43	13	monoclonal	monoclonal	NOUN
ajlm-2505	43	14	gammopathy	gammopathy	ADJ
ajlm-2505	43	15	research	research	NOUN
ajlm-2505	43	16	group	group	NOUN
ajlm-2505	43	17	–	–	PUNCT
ajlm-2505	43	18	university	university	NOUN
ajlm-2505	43	19	of	of	ADP
ajlm-2505	43	20	cape	cape	NOUN
ajlm-2505	43	21	town	town	NOUN
ajlm-2505	43	22	database	database	NOUN
ajlm-2505	43	23	(	(	PUNCT
ajlm-2505	43	24	hrec	hrec	NOUN
ajlm-2505	43	25	:	:	PUNCT
ajlm-2505	43	26	r042/2022	r042/2022	PROPN
ajlm-2505	43	27	)	)	PUNCT
ajlm-2505	43	28	for	for	ADP
ajlm-2505	43	29	subsequent	subsequent	ADJ
ajlm-2505	43	30	analysis	analysis	NOUN
ajlm-2505	43	31	.	.	PUNCT
ajlm-2505	44	1	study	study	NOUN
ajlm-2505	44	2	population	population	NOUN
ajlm-2505	44	3	the	the	DET
ajlm-2505	44	4	database	database	NOUN
ajlm-2505	44	5	comprised	comprise	VERB
ajlm-2505	44	6	de	de	ADV
ajlm-2505	44	7	-	-	VERB
ajlm-2505	44	8	identified	identify	VERB
ajlm-2505	44	9	retrospective	retrospective	ADJ
ajlm-2505	44	10	data	datum	NOUN
ajlm-2505	44	11	for	for	ADP
ajlm-2505	44	12	adult	adult	NOUN
ajlm-2505	44	13	patients	patient	NOUN
ajlm-2505	44	14	(	(	PUNCT
ajlm-2505	44	15	≥	≥	NOUN
ajlm-2505	44	16	18	18	NUM
ajlm-2505	44	17	years	year	NOUN
ajlm-2505	44	18	)	)	PUNCT
ajlm-2505	44	19	who	who	PRON
ajlm-2505	44	20	underwent	undergo	VERB
ajlm-2505	44	21	investigations	investigation	NOUN
ajlm-2505	44	22	for	for	ADP
ajlm-2505	44	23	monoclonal	monoclonal	NOUN
ajlm-2505	44	24	gammopathies	gammopathy	NOUN
ajlm-2505	44	25	in	in	ADP
ajlm-2505	44	26	our	our	PRON
ajlm-2505	44	27	laboratory	laboratory	NOUN
ajlm-2505	44	28	.	.	PUNCT
ajlm-2505	45	1	the	the	DET
ajlm-2505	45	2	data	data	PROPN
ajlm-2505	45	3	,	,	PUNCT
ajlm-2505	45	4	sourced	source	VERB
ajlm-2505	45	5	from	from	ADP
ajlm-2505	45	6	the	the	DET
ajlm-2505	45	7	laboratory	laboratory	NOUN
ajlm-2505	45	8	information	information	NOUN
ajlm-2505	45	9	system	system	NOUN
ajlm-2505	45	10	and	and	CCONJ
ajlm-2505	45	11	analysers	analyser	NOUN
ajlm-2505	45	12	,	,	PUNCT
ajlm-2505	45	13	included	include	VERB
ajlm-2505	45	14	basic	basic	ADJ
ajlm-2505	45	15	demographics	demographic	NOUN
ajlm-2505	45	16	(	(	PUNCT
ajlm-2505	45	17	age	age	NOUN
ajlm-2505	45	18	and	and	CCONJ
ajlm-2505	45	19	sex	sex	NOUN
ajlm-2505	45	20	)	)	PUNCT
ajlm-2505	45	21	and	and	CCONJ
ajlm-2505	45	22	results	result	NOUN
ajlm-2505	45	23	from	from	ADP
ajlm-2505	45	24	spe	spe	PROPN
ajlm-2505	45	25	,	,	PUNCT
ajlm-2505	45	26	immunofixation	immunofixation	NOUN
ajlm-2505	45	27	,	,	PUNCT
ajlm-2505	45	28	total	total	ADJ
ajlm-2505	45	29	protein	protein	NOUN
ajlm-2505	45	30	,	,	PUNCT
ajlm-2505	45	31	and	and	CCONJ
ajlm-2505	45	32	albumin	albumin	NOUN
ajlm-2505	45	33	conducted	conduct	VERB
ajlm-2505	45	34	from	from	ADP
ajlm-2505	45	35	01	01	NUM
ajlm-2505	45	36	september	september	PROPN
ajlm-2505	45	37	2015	2015	NUM
ajlm-2505	45	38	to	to	ADP
ajlm-2505	45	39	30	30	NUM
ajlm-2505	45	40	september	september	PROPN
ajlm-2505	45	41	2022	2022	NUM
ajlm-2505	45	42	.	.	PUNCT
ajlm-2505	46	1	all	all	DET
ajlm-2505	46	2	patients	patient	NOUN
ajlm-2505	46	3	with	with	ADP
ajlm-2505	46	4	complete	complete	ADJ
ajlm-2505	46	5	biochemical	biochemical	ADJ
ajlm-2505	46	6	data	datum	NOUN
ajlm-2505	46	7	were	be	AUX
ajlm-2505	46	8	considered	consider	VERB
ajlm-2505	46	9	for	for	ADP
ajlm-2505	46	10	inclusion	inclusion	NOUN
ajlm-2505	46	11	.	.	PUNCT
ajlm-2505	47	1	exclusion	exclusion	NOUN
ajlm-2505	47	2	criteria	criterion	NOUN
ajlm-2505	47	3	included	include	VERB
ajlm-2505	47	4	missing	miss	VERB
ajlm-2505	47	5	data	datum	NOUN
ajlm-2505	47	6	or	or	CCONJ
ajlm-2505	47	7	equivocal	equivocal	ADJ
ajlm-2505	47	8	immunofixation	immunofixation	NOUN
ajlm-2505	47	9	results	result	NOUN
ajlm-2505	47	10	,	,	PUNCT
ajlm-2505	47	11	necessary	necessary	ADJ
ajlm-2505	47	12	to	to	PART
ajlm-2505	47	13	classify	classify	VERB
ajlm-2505	47	14	patients	patient	NOUN
ajlm-2505	47	15	into	into	ADP
ajlm-2505	47	16	two	two	NUM
ajlm-2505	47	17	outcome	outcome	NOUN
ajlm-2505	47	18	groups	group	NOUN
ajlm-2505	47	19	.	.	PUNCT
ajlm-2505	48	1	cancelled	cancel	VERB
ajlm-2505	48	2	tests	test	NOUN
ajlm-2505	48	3	,	,	PUNCT
ajlm-2505	48	4	duplicate	duplicate	NOUN
ajlm-2505	48	5	tests	test	NOUN
ajlm-2505	48	6	,	,	PUNCT
ajlm-2505	48	7	and	and	CCONJ
ajlm-2505	48	8	follow	follow	VERB
ajlm-2505	48	9	-	-	PUNCT
ajlm-2505	48	10	up	up	ADP
ajlm-2505	48	11	visits	visit	NOUN
ajlm-2505	48	12	were	be	AUX
ajlm-2505	48	13	also	also	ADV
ajlm-2505	48	14	excluded	exclude	VERB
ajlm-2505	48	15	to	to	PART
ajlm-2505	48	16	prevent	prevent	VERB
ajlm-2505	48	17	verification	verification	NOUN
ajlm-2505	48	18	or	or	CCONJ
ajlm-2505	48	19	spectrum	spectrum	NOUN
ajlm-2505	48	20	bias	bias	NOUN
ajlm-2505	48	21	.	.	PUNCT
ajlm-2505	49	1	hypogammaglobulinaemic	hypogammaglobulinaemic	ADJ
ajlm-2505	49	2	patients	patient	NOUN
ajlm-2505	49	3	underwent	undergo	VERB
ajlm-2505	49	4	routine	routine	ADJ
ajlm-2505	49	5	immunofixation	immunofixation	NOUN
ajlm-2505	49	6	to	to	PART
ajlm-2505	49	7	rule	rule	VERB
ajlm-2505	49	8	out	out	ADP
ajlm-2505	49	9	small	small	ADJ
ajlm-2505	49	10	but	but	CCONJ
ajlm-2505	49	11	clinically	clinically	ADV
ajlm-2505	49	12	significant	significant	ADJ
ajlm-2505	49	13	monoclonal	monoclonal	NOUN
ajlm-2505	49	14	proteins	protein	NOUN
ajlm-2505	49	15	or	or	CCONJ
ajlm-2505	49	16	interference	interference	NOUN
ajlm-2505	49	17	.	.	PUNCT
ajlm-2505	50	1	these	these	DET
ajlm-2505	50	2	samples	sample	NOUN
ajlm-2505	50	3	were	be	AUX
ajlm-2505	50	4	included	include	VERB
ajlm-2505	50	5	in	in	ADP
ajlm-2505	50	6	primary	primary	ADJ
ajlm-2505	50	7	analysis	analysis	NOUN
ajlm-2505	50	8	but	but	CCONJ
ajlm-2505	50	9	were	be	AUX
ajlm-2505	50	10	excluded	exclude	VERB
ajlm-2505	50	11	in	in	ADP
ajlm-2505	50	12	sub	sub	ADJ
ajlm-2505	50	13	-	-	NOUN
ajlm-2505	50	14	group	group	NOUN
ajlm-2505	50	15	analysis	analysis	NOUN
ajlm-2505	50	16	for	for	ADP
ajlm-2505	50	17	comparison	comparison	NOUN
ajlm-2505	50	18	.	.	PUNCT
ajlm-2505	51	1	laboratory	laboratory	NOUN
ajlm-2505	51	2	analyses	analysis	NOUN
ajlm-2505	51	3	data	datum	NOUN
ajlm-2505	51	4	were	be	AUX
ajlm-2505	51	5	generated	generate	VERB
ajlm-2505	51	6	using	use	VERB
ajlm-2505	51	7	routine	routine	ADJ
ajlm-2505	51	8	clinical	clinical	ADJ
ajlm-2505	51	9	laboratory	laboratory	NOUN
ajlm-2505	51	10	analysers	analyser	NOUN
ajlm-2505	51	11	and	and	CCONJ
ajlm-2505	51	12	methods	method	NOUN
ajlm-2505	51	13	.	.	PUNCT
ajlm-2505	52	1	the	the	DET
ajlm-2505	52	2	spe	spe	PROPN
ajlm-2505	52	3	was	be	AUX
ajlm-2505	52	4	performed	perform	VERB
ajlm-2505	52	5	using	use	VERB
ajlm-2505	52	6	capillary	capillary	ADJ
ajlm-2505	52	7	zone	zone	NOUN
ajlm-2505	52	8	electrophoresis	electrophoresis	NOUN
ajlm-2505	52	9	on	on	ADP
ajlm-2505	52	10	the	the	DET
ajlm-2505	52	11	minicap	minicap	NOUN
ajlm-2505	52	12	,	,	PUNCT
ajlm-2505	52	13	and	and	CCONJ
ajlm-2505	52	14	immunofixation	immunofixation	NOUN
ajlm-2505	52	15	was	be	AUX
ajlm-2505	52	16	performed	perform	VERB
ajlm-2505	52	17	using	use	VERB
ajlm-2505	52	18	agarose	agarose	NOUN
ajlm-2505	52	19	gel	gel	NOUN
ajlm-2505	52	20	electrophoresis	electrophoresis	NOUN
ajlm-2505	52	21	on	on	ADP
ajlm-2505	52	22	the	the	DET
ajlm-2505	52	23	hydrasys	hydrasys	NOUN
ajlm-2505	52	24	2	2	NUM
ajlm-2505	52	25	(	(	PUNCT
ajlm-2505	52	26	both	both	CCONJ
ajlm-2505	52	27	sebia	sebia	ADJ
ajlm-2505	52	28	,	,	PUNCT
ajlm-2505	52	29	lisses	lisse	NOUN
ajlm-2505	52	30	,	,	PUNCT
ajlm-2505	52	31	france	france	PROPN
ajlm-2505	52	32	)	)	PUNCT
ajlm-2505	52	33	.	.	PUNCT
ajlm-2505	53	1	albumin	albumin	NOUN
ajlm-2505	53	2	and	and	CCONJ
ajlm-2505	53	3	total	total	ADJ
ajlm-2505	53	4	protein	protein	NOUN
ajlm-2505	53	5	were	be	AUX
ajlm-2505	53	6	measured	measure	VERB
ajlm-2505	53	7	on	on	ADP
ajlm-2505	53	8	the	the	DET
ajlm-2505	53	9	roche	roche	PROPN
ajlm-2505	53	10	cobas	cobas	PROPN
ajlm-2505	53	11	©	©	PROPN
ajlm-2505	53	12	6000	6000	NUM
ajlm-2505	53	13	analyser	analyser	NOUN
ajlm-2505	53	14	(	(	PUNCT
ajlm-2505	53	15	roche	roche	PROPN
ajlm-2505	53	16	diagnostics	diagnostic	NOUN
ajlm-2505	53	17	gmbh	gmbh	PROPN
ajlm-2505	53	18	,	,	PUNCT
ajlm-2505	53	19	mannheim	mannheim	PROPN
ajlm-2505	53	20	,	,	PUNCT
ajlm-2505	53	21	germany	germany	PROPN
ajlm-2505	53	22	)	)	PUNCT
ajlm-2505	53	23	with	with	ADP
ajlm-2505	53	24	a	a	DET
ajlm-2505	53	25	coefficient	coefficient	NOUN
ajlm-2505	53	26	of	of	ADP
ajlm-2505	53	27	variation	variation	NOUN
ajlm-2505	53	28	of	of	ADP
ajlm-2505	53	29	5.02	5.02	NUM
ajlm-2505	53	30	%	%	NOUN
ajlm-2505	53	31	for	for	ADP
ajlm-2505	53	32	albumin	albumin	NOUN
ajlm-2505	53	33	and	and	CCONJ
ajlm-2505	53	34	3.95	3.95	NUM
ajlm-2505	53	35	%	%	NOUN
ajlm-2505	53	36	for	for	ADP
ajlm-2505	53	37	total	total	ADJ
ajlm-2505	53	38	protein	protein	NOUN
ajlm-2505	53	39	.	.	PUNCT
ajlm-2505	54	1	the	the	DET
ajlm-2505	54	2	laboratory	laboratory	NOUN
ajlm-2505	54	3	processes	process	VERB
ajlm-2505	54	4	spe	spe	NOUN
ajlm-2505	54	5	requests	request	NOUN
ajlm-2505	54	6	from	from	ADP
ajlm-2505	54	7	clinicians	clinician	NOUN
ajlm-2505	54	8	,	,	PUNCT
ajlm-2505	54	9	and	and	CCONJ
ajlm-2505	54	10	immunofixation	immunofixation	NOUN
ajlm-2505	54	11	is	be	AUX
ajlm-2505	54	12	reflexively	reflexively	ADV
ajlm-2505	54	13	added	add	VERB
ajlm-2505	54	14	by	by	ADP
ajlm-2505	54	15	the	the	DET
ajlm-2505	54	16	pathologist	pathologist	NOUN
ajlm-2505	54	17	based	base	VERB
ajlm-2505	54	18	on	on	ADP
ajlm-2505	54	19	clinical	clinical	ADJ
ajlm-2505	54	20	and	and	CCONJ
ajlm-2505	54	21	biochemical	biochemical	ADJ
ajlm-2505	54	22	information	information	NOUN
ajlm-2505	54	23	,	,	PUNCT
ajlm-2505	54	24	detection	detection	NOUN
ajlm-2505	54	25	of	of	ADP
ajlm-2505	54	26	suspicious	suspicious	ADJ
ajlm-2505	54	27	peaks	peak	NOUN
ajlm-2505	54	28	,	,	PUNCT
ajlm-2505	54	29	or	or	CCONJ
ajlm-2505	54	30	the	the	DET
ajlm-2505	54	31	presence	presence	NOUN
ajlm-2505	54	32	of	of	ADP
ajlm-2505	54	33	hypogammaglobulinaemia	hypogammaglobulinaemia	NOUN
ajlm-2505	54	34	.	.	PUNCT
ajlm-2505	55	1	data	datum	NOUN
ajlm-2505	55	2	analysis	analysis	NOUN
ajlm-2505	55	3	the	the	DET
ajlm-2505	55	4	monoclonal	monoclonal	NOUN
ajlm-2505	55	5	gammopathy	gammopathy	ADJ
ajlm-2505	55	6	research	research	NOUN
ajlm-2505	55	7	group	group	NOUN
ajlm-2505	55	8	–	–	PUNCT
ajlm-2505	55	9	university	university	NOUN
ajlm-2505	55	10	of	of	ADP
ajlm-2505	55	11	cape	cape	NOUN
ajlm-2505	55	12	town	town	NOUN
ajlm-2505	55	13	database	database	NOUN
ajlm-2505	55	14	underwent	undergo	VERB
ajlm-2505	55	15	a	a	DET
ajlm-2505	55	16	curation	curation	NOUN
ajlm-2505	55	17	pipeline	pipeline	NOUN
ajlm-2505	55	18	for	for	ADP
ajlm-2505	55	19	checking	checking	NOUN
ajlm-2505	55	20	and	and	CCONJ
ajlm-2505	55	21	cleaning	clean	VERB
ajlm-2505	55	22	,	,	PUNCT
ajlm-2505	55	23	with	with	ADP
ajlm-2505	55	24	quality	quality	NOUN
ajlm-2505	55	25	control	control	NOUN
ajlm-2505	55	26	checks	check	NOUN
ajlm-2505	55	27	to	to	PART
ajlm-2505	55	28	ensure	ensure	VERB
ajlm-2505	55	29	accuracy	accuracy	NOUN
ajlm-2505	55	30	and	and	CCONJ
ajlm-2505	55	31	reliability	reliability	NOUN
ajlm-2505	55	32	for	for	ADP
ajlm-2505	55	33	this	this	DET
ajlm-2505	55	34	study	study	NOUN
ajlm-2505	55	35	.	.	PUNCT
ajlm-2505	56	1	statistical	statistical	ADJ
ajlm-2505	56	2	analyses	analysis	NOUN
ajlm-2505	56	3	were	be	AUX
ajlm-2505	56	4	performed	perform	VERB
ajlm-2505	56	5	using	use	VERB
ajlm-2505	56	6	python	python	NOUN
ajlm-2505	56	7	-	-	PUNCT
ajlm-2505	56	8	based	base	VERB
ajlm-2505	56	9	packages	package	NOUN
ajlm-2505	56	10	(	(	PUNCT
ajlm-2505	56	11	python	python	PROPN
ajlm-2505	56	12	software	software	PROPN
ajlm-2505	56	13	foundation	foundation	PROPN
ajlm-2505	56	14	,	,	PUNCT
ajlm-2505	56	15	beaverton	beaverton	PROPN
ajlm-2505	56	16	,	,	PUNCT
ajlm-2505	56	17	oregon	oregon	PROPN
ajlm-2505	56	18	,	,	PUNCT
ajlm-2505	56	19	united	united	PROPN
ajlm-2505	56	20	states	states	PROPN
ajlm-2505	56	21	)	)	PUNCT
ajlm-2505	56	22	in	in	ADP
ajlm-2505	56	23	pycharm	pycharm	PROPN
ajlm-2505	56	24	(	(	PUNCT
ajlm-2505	56	25	jetbrains	jetbrain	NOUN
ajlm-2505	56	26	,	,	PUNCT
ajlm-2505	56	27	prague	prague	NOUN
ajlm-2505	56	28	,	,	PUNCT
ajlm-2505	56	29	czech	czech	PROPN
ajlm-2505	56	30	republic	republic	NOUN
ajlm-2505	56	31	)	)	PUNCT
ajlm-2505	56	32	.	.	PUNCT
ajlm-2505	57	1	figure	figure	NOUN
ajlm-2505	57	2	1	1	NUM
ajlm-2505	57	3	shows	show	VERB
ajlm-2505	57	4	the	the	DET
ajlm-2505	57	5	flow	flow	NOUN
ajlm-2505	57	6	of	of	ADP
ajlm-2505	57	7	patients	patient	NOUN
ajlm-2505	57	8	,	,	PUNCT
ajlm-2505	57	9	and	and	CCONJ
ajlm-2505	57	10	the	the	DET
ajlm-2505	57	11	algorithm	algorithm	NOUN
ajlm-2505	57	12	used	use	VERB
ajlm-2505	57	13	to	to	PART
ajlm-2505	57	14	categorise	categorise	VERB
ajlm-2505	57	15	patients	patient	NOUN
ajlm-2505	57	16	into	into	ADP
ajlm-2505	57	17	two	two	NUM
ajlm-2505	57	18	groups	group	NOUN
ajlm-2505	57	19	(	(	PUNCT
ajlm-2505	57	20	‘	'	PUNCT
ajlm-2505	57	21	group	group	NOUN
ajlm-2505	57	22	0	0	NUM
ajlm-2505	57	23	’	'	PUNCT
ajlm-2505	58	1	[	[	X
ajlm-2505	58	2	no	no	DET
ajlm-2505	58	3	monoclonal	monoclonal	NOUN
ajlm-2505	58	4	protein	protein	NOUN
ajlm-2505	58	5	]	]	PUNCT
ajlm-2505	58	6	and	and	CCONJ
ajlm-2505	58	7	‘	'	PUNCT
ajlm-2505	58	8	group	group	NOUN
ajlm-2505	58	9	1	1	NUM
ajlm-2505	58	10	’	'	PUNCT
ajlm-2505	58	11	[	[	X
ajlm-2505	58	12	monoclonal	monoclonal	NOUN
ajlm-2505	58	13	protein	protein	NOUN
ajlm-2505	58	14	detected	detect	VERB
ajlm-2505	58	15	]	]	PUNCT
ajlm-2505	58	16	)	)	PUNCT
ajlm-2505	58	17	.	.	PUNCT
ajlm-2505	59	1	patients	patient	NOUN
ajlm-2505	59	2	were	be	AUX
ajlm-2505	59	3	initially	initially	ADV
ajlm-2505	59	4	classified	classify	VERB
ajlm-2505	59	5	into	into	ADP
ajlm-2505	59	6	three	three	NUM
ajlm-2505	59	7	categories	category	NOUN
ajlm-2505	59	8	based	base	VERB
ajlm-2505	59	9	on	on	ADP
ajlm-2505	59	10	their	their	PRON
ajlm-2505	59	11	spe	spe	ADJ
ajlm-2505	59	12	results	result	NOUN
ajlm-2505	59	13	and	and	CCONJ
ajlm-2505	59	14	local	local	ADJ
ajlm-2505	59	15	policy	policy	NOUN
ajlm-2505	59	16	.	.	PUNCT
ajlm-2505	60	1	those	those	PRON
ajlm-2505	60	2	with	with	ADP
ajlm-2505	60	3	‘	'	PUNCT
ajlm-2505	60	4	unremarkable	unremarkable	ADJ
ajlm-2505	60	5	’	'	PUNCT
ajlm-2505	60	6	spes	spe	NOUN
ajlm-2505	60	7	,	,	PUNCT
ajlm-2505	60	8	showing	show	VERB
ajlm-2505	60	9	no	no	DET
ajlm-2505	60	10	suspicious	suspicious	ADJ
ajlm-2505	60	11	peaks	peak	NOUN
ajlm-2505	60	12	or	or	CCONJ
ajlm-2505	60	13	irregularities	irregularity	NOUN
ajlm-2505	60	14	(	(	PUNCT
ajlm-2505	60	15	<	<	X
ajlm-2505	60	16	1	1	NUM
ajlm-2505	60	17	g	g	NOUN
ajlm-2505	60	18	/	/	SYM
ajlm-2505	60	19	l	l	NOUN
ajlm-2505	60	20	)	)	PUNCT
ajlm-2505	60	21	,	,	PUNCT
ajlm-2505	60	22	were	be	AUX
ajlm-2505	60	23	placed	place	VERB
ajlm-2505	60	24	in	in	ADP
ajlm-2505	60	25	group	group	NOUN
ajlm-2505	60	26	0	0	NUM
ajlm-2505	60	27	.	.	PUNCT
ajlm-2505	61	1	patients	patient	NOUN
ajlm-2505	61	2	whose	whose	DET
ajlm-2505	61	3	spe	spe	PROPN
ajlm-2505	61	4	showed	show	VERB
ajlm-2505	61	5	a	a	DET
ajlm-2505	61	6	suspicious	suspicious	ADJ
ajlm-2505	61	7	peak	peak	NOUN
ajlm-2505	61	8	required	require	VERB
ajlm-2505	61	9	immunofixation	immunofixation	NOUN
ajlm-2505	61	10	and	and	CCONJ
ajlm-2505	61	11	,	,	PUNCT
ajlm-2505	61	12	based	base	VERB
ajlm-2505	61	13	on	on	ADP
ajlm-2505	61	14	the	the	DET
ajlm-2505	61	15	results	result	NOUN
ajlm-2505	61	16	,	,	PUNCT
ajlm-2505	61	17	were	be	AUX
ajlm-2505	61	18	placed	place	VERB
ajlm-2505	61	19	into	into	ADP
ajlm-2505	61	20	either	either	PRON
ajlm-2505	61	21	group	group	NOUN
ajlm-2505	61	22	0	0	NUM
ajlm-2505	61	23	or	or	CCONJ
ajlm-2505	61	24	group	group	NOUN
ajlm-2505	61	25	1	1	NUM
ajlm-2505	61	26	.	.	PUNCT
ajlm-2505	62	1	patients	patient	NOUN
ajlm-2505	62	2	with	with	ADP
ajlm-2505	62	3	equivocal	equivocal	ADJ
ajlm-2505	62	4	immunofixation	immunofixation	NOUN
ajlm-2505	62	5	results	result	NOUN
ajlm-2505	62	6	were	be	AUX
ajlm-2505	62	7	excluded	exclude	VERB
ajlm-2505	62	8	to	to	PART
ajlm-2505	62	9	prevent	prevent	VERB
ajlm-2505	62	10	misclassification	misclassification	NOUN
ajlm-2505	62	11	.	.	PUNCT
ajlm-2505	63	1	figure	figure	NOUN
ajlm-2505	63	2	1	1	NUM
ajlm-2505	63	3	:	:	PUNCT
ajlm-2505	63	4	flowchart	flowchart	NOUN
ajlm-2505	63	5	depicting	depict	VERB
ajlm-2505	63	6	the	the	DET
ajlm-2505	63	7	stepwise	stepwise	ADJ
ajlm-2505	63	8	categorisation	categorisation	NOUN
ajlm-2505	63	9	of	of	ADP
ajlm-2505	63	10	patients	patient	NOUN
ajlm-2505	63	11	evaluated	evaluate	VERB
ajlm-2505	63	12	for	for	ADP
ajlm-2505	63	13	monoclonal	monoclonal	NOUN
ajlm-2505	63	14	gammopathy	gammopathy	ADJ
ajlm-2505	63	15	at	at	ADP
ajlm-2505	63	16	a	a	DET
ajlm-2505	63	17	tertiary	tertiary	ADJ
ajlm-2505	63	18	hospital	hospital	NOUN
ajlm-2505	63	19	laboratory	laboratory	NOUN
ajlm-2505	63	20	in	in	ADP
ajlm-2505	63	21	south	south	PROPN
ajlm-2505	63	22	africa	africa	PROPN
ajlm-2505	63	23	from	from	ADP
ajlm-2505	63	24	01	01	NUM
ajlm-2505	63	25	september	september	PROPN
ajlm-2505	63	26	2015	2015	NUM
ajlm-2505	63	27	to	to	ADP
ajlm-2505	63	28	30	30	NUM
ajlm-2505	63	29	september	september	PROPN
ajlm-2505	63	30	2022	2022	NUM
ajlm-2505	63	31	.	.	PUNCT
ajlm-2505	64	1	the	the	DET
ajlm-2505	64	2	patients	patient	NOUN
ajlm-2505	64	3	were	be	AUX
ajlm-2505	64	4	categorised	categorise	VERB
ajlm-2505	64	5	into	into	ADP
ajlm-2505	64	6	‘	'	PUNCT
ajlm-2505	64	7	group	group	NOUN
ajlm-2505	64	8	0	0	NUM
ajlm-2505	64	9	’	'	PUNCT
ajlm-2505	64	10	(	(	PUNCT
ajlm-2505	64	11	no	no	DET
ajlm-2505	64	12	monoclonal	monoclonal	NOUN
ajlm-2505	64	13	protein	protein	NOUN
ajlm-2505	64	14	detected	detect	VERB
ajlm-2505	64	15	)	)	PUNCT
ajlm-2505	64	16	,	,	PUNCT
ajlm-2505	64	17	‘	'	PUNCT
ajlm-2505	64	18	group	group	NOUN
ajlm-2505	64	19	1	1	NUM
ajlm-2505	64	20	’	'	PUNCT
ajlm-2505	64	21	(	(	PUNCT
ajlm-2505	64	22	monoclonal	monoclonal	NOUN
ajlm-2505	64	23	protein	protein	NOUN
ajlm-2505	64	24	detected	detect	VERB
ajlm-2505	64	25	)	)	PUNCT
ajlm-2505	64	26	,	,	PUNCT
ajlm-2505	64	27	and	and	CCONJ
ajlm-2505	64	28	the	the	DET
ajlm-2505	64	29	‘	'	PUNCT
ajlm-2505	64	30	excluded	exclude	VERB
ajlm-2505	64	31	group	group	NOUN
ajlm-2505	64	32	’	'	PUNCT
ajlm-2505	64	33	(	(	PUNCT
ajlm-2505	64	34	exclusion	exclusion	NOUN
ajlm-2505	64	35	criterion	criterion	NOUN
ajlm-2505	64	36	met	meet	VERB
ajlm-2505	64	37	)	)	PUNCT
ajlm-2505	64	38	.	.	PUNCT
ajlm-2505	65	1	a	a	DET
ajlm-2505	65	2	total	total	NOUN
ajlm-2505	65	3	of	of	ADP
ajlm-2505	65	4	13	13	NUM
ajlm-2505	65	5	931	931	NUM
ajlm-2505	65	6	spes	spe	NOUN
ajlm-2505	65	7	were	be	AUX
ajlm-2505	65	8	assessed	assess	VERB
ajlm-2505	65	9	for	for	ADP
ajlm-2505	65	10	eligibility	eligibility	NOUN
ajlm-2505	65	11	.	.	PUNCT
ajlm-2505	66	1	after	after	ADP
ajlm-2505	66	2	excluding	exclude	VERB
ajlm-2505	66	3	5985	5985	NUM
ajlm-2505	66	4	tests	test	NOUN
ajlm-2505	66	5	,	,	PUNCT
ajlm-2505	66	6	7946	7946	NUM
ajlm-2505	66	7	unique	unique	ADJ
ajlm-2505	66	8	patients	patient	NOUN
ajlm-2505	66	9	were	be	AUX
ajlm-2505	66	10	included	include	VERB
ajlm-2505	66	11	.	.	PUNCT
ajlm-2505	67	1	patients	patient	NOUN
ajlm-2505	67	2	were	be	AUX
ajlm-2505	67	3	then	then	ADV
ajlm-2505	67	4	classified	classify	VERB
ajlm-2505	67	5	by	by	ADP
ajlm-2505	67	6	immunofixation	immunofixation	NOUN
ajlm-2505	67	7	.	.	PUNCT
ajlm-2505	68	1	5675	5675	NUM
ajlm-2505	68	2	patients	patient	NOUN
ajlm-2505	68	3	did	do	AUX
ajlm-2505	68	4	not	not	PART
ajlm-2505	68	5	require	require	VERB
ajlm-2505	68	6	immunofixation	immunofixation	NOUN
ajlm-2505	68	7	and	and	CCONJ
ajlm-2505	68	8	were	be	AUX
ajlm-2505	68	9	assigned	assign	VERB
ajlm-2505	68	10	to	to	ADP
ajlm-2505	68	11	group	group	NOUN
ajlm-2505	68	12	0	0	NUM
ajlm-2505	68	13	.	.	PUNCT
ajlm-2505	68	14	from	from	ADP
ajlm-2505	68	15	immunofixation	immunofixation	NOUN
ajlm-2505	68	16	,	,	PUNCT
ajlm-2505	68	17	1040	1040	NUM
ajlm-2505	68	18	were	be	AUX
ajlm-2505	68	19	negative	negative	ADJ
ajlm-2505	68	20	for	for	ADP
ajlm-2505	68	21	monoclonality	monoclonality	NOUN
ajlm-2505	68	22	and	and	CCONJ
ajlm-2505	68	23	thus	thus	ADV
ajlm-2505	68	24	also	also	ADV
ajlm-2505	68	25	categorised	categorise	VERB
ajlm-2505	68	26	into	into	ADP
ajlm-2505	68	27	group	group	NOUN
ajlm-2505	68	28	0	0	NUM
ajlm-2505	68	29	.	.	PUNCT
ajlm-2505	69	1	positive	positive	ADJ
ajlm-2505	69	2	immunofixation	immunofixation	NOUN
ajlm-2505	69	3	results	result	NOUN
ajlm-2505	69	4	categorised	categorise	VERB
ajlm-2505	69	5	patients	patient	NOUN
ajlm-2505	69	6	into	into	ADP
ajlm-2505	69	7	group	group	NOUN
ajlm-2505	69	8	1	1	NUM
ajlm-2505	69	9	.	.	PUNCT
ajlm-2505	70	1	the	the	DET
ajlm-2505	70	2	gamma	gamma	NOUN
ajlm-2505	70	3	gap	gap	NOUN
ajlm-2505	70	4	was	be	AUX
ajlm-2505	70	5	calculated	calculate	VERB
ajlm-2505	70	6	as	as	ADP
ajlm-2505	70	7	the	the	DET
ajlm-2505	70	8	difference	difference	NOUN
ajlm-2505	70	9	between	between	ADP
ajlm-2505	70	10	total	total	ADJ
ajlm-2505	70	11	protein	protein	NOUN
ajlm-2505	70	12	and	and	CCONJ
ajlm-2505	70	13	albumin	albumin	ADJ
ajlm-2505	70	14	concentrations	concentration	NOUN
ajlm-2505	70	15	(	(	PUNCT
ajlm-2505	70	16	g	g	NOUN
ajlm-2505	70	17	/	/	SYM
ajlm-2505	70	18	l	l	NOUN
ajlm-2505	70	19	)	)	PUNCT
ajlm-2505	70	20	.	.	PUNCT
ajlm-2505	71	1	the	the	DET
ajlm-2505	71	2	agr	agr	NOUN
ajlm-2505	71	3	was	be	AUX
ajlm-2505	71	4	calculated	calculate	VERB
ajlm-2505	71	5	as	as	ADP
ajlm-2505	71	6	albumin	albumin	NOUN
ajlm-2505	71	7	divided	divide	VERB
ajlm-2505	71	8	by	by	ADP
ajlm-2505	71	9	globulin	globulin	NOUN
ajlm-2505	71	10	,	,	PUNCT
ajlm-2505	71	11	where	where	SCONJ
ajlm-2505	71	12	globulin	globulin	NOUN
ajlm-2505	71	13	was	be	AUX
ajlm-2505	71	14	equivalent	equivalent	ADJ
ajlm-2505	71	15	to	to	ADP
ajlm-2505	71	16	the	the	DET
ajlm-2505	71	17	gamma	gamma	NOUN
ajlm-2505	71	18	gap	gap	NOUN
ajlm-2505	71	19	.	.	PUNCT
ajlm-2505	72	1	normality	normality	NOUN
ajlm-2505	72	2	of	of	ADP
ajlm-2505	72	3	continuous	continuous	ADJ
ajlm-2505	72	4	variables	variable	NOUN
ajlm-2505	72	5	was	be	AUX
ajlm-2505	72	6	assessed	assess	VERB
ajlm-2505	72	7	using	use	VERB
ajlm-2505	72	8	histograms	histogram	NOUN
ajlm-2505	72	9	,	,	PUNCT
ajlm-2505	72	10	quantile	quantile	NOUN
ajlm-2505	72	11	-	-	PUNCT
ajlm-2505	72	12	quantile	quantile	NOUN
ajlm-2505	72	13	plots	plot	NOUN
ajlm-2505	72	14	,	,	PUNCT
ajlm-2505	72	15	and	and	CCONJ
ajlm-2505	72	16	the	the	DET
ajlm-2505	72	17	anderson	anderson	PROPN
ajlm-2505	72	18	-	-	PUNCT
ajlm-2505	72	19	darling	darling	NOUN
ajlm-2505	72	20	test	test	NOUN
ajlm-2505	72	21	.	.	PUNCT
ajlm-2505	73	1	categorical	categorical	ADJ
ajlm-2505	73	2	variables	variable	NOUN
ajlm-2505	73	3	were	be	AUX
ajlm-2505	73	4	described	describe	VERB
ajlm-2505	73	5	as	as	ADP
ajlm-2505	73	6	numbers	number	NOUN
ajlm-2505	73	7	,	,	PUNCT
ajlm-2505	73	8	proportions	proportion	NOUN
ajlm-2505	73	9	,	,	PUNCT
ajlm-2505	73	10	and	and	CCONJ
ajlm-2505	73	11	percentages	percentage	NOUN
ajlm-2505	73	12	,	,	PUNCT
ajlm-2505	73	13	and	and	CCONJ
ajlm-2505	73	14	visualised	visualise	VERB
ajlm-2505	73	15	using	use	VERB
ajlm-2505	73	16	pie	pie	NOUN
ajlm-2505	73	17	charts	chart	NOUN
ajlm-2505	73	18	(	(	PUNCT
ajlm-2505	73	19	online	online	ADJ
ajlm-2505	73	20	supplementary	supplementary	ADJ
ajlm-2505	73	21	figure	figure	NOUN
ajlm-2505	73	22	1	1	NUM
ajlm-2505	73	23	)	)	PUNCT
ajlm-2505	73	24	.	.	PUNCT
ajlm-2505	74	1	continuous	continuous	ADJ
ajlm-2505	74	2	variables	variable	NOUN
ajlm-2505	74	3	were	be	AUX
ajlm-2505	74	4	expressed	express	VERB
ajlm-2505	74	5	as	as	ADP
ajlm-2505	74	6	median	median	NOUN
ajlm-2505	74	7	(	(	PUNCT
ajlm-2505	74	8	interquartile	interquartile	NOUN
ajlm-2505	74	9	range	range	NOUN
ajlm-2505	74	10	)	)	PUNCT
ajlm-2505	74	11	,	,	PUNCT
ajlm-2505	74	12	and	and	CCONJ
ajlm-2505	74	13	illustrated	illustrate	VERB
ajlm-2505	74	14	with	with	ADP
ajlm-2505	74	15	histograms	histogram	NOUN
ajlm-2505	74	16	(	(	PUNCT
ajlm-2505	74	17	online	online	ADJ
ajlm-2505	74	18	supplementary	supplementary	ADJ
ajlm-2505	74	19	figure	figure	NOUN
ajlm-2505	74	20	2	2	NUM
ajlm-2505	74	21	)	)	PUNCT
ajlm-2505	74	22	.	.	PUNCT
ajlm-2505	75	1	chi	chi	ADJ
ajlm-2505	75	2	-	-	PUNCT
ajlm-2505	75	3	squared	square	VERB
ajlm-2505	75	4	tests	test	NOUN
ajlm-2505	75	5	were	be	AUX
ajlm-2505	75	6	used	use	VERB
ajlm-2505	75	7	for	for	ADP
ajlm-2505	75	8	categorical	categorical	ADJ
ajlm-2505	75	9	variables	variable	NOUN
ajlm-2505	75	10	,	,	PUNCT
ajlm-2505	75	11	and	and	CCONJ
ajlm-2505	75	12	wilcoxon	wilcoxon	VERB
ajlm-2505	75	13	rank	rank	NOUN
ajlm-2505	75	14	-	-	PUNCT
ajlm-2505	75	15	sum	sum	NOUN
ajlm-2505	75	16	for	for	ADP
ajlm-2505	75	17	continuous	continuous	ADJ
ajlm-2505	75	18	variables	variable	NOUN
ajlm-2505	75	19	.	.	PUNCT
ajlm-2505	76	1	a	a	DET
ajlm-2505	76	2	p	p	NOUN
ajlm-2505	76	3	-	-	PUNCT
ajlm-2505	76	4	value	value	NOUN
ajlm-2505	76	5	<	<	X
ajlm-2505	76	6	0.05	0.05	NUM
ajlm-2505	76	7	was	be	AUX
ajlm-2505	76	8	considered	consider	VERB
ajlm-2505	76	9	significant	significant	ADJ
ajlm-2505	76	10	.	.	PUNCT
ajlm-2505	77	1	figure	figure	NOUN
ajlm-2505	77	2	2	2	NUM
ajlm-2505	77	3	:	:	PUNCT
ajlm-2505	77	4	receiver	receiver	ADJ
ajlm-2505	77	5	operating	operate	VERB
ajlm-2505	77	6	characteristic	characteristic	ADJ
ajlm-2505	77	7	curves	curve	NOUN
ajlm-2505	77	8	illustrating	illustrate	VERB
ajlm-2505	77	9	the	the	DET
ajlm-2505	77	10	ability	ability	NOUN
ajlm-2505	77	11	of	of	ADP
ajlm-2505	77	12	the	the	DET
ajlm-2505	77	13	gamma	gamma	NOUN
ajlm-2505	77	14	gap	gap	NOUN
ajlm-2505	77	15	and	and	CCONJ
ajlm-2505	77	16	albumin	albumin	NOUN
ajlm-2505	77	17	-	-	PUNCT
ajlm-2505	77	18	to	to	ADP
ajlm-2505	77	19	-	-	PUNCT
ajlm-2505	77	20	globulin	globulin	NOUN
ajlm-2505	77	21	ratio	ratio	NOUN
ajlm-2505	77	22	(	(	PUNCT
ajlm-2505	77	23	agr	agr	NOUN
ajlm-2505	77	24	)	)	PUNCT
ajlm-2505	77	25	to	to	PART
ajlm-2505	77	26	predict	predict	VERB
ajlm-2505	77	27	monoclonality	monoclonality	NOUN
ajlm-2505	77	28	in	in	ADP
ajlm-2505	77	29	patients	patient	NOUN
ajlm-2505	77	30	being	be	AUX
ajlm-2505	77	31	evaluated	evaluate	VERB
ajlm-2505	77	32	for	for	ADP
ajlm-2505	77	33	monoclonal	monoclonal	NOUN
ajlm-2505	77	34	gammopathy	gammopathy	ADJ
ajlm-2505	77	35	at	at	ADP
ajlm-2505	77	36	a	a	DET
ajlm-2505	77	37	tertiary	tertiary	ADJ
ajlm-2505	77	38	hospital	hospital	NOUN
ajlm-2505	77	39	laboratory	laboratory	NOUN
ajlm-2505	77	40	in	in	ADP
ajlm-2505	77	41	south	south	PROPN
ajlm-2505	77	42	africa	africa	PROPN
ajlm-2505	77	43	from	from	ADP
ajlm-2505	77	44	01	01	NUM
ajlm-2505	77	45	september	september	PROPN
ajlm-2505	77	46	2015	2015	NUM
ajlm-2505	77	47	to	to	ADP
ajlm-2505	77	48	30	30	NUM
ajlm-2505	77	49	september	september	PROPN
ajlm-2505	77	50	2022	2022	NUM
ajlm-2505	77	51	.	.	PUNCT
ajlm-2505	78	1	(	(	PUNCT
ajlm-2505	78	2	a	a	X
ajlm-2505	78	3	)	)	PUNCT
ajlm-2505	78	4	in	in	ADP
ajlm-2505	78	5	the	the	DET
ajlm-2505	78	6	whole	whole	ADJ
ajlm-2505	78	7	population	population	NOUN
ajlm-2505	78	8	;	;	PUNCT
ajlm-2505	78	9	(	(	PUNCT
ajlm-2505	78	10	b	b	X
ajlm-2505	78	11	)	)	PUNCT
ajlm-2505	78	12	by	by	ADP
ajlm-2505	78	13	albumin	albumin	NOUN
ajlm-2505	78	14	(	(	PUNCT
ajlm-2505	78	15	<	<	X
ajlm-2505	78	16	35	35	NUM
ajlm-2505	78	17	g	g	NOUN
ajlm-2505	78	18	/	/	SYM
ajlm-2505	78	19	l	l	NOUN
ajlm-2505	78	20	)	)	PUNCT
ajlm-2505	78	21	and	and	CCONJ
ajlm-2505	78	22	protein	protein	NOUN
ajlm-2505	78	23	(	(	PUNCT
ajlm-2505	78	24	>	>	X
ajlm-2505	78	25	78	78	NUM
ajlm-2505	78	26	g	g	NOUN
ajlm-2505	78	27	/	/	SYM
ajlm-2505	78	28	l	l	NOUN
ajlm-2505	78	29	)	)	PUNCT
ajlm-2505	78	30	categories	category	NOUN
ajlm-2505	78	31	in	in	ADP
ajlm-2505	78	32	the	the	DET
ajlm-2505	78	33	whole	whole	ADJ
ajlm-2505	78	34	population	population	NOUN
ajlm-2505	78	35	;	;	PUNCT
ajlm-2505	78	36	(	(	PUNCT
ajlm-2505	78	37	c	c	X
ajlm-2505	78	38	)	)	PUNCT
ajlm-2505	78	39	by	by	ADP
ajlm-2505	78	40	albumin	albumin	ADJ
ajlm-2505	78	41	and	and	CCONJ
ajlm-2505	78	42	protein	protein	NOUN
ajlm-2505	78	43	categories	category	NOUN
ajlm-2505	78	44	excluding	exclude	VERB
ajlm-2505	78	45	hypogammaglobulinaemic	hypogammaglobulinaemic	ADJ
ajlm-2505	78	46	patients	patient	NOUN
ajlm-2505	78	47	;	;	PUNCT
ajlm-2505	78	48	(	(	PUNCT
ajlm-2505	78	49	d	d	X
ajlm-2505	78	50	)	)	PUNCT
ajlm-2505	78	51	illustrates	illustrate	VERB
ajlm-2505	78	52	the	the	DET
ajlm-2505	78	53	performance	performance	NOUN
ajlm-2505	78	54	of	of	ADP
ajlm-2505	78	55	the	the	DET
ajlm-2505	78	56	multivariable	multivariable	ADJ
ajlm-2505	78	57	logistic	logistic	ADJ
ajlm-2505	78	58	regression	regression	NOUN
ajlm-2505	78	59	models	model	NOUN
ajlm-2505	78	60	.	.	PUNCT
ajlm-2505	79	1	continuous	continuous	ADJ
ajlm-2505	79	2	variables	variable	NOUN
ajlm-2505	79	3	were	be	AUX
ajlm-2505	79	4	z	z	NOUN
ajlm-2505	79	5	-	-	PUNCT
ajlm-2505	79	6	score	score	NOUN
ajlm-2505	79	7	normalised	normalise	VERB
ajlm-2505	79	8	,	,	PUNCT
ajlm-2505	79	9	and	and	CCONJ
ajlm-2505	79	10	categorical	categorical	ADJ
ajlm-2505	79	11	variables	variable	NOUN
ajlm-2505	79	12	were	be	AUX
ajlm-2505	79	13	encoded	encode	VERB
ajlm-2505	79	14	.	.	PUNCT
ajlm-2505	80	1	receiver	receiver	ADJ
ajlm-2505	80	2	operating	operate	VERB
ajlm-2505	80	3	characteristic	characteristic	NOUN
ajlm-2505	80	4	(	(	PUNCT
ajlm-2505	80	5	roc	roc	PROPN
ajlm-2505	80	6	)	)	PUNCT
ajlm-2505	80	7	curves	curve	NOUN
ajlm-2505	80	8	were	be	AUX
ajlm-2505	80	9	constructed	construct	VERB
ajlm-2505	80	10	to	to	PART
ajlm-2505	80	11	evaluate	evaluate	VERB
ajlm-2505	80	12	diagnostic	diagnostic	ADJ
ajlm-2505	80	13	performance	performance	NOUN
ajlm-2505	80	14	of	of	ADP
ajlm-2505	80	15	gamma	gamma	NOUN
ajlm-2505	80	16	gap	gap	PROPN
ajlm-2505	80	17	,	,	PUNCT
ajlm-2505	80	18	agr	agr	NOUN
ajlm-2505	80	19	,	,	PUNCT
ajlm-2505	80	20	and	and	CCONJ
ajlm-2505	80	21	logistic	logistic	ADJ
ajlm-2505	80	22	regression	regression	NOUN
ajlm-2505	80	23	models	model	NOUN
ajlm-2505	80	24	,	,	PUNCT
ajlm-2505	80	25	with	with	ADP
ajlm-2505	80	26	area	area	NOUN
ajlm-2505	80	27	under	under	ADP
ajlm-2505	80	28	the	the	DET
ajlm-2505	80	29	curve	curve	NOUN
ajlm-2505	80	30	(	(	PUNCT
ajlm-2505	80	31	auc	auc	NOUN
ajlm-2505	80	32	)	)	PUNCT
ajlm-2505	80	33	used	use	VERB
ajlm-2505	80	34	as	as	ADP
ajlm-2505	80	35	a	a	DET
ajlm-2505	80	36	measure	measure	NOUN
ajlm-2505	80	37	of	of	ADP
ajlm-2505	80	38	accuracy	accuracy	NOUN
ajlm-2505	80	39	(	(	PUNCT
ajlm-2505	80	40	online	online	ADJ
ajlm-2505	80	41	supplementary	supplementary	ADJ
ajlm-2505	80	42	text	text	NOUN
ajlm-2505	80	43	1	1	NUM
ajlm-2505	80	44	)	)	PUNCT
ajlm-2505	80	45	.	.	PUNCT
ajlm-2505	81	1	the	the	DET
ajlm-2505	81	2	optimal	optimal	ADJ
ajlm-2505	81	3	cut	cut	NOUN
ajlm-2505	81	4	-	-	PUNCT
ajlm-2505	81	5	offs	off	NOUN
ajlm-2505	81	6	were	be	AUX
ajlm-2505	81	7	determined	determine	VERB
ajlm-2505	81	8	using	use	VERB
ajlm-2505	81	9	the	the	DET
ajlm-2505	81	10	youden	youden	PROPN
ajlm-2505	81	11	index	index	NOUN
ajlm-2505	81	12	,	,	PUNCT
ajlm-2505	81	13	and	and	CCONJ
ajlm-2505	81	14	sensitivity	sensitivity	NOUN
ajlm-2505	81	15	and	and	CCONJ
ajlm-2505	81	16	specificity	specificity	NOUN
ajlm-2505	81	17	were	be	AUX
ajlm-2505	81	18	calculated	calculate	VERB
ajlm-2505	81	19	at	at	ADP
ajlm-2505	81	20	these	these	DET
ajlm-2505	81	21	cut	cut	NOUN
ajlm-2505	81	22	-	-	PUNCT
ajlm-2505	81	23	offs	off	NOUN
ajlm-2505	81	24	.	.	PUNCT
ajlm-2505	82	1	univariable	univariable	ADJ
ajlm-2505	82	2	logistic	logistic	ADJ
ajlm-2505	82	3	regression	regression	NOUN
ajlm-2505	82	4	was	be	AUX
ajlm-2505	82	5	performed	perform	VERB
ajlm-2505	82	6	to	to	PART
ajlm-2505	82	7	identify	identify	VERB
ajlm-2505	82	8	predictors	predictor	NOUN
ajlm-2505	82	9	of	of	ADP
ajlm-2505	82	10	the	the	DET
ajlm-2505	82	11	outcome	outcome	NOUN
ajlm-2505	82	12	.	.	PUNCT
ajlm-2505	83	1	multivariable	multivariable	ADJ
ajlm-2505	83	2	models	model	NOUN
ajlm-2505	83	3	were	be	AUX
ajlm-2505	83	4	then	then	ADV
ajlm-2505	83	5	developed	develop	VERB
ajlm-2505	83	6	and	and	CCONJ
ajlm-2505	83	7	optimised	optimise	VERB
ajlm-2505	83	8	.	.	PUNCT
ajlm-2505	84	1	akaike	akaike	ADJ
ajlm-2505	84	2	information	information	NOUN
ajlm-2505	84	3	criterion	criterion	NOUN
ajlm-2505	84	4	(	(	PUNCT
ajlm-2505	84	5	aic	aic	PROPN
ajlm-2505	84	6	)	)	PUNCT
ajlm-2505	84	7	values	value	NOUN
ajlm-2505	84	8	were	be	AUX
ajlm-2505	84	9	calculated	calculate	VERB
ajlm-2505	84	10	to	to	PART
ajlm-2505	84	11	compare	compare	VERB
ajlm-2505	84	12	univariable	univariable	ADJ
ajlm-2505	84	13	and	and	CCONJ
ajlm-2505	84	14	multivariable	multivariable	ADJ
ajlm-2505	84	15	models	model	NOUN
ajlm-2505	84	16	.	.	PUNCT
ajlm-2505	85	1	confusion	confusion	NOUN
ajlm-2505	85	2	matrices	matrix	NOUN
ajlm-2505	85	3	and	and	CCONJ
ajlm-2505	85	4	classification	classification	NOUN
ajlm-2505	85	5	reports	report	NOUN
ajlm-2505	85	6	were	be	AUX
ajlm-2505	85	7	generated	generate	VERB
ajlm-2505	85	8	to	to	PART
ajlm-2505	85	9	assess	assess	VERB
ajlm-2505	85	10	model	model	NOUN
ajlm-2505	85	11	performance	performance	NOUN
ajlm-2505	85	12	.	.	PUNCT
ajlm-2505	86	1	subgroup	subgroup	PROPN
ajlm-2505	86	2	analyses	analysis	NOUN
ajlm-2505	86	3	were	be	AUX
ajlm-2505	86	4	performed	perform	VERB
ajlm-2505	86	5	to	to	PART
ajlm-2505	86	6	further	far	ADV
ajlm-2505	86	7	evaluate	evaluate	VERB
ajlm-2505	86	8	factors	factor	NOUN
ajlm-2505	86	9	that	that	PRON
ajlm-2505	86	10	may	may	AUX
ajlm-2505	86	11	influence	influence	VERB
ajlm-2505	86	12	metric	metric	ADJ
ajlm-2505	86	13	performance	performance	NOUN
ajlm-2505	86	14	.	.	PUNCT
ajlm-2505	87	1	patients	patient	NOUN
ajlm-2505	87	2	with	with	ADP
ajlm-2505	87	3	hypogammaglobulinaemia	hypogammaglobulinaemia	NOUN
ajlm-2505	87	4	were	be	AUX
ajlm-2505	87	5	excluded	exclude	VERB
ajlm-2505	87	6	,	,	PUNCT
ajlm-2505	87	7	and	and	CCONJ
ajlm-2505	87	8	subgroups	subgroup	NOUN
ajlm-2505	87	9	based	base	VERB
ajlm-2505	87	10	on	on	ADP
ajlm-2505	87	11	albumin	albumin	NOUN
ajlm-2505	87	12	(	(	PUNCT
ajlm-2505	87	13	<	<	X
ajlm-2505	87	14	35	35	NUM
ajlm-2505	87	15	g	g	NOUN
ajlm-2505	87	16	/	/	SYM
ajlm-2505	87	17	l	l	NOUN
ajlm-2505	87	18	vs	vs	ADP
ajlm-2505	87	19	≥	≥	NUM
ajlm-2505	87	20	35	35	NUM
ajlm-2505	87	21	g	g	NOUN
ajlm-2505	87	22	/	/	SYM
ajlm-2505	87	23	l	l	NOUN
ajlm-2505	87	24	)	)	PUNCT
ajlm-2505	87	25	and	and	CCONJ
ajlm-2505	87	26	total	total	ADJ
ajlm-2505	87	27	protein	protein	NOUN
ajlm-2505	87	28	(	(	PUNCT
ajlm-2505	87	29	≤	≤	NUM
ajlm-2505	87	30	78	78	NUM
ajlm-2505	87	31	g	g	NOUN
ajlm-2505	87	32	/	/	SYM
ajlm-2505	87	33	l	l	NOUN
ajlm-2505	87	34	vs	vs	ADP
ajlm-2505	87	35	>	>	X
ajlm-2505	87	36	78	78	NUM
ajlm-2505	87	37	g	g	NOUN
ajlm-2505	87	38	/	/	SYM
ajlm-2505	87	39	l	l	NOUN
ajlm-2505	87	40	)	)	PUNCT
ajlm-2505	87	41	categories	category	NOUN
ajlm-2505	87	42	,	,	PUNCT
ajlm-2505	87	43	based	base	VERB
ajlm-2505	87	44	on	on	ADP
ajlm-2505	87	45	their	their	PRON
ajlm-2505	87	46	respective	respective	ADJ
ajlm-2505	87	47	reference	reference	NOUN
ajlm-2505	87	48	intervals	interval	NOUN
ajlm-2505	87	49	,	,	PUNCT
ajlm-2505	87	50	were	be	AUX
ajlm-2505	87	51	also	also	ADV
ajlm-2505	87	52	examined	examine	VERB
ajlm-2505	87	53	.	.	PUNCT
ajlm-2505	88	1	results	result	NOUN
ajlm-2505	88	2	patient	patient	ADJ
ajlm-2505	88	3	characteristics	characteristic	NOUN
ajlm-2505	88	4	a	a	DET
ajlm-2505	88	5	total	total	NOUN
ajlm-2505	88	6	of	of	ADP
ajlm-2505	88	7	13	13	NUM
ajlm-2505	88	8	931	931	NUM
ajlm-2505	88	9	records	record	NOUN
ajlm-2505	88	10	from	from	ADP
ajlm-2505	88	11	8705	8705	NUM
ajlm-2505	88	12	unique	unique	ADJ
ajlm-2505	88	13	patients	patient	NOUN
ajlm-2505	88	14	were	be	AUX
ajlm-2505	88	15	evaluated	evaluate	VERB
ajlm-2505	88	16	for	for	ADP
ajlm-2505	88	17	eligibility	eligibility	NOUN
ajlm-2505	88	18	(	(	PUNCT
ajlm-2505	88	19	figure	figure	NOUN
ajlm-2505	88	20	1	1	NUM
ajlm-2505	88	21	)	)	PUNCT
ajlm-2505	88	22	.	.	PUNCT
ajlm-2505	89	1	after	after	ADP
ajlm-2505	89	2	applying	apply	VERB
ajlm-2505	89	3	the	the	DET
ajlm-2505	89	4	inclusion	inclusion	NOUN
ajlm-2505	89	5	and	and	CCONJ
ajlm-2505	89	6	exclusion	exclusion	NOUN
ajlm-2505	89	7	criteria	criterion	NOUN
ajlm-2505	89	8	,	,	PUNCT
ajlm-2505	89	9	5985	5985	NUM
ajlm-2505	89	10	records	record	NOUN
ajlm-2505	89	11	were	be	AUX
ajlm-2505	89	12	removed	remove	VERB
ajlm-2505	89	13	,	,	PUNCT
ajlm-2505	89	14	leaving	leave	VERB
ajlm-2505	89	15	7946	7946	NUM
ajlm-2505	89	16	unique	unique	ADJ
ajlm-2505	89	17	patients	patient	NOUN
ajlm-2505	89	18	.	.	PUNCT
ajlm-2505	90	1	these	these	DET
ajlm-2505	90	2	patients	patient	NOUN
ajlm-2505	90	3	were	be	AUX
ajlm-2505	90	4	categorised	categorise	VERB
ajlm-2505	90	5	into	into	ADP
ajlm-2505	90	6	‘	'	PUNCT
ajlm-2505	90	7	group	group	NOUN
ajlm-2505	90	8	0	0	NUM
ajlm-2505	90	9	’	'	PUNCT
ajlm-2505	90	10	(	(	PUNCT
ajlm-2505	90	11	no	no	DET
ajlm-2505	90	12	monoclonal	monoclonal	NOUN
ajlm-2505	90	13	detected	detect	VERB
ajlm-2505	90	14	,	,	PUNCT
ajlm-2505	90	15	n	n	NOUN
ajlm-2505	90	16	=	=	SYM
ajlm-2505	90	17	6715	6715	NUM
ajlm-2505	90	18	)	)	PUNCT
ajlm-2505	90	19	and	and	CCONJ
ajlm-2505	90	20	‘	'	PUNCT
ajlm-2505	90	21	group	group	NOUN
ajlm-2505	90	22	1	1	NUM
ajlm-2505	90	23	’	'	PUNCT
ajlm-2505	90	24	(	(	PUNCT
ajlm-2505	90	25	monoclonal	monoclonal	NOUN
ajlm-2505	90	26	detected	detect	VERB
ajlm-2505	90	27	,	,	PUNCT
ajlm-2505	90	28	n	n	PROPN
ajlm-2505	90	29	=	=	SYM
ajlm-2505	90	30	1231	1231	NUM
ajlm-2505	90	31	)	)	PUNCT
ajlm-2505	90	32	.	.	PUNCT
ajlm-2505	91	1	continuous	continuous	ADJ
ajlm-2505	91	2	variables	variable	NOUN
ajlm-2505	91	3	were	be	AUX
ajlm-2505	91	4	distributed	distribute	VERB
ajlm-2505	91	5	non	non	ADJ
ajlm-2505	91	6	-	-	ADJ
ajlm-2505	91	7	parametrically	parametrically	ADV
ajlm-2505	91	8	.	.	PUNCT
ajlm-2505	92	1	a	a	DET
ajlm-2505	92	2	total	total	NOUN
ajlm-2505	92	3	of	of	ADP
ajlm-2505	92	4	58	58	NUM
ajlm-2505	92	5	%	%	NOUN
ajlm-2505	92	6	of	of	ADP
ajlm-2505	92	7	patients	patient	NOUN
ajlm-2505	92	8	were	be	AUX
ajlm-2505	92	9	female	female	ADJ
ajlm-2505	92	10	and	and	CCONJ
ajlm-2505	92	11	42	42	NUM
ajlm-2505	92	12	%	%	NOUN
ajlm-2505	92	13	were	be	AUX
ajlm-2505	92	14	male	male	ADJ
ajlm-2505	92	15	patients	patient	NOUN
ajlm-2505	92	16	(	(	PUNCT
ajlm-2505	92	17	table	table	NOUN
ajlm-2505	92	18	1	1	NUM
ajlm-2505	92	19	)	)	PUNCT
ajlm-2505	92	20	.	.	PUNCT
ajlm-2505	93	1	sex	sex	NOUN
ajlm-2505	93	2	distribution	distribution	NOUN
ajlm-2505	93	3	was	be	AUX
ajlm-2505	93	4	more	more	ADV
ajlm-2505	93	5	balanced	balanced	ADJ
ajlm-2505	93	6	(	(	PUNCT
ajlm-2505	93	7	54	54	NUM
ajlm-2505	93	8	%	%	NOUN
ajlm-2505	93	9	women	woman	NOUN
ajlm-2505	93	10	and	and	CCONJ
ajlm-2505	93	11	46	46	NUM
ajlm-2505	93	12	%	%	NOUN
ajlm-2505	93	13	men	man	NOUN
ajlm-2505	93	14	)	)	PUNCT
ajlm-2505	93	15	among	among	ADP
ajlm-2505	93	16	patients	patient	NOUN
ajlm-2505	93	17	with	with	ADP
ajlm-2505	93	18	monoclonality	monoclonality	NOUN
ajlm-2505	93	19	.	.	PUNCT
ajlm-2505	94	1	the	the	DET
ajlm-2505	94	2	median	median	NOUN
ajlm-2505	94	3	(	(	PUNCT
ajlm-2505	94	4	p25	p25	PROPN
ajlm-2505	94	5	,	,	PUNCT
ajlm-2505	94	6	p75	p75	ADJ
ajlm-2505	94	7	)	)	PUNCT
ajlm-2505	94	8	age	age	NOUN
ajlm-2505	94	9	was	be	AUX
ajlm-2505	94	10	61	61	NUM
ajlm-2505	94	11	(	(	PUNCT
ajlm-2505	94	12	50	50	NUM
ajlm-2505	94	13	,	,	PUNCT
ajlm-2505	94	14	71	71	NUM
ajlm-2505	94	15	)	)	PUNCT
ajlm-2505	94	16	years	year	NOUN
ajlm-2505	94	17	.	.	PUNCT
ajlm-2505	95	1	table	table	NOUN
ajlm-2505	95	2	1	1	NUM
ajlm-2505	95	3	:	:	PUNCT
ajlm-2505	95	4	 	 	SPACE
ajlm-2505	95	5	population	population	NOUN
ajlm-2505	95	6	characteristics	characteristic	NOUN
ajlm-2505	95	7	of	of	ADP
ajlm-2505	95	8	patients	patient	NOUN
ajlm-2505	95	9	evaluated	evaluate	VERB
ajlm-2505	95	10	for	for	ADP
ajlm-2505	95	11	monoclonal	monoclonal	NOUN
ajlm-2505	95	12	gammopathy	gammopathy	ADJ
ajlm-2505	95	13	at	at	ADP
ajlm-2505	95	14	a	a	DET
ajlm-2505	95	15	tertiary	tertiary	ADJ
ajlm-2505	95	16	hospital	hospital	NOUN
ajlm-2505	95	17	laboratory	laboratory	NOUN
ajlm-2505	95	18	in	in	ADP
ajlm-2505	95	19	south	south	PROPN
ajlm-2505	95	20	africa	africa	PROPN
ajlm-2505	95	21	from	from	ADP
ajlm-2505	95	22	01	01	NUM
ajlm-2505	95	23	september	september	PROPN
ajlm-2505	95	24	2015	2015	NUM
ajlm-2505	95	25	to	to	ADP
ajlm-2505	95	26	30	30	NUM
ajlm-2505	95	27	september	september	PROPN
ajlm-2505	95	28	2022	2022	NUM
ajlm-2505	95	29	.	.	PUNCT
ajlm-2505	96	1	total	total	ADJ
ajlm-2505	96	2	protein	protein	NOUN
ajlm-2505	96	3	was	be	AUX
ajlm-2505	96	4	higher	high	ADJ
ajlm-2505	96	5	in	in	ADP
ajlm-2505	96	6	the	the	DET
ajlm-2505	96	7	monoclonal	monoclonal	NOUN
ajlm-2505	96	8	compared	compare	VERB
ajlm-2505	96	9	to	to	ADP
ajlm-2505	96	10	no	no	DET
ajlm-2505	96	11	monoclonal	monoclonal	NOUN
ajlm-2505	96	12	detected	detect	VERB
ajlm-2505	96	13	group	group	NOUN
ajlm-2505	96	14	(	(	PUNCT
ajlm-2505	96	15	75	75	NUM
ajlm-2505	96	16	[	[	SYM
ajlm-2505	96	17	66	66	NUM
ajlm-2505	96	18	,	,	PUNCT
ajlm-2505	96	19	89	89	NUM
ajlm-2505	96	20	]	]	PUNCT
ajlm-2505	96	21	vs	vs	ADP
ajlm-2505	96	22	73	73	NUM
ajlm-2505	96	23	[	[	SYM
ajlm-2505	96	24	67	67	NUM
ajlm-2505	96	25	,	,	PUNCT
ajlm-2505	96	26	78	78	NUM
ajlm-2505	96	27	]	]	SYM
ajlm-2505	96	28	g	g	PROPN
ajlm-2505	96	29	/	/	SYM
ajlm-2505	96	30	l	l	NOUN
ajlm-2505	96	31	,	,	PUNCT
ajlm-2505	96	32	p	p	X
ajlm-2505	96	33	<	<	X
ajlm-2505	96	34	0.001	0.001	NUM
ajlm-2505	96	35	)	)	PUNCT
ajlm-2505	96	36	,	,	PUNCT
ajlm-2505	96	37	while	while	SCONJ
ajlm-2505	96	38	albumin	albumin	NOUN
ajlm-2505	96	39	was	be	AUX
ajlm-2505	96	40	lower	low	ADJ
ajlm-2505	96	41	(	(	PUNCT
ajlm-2505	96	42	36	36	NUM
ajlm-2505	96	43	[	[	X
ajlm-2505	96	44	28	28	NUM
ajlm-2505	96	45	,	,	PUNCT
ajlm-2505	96	46	41	41	NUM
ajlm-2505	96	47	]	]	PUNCT
ajlm-2505	96	48	vs	vs	ADP
ajlm-2505	96	49	40	40	NUM
ajlm-2505	96	50	[	[	SYM
ajlm-2505	96	51	34	34	NUM
ajlm-2505	96	52	,	,	PUNCT
ajlm-2505	96	53	44	44	NUM
ajlm-2505	96	54	]	]	SYM
ajlm-2505	96	55	g	g	PROPN
ajlm-2505	96	56	/	/	SYM
ajlm-2505	96	57	l	l	NOUN
ajlm-2505	96	58	,	,	PUNCT
ajlm-2505	96	59	p	p	X
ajlm-2505	96	60	<	<	X
ajlm-2505	96	61	0.001	0.001	NUM
ajlm-2505	96	62	)	)	PUNCT
ajlm-2505	96	63	.	.	PUNCT
ajlm-2505	97	1	the	the	DET
ajlm-2505	97	2	gamma	gamma	NOUN
ajlm-2505	97	3	gap	gap	NOUN
ajlm-2505	97	4	was	be	AUX
ajlm-2505	97	5	higher	high	ADJ
ajlm-2505	97	6	in	in	ADP
ajlm-2505	97	7	the	the	DET
ajlm-2505	97	8	monoclonal	monoclonal	NOUN
ajlm-2505	97	9	group	group	NOUN
ajlm-2505	97	10	(	(	PUNCT
ajlm-2505	97	11	36	36	NUM
ajlm-2505	97	12	[	[	X
ajlm-2505	97	13	28	28	NUM
ajlm-2505	97	14	,	,	PUNCT
ajlm-2505	97	15	55	55	NUM
ajlm-2505	97	16	]	]	PUNCT
ajlm-2505	97	17	vs	vs	ADP
ajlm-2505	97	18	32	32	NUM
ajlm-2505	97	19	[	[	SYM
ajlm-2505	97	20	28	28	NUM
ajlm-2505	97	21	,	,	PUNCT
ajlm-2505	97	22	38	38	NUM
ajlm-2505	97	23	]	]	PUNCT
ajlm-2505	97	24	,	,	PUNCT
ajlm-2505	97	25	p	p	X
ajlm-2505	97	26	<	<	X
ajlm-2505	97	27	0.001	0.001	NUM
ajlm-2505	97	28	)	)	PUNCT
ajlm-2505	97	29	,	,	PUNCT
ajlm-2505	97	30	while	while	SCONJ
ajlm-2505	97	31	the	the	DET
ajlm-2505	97	32	agr	agr	NOUN
ajlm-2505	97	33	was	be	AUX
ajlm-2505	97	34	lower	low	ADJ
ajlm-2505	97	35	(	(	PUNCT
ajlm-2505	97	36	0.97	0.97	NUM
ajlm-2505	97	37	[	[	X
ajlm-2505	97	38	0.54	0.54	NUM
ajlm-2505	97	39	,	,	PUNCT
ajlm-2505	97	40	1.39	1.39	NUM
ajlm-2505	97	41	]	]	PUNCT
ajlm-2505	97	42	vs	vs	ADP
ajlm-2505	97	43	1.23	1.23	NUM
ajlm-2505	98	1	[	[	X
ajlm-2505	98	2	0.92	0.92	NUM
ajlm-2505	98	3	,	,	PUNCT
ajlm-2505	98	4	1.52	1.52	NUM
ajlm-2505	98	5	]	]	PUNCT
ajlm-2505	98	6	,	,	PUNCT
ajlm-2505	98	7	p	p	X
ajlm-2505	98	8	<	<	X
ajlm-2505	98	9	0.001	0.001	NUM
ajlm-2505	98	10	)	)	PUNCT
ajlm-2505	98	11	.	.	PUNCT
ajlm-2505	99	1	among	among	ADP
ajlm-2505	99	2	615	615	NUM
ajlm-2505	99	3	hypogammaglobulinaemic	hypogammaglobulinaemic	ADJ
ajlm-2505	99	4	patients	patient	NOUN
ajlm-2505	99	5	,	,	PUNCT
ajlm-2505	99	6	41	41	NUM
ajlm-2505	99	7	%	%	NOUN
ajlm-2505	99	8	had	have	VERB
ajlm-2505	99	9	a	a	DET
ajlm-2505	99	10	monoclonal	monoclonal	NOUN
ajlm-2505	99	11	protein	protein	NOUN
ajlm-2505	99	12	,	,	PUNCT
ajlm-2505	99	13	while	while	SCONJ
ajlm-2505	99	14	59	59	NUM
ajlm-2505	99	15	%	%	NOUN
ajlm-2505	99	16	did	do	AUX
ajlm-2505	99	17	not	not	PART
ajlm-2505	99	18	(	(	PUNCT
ajlm-2505	99	19	p	p	X
ajlm-2505	99	20	<	<	X
ajlm-2505	99	21	0.001	0.001	NUM
ajlm-2505	99	22	)	)	PUNCT
ajlm-2505	99	23	(	(	PUNCT
ajlm-2505	99	24	online	online	ADJ
ajlm-2505	99	25	supplementary	supplementary	ADJ
ajlm-2505	99	26	table	table	NOUN
ajlm-2505	99	27	1	1	NUM
ajlm-2505	99	28	)	)	PUNCT
ajlm-2505	99	29	.	.	PUNCT
ajlm-2505	100	1	approximately	approximately	ADV
ajlm-2505	100	2	one	one	NUM
ajlm-2505	100	3	-	-	PUNCT
ajlm-2505	100	4	third	third	NOUN
ajlm-2505	100	5	of	of	ADP
ajlm-2505	100	6	patients	patient	NOUN
ajlm-2505	100	7	had	have	VERB
ajlm-2505	100	8	low	low	ADJ
ajlm-2505	100	9	albumin	albumin	NOUN
ajlm-2505	100	10	(	(	PUNCT
ajlm-2505	100	11	<	<	X
ajlm-2505	100	12	35	35	NUM
ajlm-2505	100	13	g	g	NOUN
ajlm-2505	100	14	/	/	SYM
ajlm-2505	100	15	l	l	NOUN
ajlm-2505	100	16	;	;	PUNCT
ajlm-2505	100	17	reference	reference	NOUN
ajlm-2505	100	18	interval	interval	NOUN
ajlm-2505	100	19	:	:	PUNCT
ajlm-2505	100	20	35	35	NUM
ajlm-2505	100	21	g	g	NOUN
ajlm-2505	100	22	/	/	SYM
ajlm-2505	100	23	l	l	NOUN
ajlm-2505	100	24	–	–	PUNCT
ajlm-2505	100	25	52	52	NUM
ajlm-2505	100	26	g	g	NOUN
ajlm-2505	100	27	/	/	SYM
ajlm-2505	100	28	l	l	NOUN
ajlm-2505	100	29	)	)	PUNCT
ajlm-2505	100	30	and	and	CCONJ
ajlm-2505	100	31	one	one	NUM
ajlm-2505	100	32	-	-	PUNCT
ajlm-2505	100	33	third	third	NOUN
ajlm-2505	100	34	had	have	VERB
ajlm-2505	100	35	high	high	ADJ
ajlm-2505	100	36	total	total	ADJ
ajlm-2505	100	37	protein	protein	NOUN
ajlm-2505	100	38	(	(	PUNCT
ajlm-2505	100	39	>	>	X
ajlm-2505	100	40	78	78	NUM
ajlm-2505	100	41	g	g	NOUN
ajlm-2505	100	42	/	/	SYM
ajlm-2505	100	43	l	l	NOUN
ajlm-2505	100	44	;	;	PUNCT
ajlm-2505	100	45	reference	reference	NOUN
ajlm-2505	100	46	interval	interval	NOUN
ajlm-2505	100	47	:	:	PUNCT
ajlm-2505	100	48	60	60	NUM
ajlm-2505	100	49	g	g	NOUN
ajlm-2505	100	50	/	/	SYM
ajlm-2505	100	51	l	l	NOUN
ajlm-2505	100	52	–	–	PUNCT
ajlm-2505	100	53	78	78	NUM
ajlm-2505	100	54	g	g	NOUN
ajlm-2505	100	55	/	/	SYM
ajlm-2505	100	56	l	l	NOUN
ajlm-2505	100	57	)	)	PUNCT
ajlm-2505	100	58	.	.	PUNCT
ajlm-2505	101	1	receiver	receiver	ADJ
ajlm-2505	101	2	operating	operate	VERB
ajlm-2505	101	3	characteristic	characteristic	ADJ
ajlm-2505	101	4	curves	curve	VERB
ajlm-2505	101	5	the	the	DET
ajlm-2505	101	6	gamma	gamma	NOUN
ajlm-2505	101	7	gap	gap	NOUN
ajlm-2505	101	8	demonstrated	demonstrate	VERB
ajlm-2505	101	9	an	an	DET
ajlm-2505	101	10	auc	auc	NOUN
ajlm-2505	101	11	of	of	ADP
ajlm-2505	101	12	0.60	0.60	NUM
ajlm-2505	101	13	(	(	PUNCT
ajlm-2505	101	14	95	95	NUM
ajlm-2505	101	15	%	%	NOUN
ajlm-2505	101	16	ci	ci	NOUN
ajlm-2505	101	17	:	:	PUNCT
ajlm-2505	101	18	0.58–0.62	0.58–0.62	NUM
ajlm-2505	101	19	)	)	PUNCT
ajlm-2505	101	20	,	,	PUNCT
ajlm-2505	101	21	while	while	SCONJ
ajlm-2505	101	22	agr	agr	X
ajlm-2505	101	23	(	(	PUNCT
ajlm-2505	101	24	0.63	0.63	NUM
ajlm-2505	101	25	[	[	X
ajlm-2505	101	26	95	95	NUM
ajlm-2505	101	27	%	%	NOUN
ajlm-2505	101	28	ci	ci	NOUN
ajlm-2505	101	29	:	:	PUNCT
ajlm-2505	101	30	0.61–0.65	0.61–0.65	NUM
ajlm-2505	101	31	]	]	PUNCT
ajlm-2505	101	32	)	)	PUNCT
ajlm-2505	101	33	was	be	AUX
ajlm-2505	101	34	slightly	slightly	ADV
ajlm-2505	101	35	higher	high	ADJ
ajlm-2505	101	36	(	(	PUNCT
ajlm-2505	101	37	table	table	NOUN
ajlm-2505	101	38	2	2	NUM
ajlm-2505	101	39	;	;	PUNCT
ajlm-2505	101	40	figure	figure	NOUN
ajlm-2505	101	41	2a	2a	NUM
ajlm-2505	101	42	)	)	PUNCT
ajlm-2505	101	43	.	.	PUNCT
ajlm-2505	102	1	at	at	ADP
ajlm-2505	102	2	an	an	DET
ajlm-2505	102	3	optimal	optimal	ADJ
ajlm-2505	102	4	cutoff	cutoff	NOUN
ajlm-2505	102	5	of	of	ADP
ajlm-2505	102	6	46	46	NUM
ajlm-2505	102	7	g	g	NOUN
ajlm-2505	102	8	/	/	SYM
ajlm-2505	102	9	l	l	NOUN
ajlm-2505	102	10	for	for	ADP
ajlm-2505	102	11	the	the	DET
ajlm-2505	102	12	gamma	gamma	NOUN
ajlm-2505	102	13	gap	gap	NOUN
ajlm-2505	102	14	,	,	PUNCT
ajlm-2505	102	15	sensitivity	sensitivity	NOUN
ajlm-2505	102	16	was	be	AUX
ajlm-2505	102	17	35	35	NUM
ajlm-2505	102	18	%	%	NOUN
ajlm-2505	102	19	(	(	PUNCT
ajlm-2505	102	20	95	95	NUM
ajlm-2505	102	21	%	%	NOUN
ajlm-2505	102	22	ci	ci	NOUN
ajlm-2505	102	23	:	:	PUNCT
ajlm-2505	102	24	33–38	33–38	NUM
ajlm-2505	102	25	)	)	PUNCT
ajlm-2505	102	26	and	and	CCONJ
ajlm-2505	102	27	specificity	specificity	NOUN
ajlm-2505	102	28	was	be	AUX
ajlm-2505	102	29	91	91	NUM
ajlm-2505	102	30	%	%	NOUN
ajlm-2505	102	31	(	(	PUNCT
ajlm-2505	102	32	95	95	NUM
ajlm-2505	102	33	%	%	NOUN
ajlm-2505	102	34	ci	ci	NOUN
ajlm-2505	102	35	:	:	PUNCT
ajlm-2505	102	36	90–92	90–92	NUM
ajlm-2505	102	37	)	)	PUNCT
ajlm-2505	102	38	.	.	PUNCT
ajlm-2505	103	1	for	for	ADP
ajlm-2505	103	2	agr	agr	NOUN
ajlm-2505	103	3	,	,	PUNCT
ajlm-2505	103	4	an	an	DET
ajlm-2505	103	5	optimal	optimal	ADJ
ajlm-2505	103	6	cutoff	cutoff	NOUN
ajlm-2505	103	7	of	of	ADP
ajlm-2505	103	8	0.85	0.85	NUM
ajlm-2505	103	9	had	have	VERB
ajlm-2505	103	10	a	a	DET
ajlm-2505	103	11	sensitivity	sensitivity	NOUN
ajlm-2505	103	12	of	of	ADP
ajlm-2505	103	13	44	44	NUM
ajlm-2505	103	14	%	%	NOUN
ajlm-2505	103	15	(	(	PUNCT
ajlm-2505	103	16	95	95	NUM
ajlm-2505	103	17	%	%	NOUN
ajlm-2505	103	18	ci	ci	NOUN
ajlm-2505	103	19	:	:	PUNCT
ajlm-2505	103	20	41–47	41–47	NUM
ajlm-2505	103	21	)	)	PUNCT
ajlm-2505	103	22	and	and	CCONJ
ajlm-2505	103	23	specificity	specificity	NOUN
ajlm-2505	103	24	of	of	ADP
ajlm-2505	103	25	80	80	NUM
ajlm-2505	103	26	%	%	NOUN
ajlm-2505	103	27	(	(	PUNCT
ajlm-2505	103	28	95	95	NUM
ajlm-2505	103	29	%	%	NOUN
ajlm-2505	103	30	ci	ci	NOUN
ajlm-2505	103	31	:	:	PUNCT
ajlm-2505	103	32	79–81	79–81	NUM
ajlm-2505	103	33	)	)	PUNCT
ajlm-2505	103	34	.	.	PUNCT
ajlm-2505	104	1	table	table	NOUN
ajlm-2505	104	2	2	2	NUM
ajlm-2505	104	3	:	:	PUNCT
ajlm-2505	104	4	 	 	SPACE
ajlm-2505	104	5	diagnostic	diagnostic	ADJ
ajlm-2505	104	6	accuracy	accuracy	NOUN
ajlm-2505	104	7	of	of	ADP
ajlm-2505	104	8	gamma	gamma	NOUN
ajlm-2505	104	9	gap	gap	NOUN
ajlm-2505	104	10	,	,	PUNCT
ajlm-2505	104	11	albumin	albumin	NOUN
ajlm-2505	104	12	-	-	PUNCT
ajlm-2505	104	13	to	to	ADP
ajlm-2505	104	14	-	-	PUNCT
ajlm-2505	104	15	globulin	globulin	NOUN
ajlm-2505	104	16	ratio	ratio	NOUN
ajlm-2505	104	17	,	,	PUNCT
ajlm-2505	104	18	and	and	CCONJ
ajlm-2505	104	19	multivariable	multivariable	ADJ
ajlm-2505	104	20	logistic	logistic	ADJ
ajlm-2505	104	21	regression	regression	NOUN
ajlm-2505	104	22	models	model	NOUN
ajlm-2505	104	23	for	for	ADP
ajlm-2505	104	24	predicting	predict	VERB
ajlm-2505	104	25	monoclonality	monoclonality	NOUN
ajlm-2505	104	26	in	in	ADP
ajlm-2505	104	27	patients	patient	NOUN
ajlm-2505	104	28	evaluated	evaluate	VERB
ajlm-2505	104	29	for	for	ADP
ajlm-2505	104	30	monoclonal	monoclonal	NOUN
ajlm-2505	104	31	gammopathy	gammopathy	ADJ
ajlm-2505	104	32	at	at	ADP
ajlm-2505	104	33	a	a	DET
ajlm-2505	104	34	tertiary	tertiary	ADJ
ajlm-2505	104	35	hospital	hospital	NOUN
ajlm-2505	104	36	laboratory	laboratory	NOUN
ajlm-2505	104	37	in	in	ADP
ajlm-2505	104	38	south	south	PROPN
ajlm-2505	104	39	africa	africa	PROPN
ajlm-2505	104	40	from	from	ADP
ajlm-2505	104	41	01	01	NUM
ajlm-2505	104	42	september	september	PROPN
ajlm-2505	104	43	2015	2015	NUM
ajlm-2505	104	44	to	to	ADP
ajlm-2505	104	45	30	30	NUM
ajlm-2505	104	46	september	september	PROPN
ajlm-2505	104	47	2022	2022	NUM
ajlm-2505	104	48	.	.	PUNCT
ajlm-2505	105	1	including	include	VERB
ajlm-2505	105	2	hypogammaglobulinaemic	hypogammaglobulinaemic	ADJ
ajlm-2505	105	3	patients	patient	NOUN
ajlm-2505	105	4	detracted	detract	VERB
ajlm-2505	105	5	from	from	ADP
ajlm-2505	105	6	the	the	DET
ajlm-2505	105	7	predictive	predictive	ADJ
ajlm-2505	105	8	power	power	NOUN
ajlm-2505	105	9	of	of	ADP
ajlm-2505	105	10	both	both	DET
ajlm-2505	105	11	metrics	metric	NOUN
ajlm-2505	105	12	.	.	PUNCT
ajlm-2505	106	1	excluding	exclude	VERB
ajlm-2505	106	2	these	these	DET
ajlm-2505	106	3	patients	patient	NOUN
ajlm-2505	106	4	improved	improve	VERB
ajlm-2505	106	5	the	the	DET
ajlm-2505	106	6	auc	auc	NOUN
ajlm-2505	106	7	to	to	ADP
ajlm-2505	106	8	0.68	0.68	NUM
ajlm-2505	106	9	for	for	ADP
ajlm-2505	106	10	both	both	PRON
ajlm-2505	106	11	.	.	PUNCT
ajlm-2505	107	1	performance	performance	NOUN
ajlm-2505	107	2	was	be	AUX
ajlm-2505	107	3	further	far	ADV
ajlm-2505	107	4	influenced	influence	VERB
ajlm-2505	107	5	by	by	ADP
ajlm-2505	107	6	clinically	clinically	ADV
ajlm-2505	107	7	relevant	relevant	ADJ
ajlm-2505	107	8	albumin	albumin	NOUN
ajlm-2505	107	9	and	and	CCONJ
ajlm-2505	107	10	total	total	ADJ
ajlm-2505	107	11	protein	protein	NOUN
ajlm-2505	107	12	categories	category	NOUN
ajlm-2505	107	13	(	(	PUNCT
ajlm-2505	107	14	table	table	NOUN
ajlm-2505	107	15	2	2	NUM
ajlm-2505	107	16	;	;	PUNCT
ajlm-2505	107	17	figure	figure	NOUN
ajlm-2505	107	18	2b	2b	NOUN
ajlm-2505	107	19	and	and	CCONJ
ajlm-2505	107	20	2c	2c	NUM
ajlm-2505	107	21	)	)	PUNCT
ajlm-2505	107	22	.	.	PUNCT
ajlm-2505	108	1	the	the	DET
ajlm-2505	108	2	gamma	gamma	NOUN
ajlm-2505	108	3	gap	gap	NOUN
ajlm-2505	108	4	and	and	CCONJ
ajlm-2505	108	5	agr	agr	NOUN
ajlm-2505	108	6	performed	perform	VERB
ajlm-2505	108	7	better	well	ADV
ajlm-2505	108	8	in	in	ADP
ajlm-2505	108	9	patients	patient	NOUN
ajlm-2505	108	10	with	with	ADP
ajlm-2505	108	11	low	low	ADJ
ajlm-2505	108	12	albumin	albumin	NOUN
ajlm-2505	108	13	(	(	PUNCT
ajlm-2505	108	14	auc	auc	X
ajlm-2505	108	15	both	both	DET
ajlm-2505	108	16	0.67	0.67	NUM
ajlm-2505	108	17	)	)	PUNCT
ajlm-2505	108	18	and	and	CCONJ
ajlm-2505	108	19	even	even	ADV
ajlm-2505	108	20	better	well	ADJ
ajlm-2505	108	21	when	when	SCONJ
ajlm-2505	108	22	hypogammaglobulinaemic	hypogammaglobulinaemic	ADJ
ajlm-2505	108	23	patients	patient	NOUN
ajlm-2505	108	24	were	be	AUX
ajlm-2505	108	25	excluded	exclude	VERB
ajlm-2505	108	26	(	(	PUNCT
ajlm-2505	108	27	auc	auc	NOUN
ajlm-2505	108	28	0.75	0.75	NUM
ajlm-2505	108	29	and	and	CCONJ
ajlm-2505	108	30	0.73	0.73	NUM
ajlm-2505	108	31	)	)	PUNCT
ajlm-2505	108	32	.	.	PUNCT
ajlm-2505	109	1	both	both	DET
ajlm-2505	109	2	metrics	metric	NOUN
ajlm-2505	109	3	showed	show	VERB
ajlm-2505	109	4	improved	improved	ADJ
ajlm-2505	109	5	performance	performance	NOUN
ajlm-2505	109	6	in	in	ADP
ajlm-2505	109	7	patients	patient	NOUN
ajlm-2505	109	8	with	with	ADP
ajlm-2505	109	9	high	high	ADJ
ajlm-2505	109	10	total	total	ADJ
ajlm-2505	109	11	protein	protein	NOUN
ajlm-2505	109	12	(	(	PUNCT
ajlm-2505	109	13	auc	auc	NOUN
ajlm-2505	109	14	0.81	0.81	NUM
ajlm-2505	109	15	and	and	CCONJ
ajlm-2505	109	16	0.80	0.80	NUM
ajlm-2505	109	17	)	)	PUNCT
ajlm-2505	109	18	.	.	PUNCT
ajlm-2505	110	1	excluding	exclude	VERB
ajlm-2505	110	2	hypogammaglobulinaemic	hypogammaglobulinaemic	ADJ
ajlm-2505	110	3	patients	patient	NOUN
ajlm-2505	110	4	did	do	AUX
ajlm-2505	110	5	not	not	PART
ajlm-2505	110	6	affect	affect	VERB
ajlm-2505	110	7	performance	performance	NOUN
ajlm-2505	110	8	in	in	ADP
ajlm-2505	110	9	this	this	DET
ajlm-2505	110	10	subgroup	subgroup	NOUN
ajlm-2505	110	11	.	.	PUNCT
ajlm-2505	111	1	conversely	conversely	ADV
ajlm-2505	111	2	,	,	PUNCT
ajlm-2505	111	3	the	the	DET
ajlm-2505	111	4	metrics	metric	NOUN
ajlm-2505	111	5	performed	perform	VERB
ajlm-2505	111	6	more	more	ADV
ajlm-2505	111	7	poorly	poorly	ADV
ajlm-2505	111	8	in	in	ADP
ajlm-2505	111	9	subgroups	subgroup	NOUN
ajlm-2505	111	10	with	with	ADP
ajlm-2505	111	11	normal	normal	ADJ
ajlm-2505	111	12	/	/	SYM
ajlm-2505	111	13	raised	raise	VERB
ajlm-2505	111	14	albumin	albumin	NOUN
ajlm-2505	111	15	and	and	CCONJ
ajlm-2505	111	16	low	low	ADJ
ajlm-2505	111	17	/	/	SYM
ajlm-2505	111	18	normal	normal	ADJ
ajlm-2505	111	19	total	total	ADJ
ajlm-2505	111	20	protein	protein	NOUN
ajlm-2505	111	21	.	.	PUNCT
ajlm-2505	112	1	excluding	exclude	VERB
ajlm-2505	112	2	hypogammaglobulinaemic	hypogammaglobulinaemic	ADJ
ajlm-2505	112	3	patients	patient	NOUN
ajlm-2505	112	4	from	from	ADP
ajlm-2505	112	5	these	these	DET
ajlm-2505	112	6	analyses	analysis	NOUN
ajlm-2505	112	7	improved	improve	VERB
ajlm-2505	112	8	the	the	DET
ajlm-2505	112	9	performance	performance	NOUN
ajlm-2505	112	10	in	in	ADP
ajlm-2505	112	11	the	the	DET
ajlm-2505	112	12	normal	normal	ADJ
ajlm-2505	112	13	/	/	SYM
ajlm-2505	112	14	raised	raise	VERB
ajlm-2505	112	15	albumin	albumin	ADJ
ajlm-2505	112	16	group	group	NOUN
ajlm-2505	112	17	(	(	PUNCT
ajlm-2505	112	18	auc	auc	NOUN
ajlm-2505	112	19	0.61	0.61	NUM
ajlm-2505	112	20	and	and	CCONJ
ajlm-2505	112	21	0.62	0.62	NUM
ajlm-2505	112	22	)	)	PUNCT
ajlm-2505	112	23	.	.	PUNCT
ajlm-2505	113	1	logistic	logistic	ADJ
ajlm-2505	113	2	regression	regression	NOUN
ajlm-2505	113	3	models	model	VERB
ajlm-2505	113	4	two	two	NUM
ajlm-2505	113	5	multivariable	multivariable	ADJ
ajlm-2505	113	6	models	model	NOUN
ajlm-2505	113	7	were	be	AUX
ajlm-2505	113	8	developed	develop	VERB
ajlm-2505	113	9	for	for	ADP
ajlm-2505	113	10	the	the	DET
ajlm-2505	113	11	gamma	gamma	NOUN
ajlm-2505	113	12	gap	gap	NOUN
ajlm-2505	113	13	and	and	CCONJ
ajlm-2505	113	14	agr	agr	NOUN
ajlm-2505	113	15	using	use	VERB
ajlm-2505	113	16	an	an	DET
ajlm-2505	113	17	iterative	iterative	NOUN
ajlm-2505	113	18	process	process	NOUN
ajlm-2505	113	19	.	.	PUNCT
ajlm-2505	114	1	univariable	univariable	ADJ
ajlm-2505	114	2	logistic	logistic	ADJ
ajlm-2505	114	3	regression	regression	NOUN
ajlm-2505	114	4	indicated	indicate	VERB
ajlm-2505	114	5	that	that	SCONJ
ajlm-2505	114	6	gamma	gamma	NOUN
ajlm-2505	114	7	gap	gap	PROPN
ajlm-2505	114	8	,	,	PUNCT
ajlm-2505	114	9	agr	agr	NOUN
ajlm-2505	114	10	,	,	PUNCT
ajlm-2505	114	11	age	age	NOUN
ajlm-2505	114	12	,	,	PUNCT
ajlm-2505	114	13	albumin	albumin	NOUN
ajlm-2505	114	14	,	,	PUNCT
ajlm-2505	114	15	and	and	CCONJ
ajlm-2505	114	16	total	total	ADJ
ajlm-2505	114	17	protein	protein	NOUN
ajlm-2505	114	18	,	,	PUNCT
ajlm-2505	114	19	as	as	ADV
ajlm-2505	114	20	well	well	ADV
ajlm-2505	114	21	as	as	ADP
ajlm-2505	114	22	the	the	DET
ajlm-2505	114	23	categories	category	NOUN
ajlm-2505	114	24	sex	sex	NOUN
ajlm-2505	114	25	,	,	PUNCT
ajlm-2505	114	26	albumin	albumin	NOUN
ajlm-2505	114	27	,	,	PUNCT
ajlm-2505	114	28	protein	protein	NOUN
ajlm-2505	114	29	,	,	PUNCT
ajlm-2505	114	30	and	and	CCONJ
ajlm-2505	114	31	hypogammaglobulinaemia	hypogammaglobulinaemia	NOUN
ajlm-2505	114	32	,	,	PUNCT
ajlm-2505	114	33	were	be	AUX
ajlm-2505	114	34	all	all	PRON
ajlm-2505	114	35	predictors	predictor	NOUN
ajlm-2505	114	36	of	of	ADP
ajlm-2505	114	37	the	the	DET
ajlm-2505	114	38	outcome	outcome	NOUN
ajlm-2505	114	39	(	(	PUNCT
ajlm-2505	114	40	all	all	PRON
ajlm-2505	114	41	p	p	X
ajlm-2505	114	42	<	<	X
ajlm-2505	114	43	0.001	0.001	NUM
ajlm-2505	114	44	;	;	PUNCT
ajlm-2505	114	45	online	online	ADJ
ajlm-2505	114	46	supplementary	supplementary	ADJ
ajlm-2505	114	47	table	table	NOUN
ajlm-2505	114	48	2	2	NUM
ajlm-2505	114	49	)	)	PUNCT
ajlm-2505	114	50	.	.	PUNCT
ajlm-2505	115	1	during	during	ADP
ajlm-2505	115	2	development	development	NOUN
ajlm-2505	115	3	,	,	PUNCT
ajlm-2505	115	4	high	high	ADJ
ajlm-2505	115	5	correlation	correlation	NOUN
ajlm-2505	115	6	between	between	ADP
ajlm-2505	115	7	gamma	gamma	NOUN
ajlm-2505	115	8	gap	gap	NOUN
ajlm-2505	115	9	,	,	PUNCT
ajlm-2505	115	10	agr	agr	NOUN
ajlm-2505	115	11	,	,	PUNCT
ajlm-2505	115	12	total	total	ADJ
ajlm-2505	115	13	protein	protein	NOUN
ajlm-2505	115	14	,	,	PUNCT
ajlm-2505	115	15	and	and	CCONJ
ajlm-2505	115	16	albumin	albumin	NOUN
ajlm-2505	115	17	prompted	prompt	VERB
ajlm-2505	115	18	development	development	NOUN
ajlm-2505	115	19	of	of	ADP
ajlm-2505	115	20	two	two	NUM
ajlm-2505	115	21	separate	separate	ADJ
ajlm-2505	115	22	multivariable	multivariable	ADJ
ajlm-2505	115	23	models	model	NOUN
ajlm-2505	115	24	:	:	PUNCT
ajlm-2505	115	25	the	the	DET
ajlm-2505	115	26	‘	'	PUNCT
ajlm-2505	115	27	gap	gap	NOUN
ajlm-2505	115	28	’	'	PUNCT
ajlm-2505	115	29	model	model	NOUN
ajlm-2505	115	30	and	and	CCONJ
ajlm-2505	115	31	the	the	DET
ajlm-2505	115	32	agr	agr	PROPN
ajlm-2505	115	33	model	model	NOUN
ajlm-2505	115	34	.	.	PUNCT
ajlm-2505	116	1	initially	initially	ADV
ajlm-2505	116	2	,	,	PUNCT
ajlm-2505	116	3	the	the	DET
ajlm-2505	116	4	gap	gap	NOUN
ajlm-2505	116	5	model	model	NOUN
ajlm-2505	116	6	included	include	VERB
ajlm-2505	116	7	gamma	gamma	NOUN
ajlm-2505	116	8	gap	gap	NOUN
ajlm-2505	116	9	,	,	PUNCT
ajlm-2505	116	10	age	age	NOUN
ajlm-2505	116	11	,	,	PUNCT
ajlm-2505	116	12	sex	sex	NOUN
ajlm-2505	116	13	,	,	PUNCT
ajlm-2505	116	14	and	and	CCONJ
ajlm-2505	116	15	categories	category	NOUN
ajlm-2505	116	16	for	for	ADP
ajlm-2505	116	17	albumin	albumin	ADJ
ajlm-2505	116	18	,	,	PUNCT
ajlm-2505	116	19	total	total	ADJ
ajlm-2505	116	20	protein	protein	NOUN
ajlm-2505	116	21	,	,	PUNCT
ajlm-2505	116	22	and	and	CCONJ
ajlm-2505	116	23	hypogammaglobulinaemia	hypogammaglobulinaemia	NOUN
ajlm-2505	116	24	.	.	PUNCT
ajlm-2505	117	1	during	during	ADP
ajlm-2505	117	2	optimisation	optimisation	NOUN
ajlm-2505	117	3	,	,	PUNCT
ajlm-2505	117	4	albumin	albumin	NOUN
ajlm-2505	117	5	and	and	CCONJ
ajlm-2505	117	6	protein	protein	NOUN
ajlm-2505	117	7	categories	category	NOUN
ajlm-2505	117	8	were	be	AUX
ajlm-2505	117	9	excluded	exclude	VERB
ajlm-2505	117	10	–	–	PUNCT
ajlm-2505	117	11	adding	add	VERB
ajlm-2505	117	12	complexity	complexity	NOUN
ajlm-2505	117	13	without	without	ADP
ajlm-2505	117	14	improving	improve	VERB
ajlm-2505	117	15	predictive	predictive	ADJ
ajlm-2505	117	16	power	power	NOUN
ajlm-2505	117	17	(	(	PUNCT
ajlm-2505	117	18	online	online	ADJ
ajlm-2505	117	19	supplementary	supplementary	ADJ
ajlm-2505	117	20	table	table	NOUN
ajlm-2505	117	21	3	3	NUM
ajlm-2505	117	22	)	)	PUNCT
ajlm-2505	117	23	.	.	PUNCT
ajlm-2505	118	1	similarly	similarly	ADV
ajlm-2505	118	2	,	,	PUNCT
ajlm-2505	118	3	the	the	DET
ajlm-2505	118	4	albumin	albumin	ADJ
ajlm-2505	118	5	category	category	NOUN
ajlm-2505	118	6	was	be	AUX
ajlm-2505	118	7	excluded	exclude	VERB
ajlm-2505	118	8	from	from	ADP
ajlm-2505	118	9	the	the	DET
ajlm-2505	118	10	agr	agr	PROPN
ajlm-2505	118	11	model	model	NOUN
ajlm-2505	118	12	.	.	PUNCT
ajlm-2505	119	1	the	the	DET
ajlm-2505	119	2	final	final	ADJ
ajlm-2505	119	3	gap	gap	NOUN
ajlm-2505	119	4	model	model	NOUN
ajlm-2505	119	5	,	,	PUNCT
ajlm-2505	119	6	based	base	VERB
ajlm-2505	119	7	on	on	ADP
ajlm-2505	119	8	5578	5578	NUM
ajlm-2505	119	9	observations	observation	NOUN
ajlm-2505	119	10	,	,	PUNCT
ajlm-2505	119	11	converged	converge	VERB
ajlm-2505	119	12	successfully	successfully	ADV
ajlm-2505	119	13	and	and	CCONJ
ajlm-2505	119	14	explained	explain	VERB
ajlm-2505	119	15	18	18	NUM
ajlm-2505	119	16	%	%	NOUN
ajlm-2505	119	17	of	of	ADP
ajlm-2505	119	18	the	the	DET
ajlm-2505	119	19	variance	variance	NOUN
ajlm-2505	119	20	(	(	PUNCT
ajlm-2505	119	21	pseudo	pseudo	NOUN
ajlm-2505	119	22	r2	r2	NOUN
ajlm-2505	119	23	=	=	NOUN
ajlm-2505	119	24	0.180	0.180	NUM
ajlm-2505	119	25	)	)	PUNCT
ajlm-2505	119	26	,	,	PUNCT
ajlm-2505	119	27	while	while	SCONJ
ajlm-2505	119	28	log	log	NOUN
ajlm-2505	119	29	-	-	PUNCT
ajlm-2505	119	30	likelihood	likelihood	NOUN
ajlm-2505	119	31	was	be	AUX
ajlm-2505	119	32	−1984.5	−1984.5	PROPN
ajlm-2505	119	33	,	,	PUNCT
ajlm-2505	119	34	outperforming	outperform	VERB
ajlm-2505	119	35	the	the	DET
ajlm-2505	119	36	null	null	ADJ
ajlm-2505	119	37	model	model	NOUN
ajlm-2505	119	38	(	(	PUNCT
ajlm-2505	119	39	−2419.9	−2419.9	PROPN
ajlm-2505	119	40	)	)	PUNCT
ajlm-2505	119	41	.	.	PUNCT
ajlm-2505	120	1	the	the	DET
ajlm-2505	120	2	likelihood	likelihood	NOUN
ajlm-2505	120	3	ratio	ratio	NOUN
ajlm-2505	120	4	test	test	NOUN
ajlm-2505	120	5	confirmed	confirm	VERB
ajlm-2505	120	6	the	the	DET
ajlm-2505	120	7	joint	joint	ADJ
ajlm-2505	120	8	significance	significance	NOUN
ajlm-2505	120	9	of	of	ADP
ajlm-2505	120	10	predictors	predictor	NOUN
ajlm-2505	120	11	(	(	PUNCT
ajlm-2505	120	12	p	p	X
ajlm-2505	120	13	<	<	X
ajlm-2505	120	14	0.0001	0.0001	NUM
ajlm-2505	120	15	)	)	PUNCT
ajlm-2505	120	16	.	.	PUNCT
ajlm-2505	121	1	the	the	DET
ajlm-2505	121	2	gap	gap	NOUN
ajlm-2505	121	3	model	model	NOUN
ajlm-2505	121	4	achieved	achieve	VERB
ajlm-2505	121	5	auc	auc	NOUN
ajlm-2505	121	6	0.73	0.73	NUM
ajlm-2505	121	7	,	,	PUNCT
ajlm-2505	121	8	sensitivity	sensitivity	NOUN
ajlm-2505	121	9	58	58	NUM
ajlm-2505	121	10	%	%	NOUN
ajlm-2505	121	11	and	and	CCONJ
ajlm-2505	121	12	specificity	specificity	NOUN
ajlm-2505	121	13	78	78	NUM
ajlm-2505	121	14	%	%	NOUN
ajlm-2505	121	15	(	(	PUNCT
ajlm-2505	121	16	table	table	NOUN
ajlm-2505	121	17	2	2	NUM
ajlm-2505	121	18	;	;	PUNCT
ajlm-2505	121	19	figure	figure	NOUN
ajlm-2505	121	20	2d	2d	NOUN
ajlm-2505	121	21	)	)	PUNCT
ajlm-2505	121	22	.	.	PUNCT
ajlm-2505	122	1	the	the	DET
ajlm-2505	122	2	agr	agr	PROPN
ajlm-2505	122	3	model	model	NOUN
ajlm-2505	122	4	performed	perform	VERB
ajlm-2505	122	5	similarly	similarly	ADV
ajlm-2505	122	6	,	,	PUNCT
ajlm-2505	122	7	with	with	ADP
ajlm-2505	122	8	auc	auc	NOUN
ajlm-2505	122	9	0.71	0.71	NUM
ajlm-2505	122	10	(	(	PUNCT
ajlm-2505	122	11	sensitivity	sensitivity	NOUN
ajlm-2505	122	12	55	55	NUM
ajlm-2505	122	13	%	%	NOUN
ajlm-2505	122	14	and	and	CCONJ
ajlm-2505	122	15	specificity	specificity	NOUN
ajlm-2505	122	16	81	81	NUM
ajlm-2505	122	17	%	%	NOUN
ajlm-2505	122	18	)	)	PUNCT
ajlm-2505	122	19	.	.	PUNCT
ajlm-2505	123	1	we	we	PRON
ajlm-2505	123	2	then	then	ADV
ajlm-2505	123	3	assessed	assess	VERB
ajlm-2505	123	4	how	how	SCONJ
ajlm-2505	123	5	well	well	ADV
ajlm-2505	123	6	the	the	DET
ajlm-2505	123	7	gamma	gamma	NOUN
ajlm-2505	123	8	gap	gap	NOUN
ajlm-2505	123	9	and	and	CCONJ
ajlm-2505	123	10	agr	agr	NOUN
ajlm-2505	123	11	could	could	AUX
ajlm-2505	123	12	predict	predict	VERB
ajlm-2505	123	13	hypogammaglobulinaemia	hypogammaglobulinaemia	NOUN
ajlm-2505	123	14	(	(	PUNCT
ajlm-2505	123	15	online	online	ADJ
ajlm-2505	123	16	supplementary	supplementary	ADJ
ajlm-2505	123	17	table	table	NOUN
ajlm-2505	123	18	4	4	NUM
ajlm-2505	123	19	)	)	PUNCT
ajlm-2505	123	20	.	.	PUNCT
ajlm-2505	124	1	at	at	ADP
ajlm-2505	124	2	an	an	DET
ajlm-2505	124	3	optimal	optimal	ADJ
ajlm-2505	124	4	cutoff	cutoff	NOUN
ajlm-2505	124	5	of	of	ADP
ajlm-2505	124	6	27	27	NUM
ajlm-2505	124	7	g	g	NOUN
ajlm-2505	124	8	/	/	SYM
ajlm-2505	124	9	l	l	NOUN
ajlm-2505	124	10	,	,	PUNCT
ajlm-2505	124	11	the	the	DET
ajlm-2505	124	12	gamma	gamma	NOUN
ajlm-2505	124	13	gap	gap	NOUN
ajlm-2505	124	14	performed	perform	VERB
ajlm-2505	124	15	well	well	ADV
ajlm-2505	124	16	,	,	PUNCT
ajlm-2505	124	17	with	with	ADP
ajlm-2505	124	18	auc	auc	NOUN
ajlm-2505	124	19	0.86	0.86	NUM
ajlm-2505	124	20	,	,	PUNCT
ajlm-2505	124	21	sensitivity	sensitivity	NOUN
ajlm-2505	124	22	80	80	NUM
ajlm-2505	124	23	%	%	NOUN
ajlm-2505	124	24	and	and	CCONJ
ajlm-2505	124	25	specificity	specificity	NOUN
ajlm-2505	124	26	83	83	NUM
ajlm-2505	124	27	%	%	NOUN
ajlm-2505	124	28	.	.	PUNCT
ajlm-2505	125	1	the	the	DET
ajlm-2505	125	2	agr	agr	NOUN
ajlm-2505	125	3	was	be	AUX
ajlm-2505	125	4	considerably	considerably	ADV
ajlm-2505	125	5	less	less	ADV
ajlm-2505	125	6	sensitive	sensitive	ADJ
ajlm-2505	125	7	(	(	PUNCT
ajlm-2505	125	8	57	57	NUM
ajlm-2505	125	9	%	%	NOUN
ajlm-2505	125	10	)	)	PUNCT
ajlm-2505	125	11	and	and	CCONJ
ajlm-2505	125	12	specific	specific	ADJ
ajlm-2505	125	13	(	(	PUNCT
ajlm-2505	125	14	75	75	NUM
ajlm-2505	125	15	%	%	NOUN
ajlm-2505	125	16	)	)	PUNCT
ajlm-2505	125	17	,	,	PUNCT
ajlm-2505	125	18	with	with	ADP
ajlm-2505	125	19	auc	auc	NOUN
ajlm-2505	125	20	0.71	0.71	NUM
ajlm-2505	125	21	.	.	PUNCT
ajlm-2505	126	1	model	model	PROPN
ajlm-2505	126	2	comparison	comparison	NOUN
ajlm-2505	126	3	the	the	DET
ajlm-2505	126	4	performance	performance	NOUN
ajlm-2505	126	5	of	of	ADP
ajlm-2505	126	6	the	the	DET
ajlm-2505	126	7	two	two	NUM
ajlm-2505	126	8	multivariable	multivariable	ADJ
ajlm-2505	126	9	models	model	NOUN
ajlm-2505	126	10	was	be	AUX
ajlm-2505	126	11	compared	compare	VERB
ajlm-2505	126	12	with	with	ADP
ajlm-2505	126	13	the	the	DET
ajlm-2505	126	14	univariable	univariable	ADJ
ajlm-2505	126	15	models	model	NOUN
ajlm-2505	126	16	for	for	ADP
ajlm-2505	126	17	gamma	gamma	NOUN
ajlm-2505	126	18	gap	gap	NOUN
ajlm-2505	126	19	and	and	CCONJ
ajlm-2505	126	20	agr	agr	NOUN
ajlm-2505	126	21	.	.	PUNCT
ajlm-2505	127	1	the	the	DET
ajlm-2505	127	2	aic	aic	PROPN
ajlm-2505	127	3	values	value	NOUN
ajlm-2505	127	4	were	be	AUX
ajlm-2505	127	5	3979	3979	NUM
ajlm-2505	127	6	for	for	ADP
ajlm-2505	127	7	the	the	DET
ajlm-2505	127	8	multivariable	multivariable	ADJ
ajlm-2505	127	9	gap	gap	NOUN
ajlm-2505	127	10	model	model	NOUN
ajlm-2505	127	11	and	and	CCONJ
ajlm-2505	127	12	4211	4211	NUM
ajlm-2505	127	13	for	for	ADP
ajlm-2505	127	14	the	the	DET
ajlm-2505	127	15	agr	agr	PROPN
ajlm-2505	127	16	model	model	NOUN
ajlm-2505	127	17	,	,	PUNCT
ajlm-2505	127	18	suggesting	suggest	VERB
ajlm-2505	127	19	that	that	SCONJ
ajlm-2505	127	20	the	the	DET
ajlm-2505	127	21	gap	gap	NOUN
ajlm-2505	127	22	model	model	NOUN
ajlm-2505	127	23	provided	provide	VERB
ajlm-2505	127	24	a	a	DET
ajlm-2505	127	25	better	well	ADJ
ajlm-2505	127	26	balance	balance	NOUN
ajlm-2505	127	27	between	between	ADP
ajlm-2505	127	28	goodness	goodness	NOUN
ajlm-2505	127	29	-	-	PUNCT
ajlm-2505	127	30	of	of	ADP
ajlm-2505	127	31	-	-	PUNCT
ajlm-2505	127	32	fit	fit	ADJ
ajlm-2505	127	33	and	and	CCONJ
ajlm-2505	127	34	complexity	complexity	NOUN
ajlm-2505	127	35	.	.	PUNCT
ajlm-2505	128	1	in	in	ADP
ajlm-2505	128	2	contrast	contrast	NOUN
ajlm-2505	128	3	,	,	PUNCT
ajlm-2505	128	4	the	the	DET
ajlm-2505	128	5	aic	aic	PROPN
ajlm-2505	128	6	values	value	NOUN
ajlm-2505	128	7	for	for	ADP
ajlm-2505	128	8	the	the	DET
ajlm-2505	128	9	univariable	univariable	ADJ
ajlm-2505	128	10	models	model	NOUN
ajlm-2505	128	11	were	be	AUX
ajlm-2505	128	12	much	much	ADV
ajlm-2505	128	13	higher	high	ADJ
ajlm-2505	128	14	(	(	PUNCT
ajlm-2505	128	15	6320	6320	NUM
ajlm-2505	128	16	for	for	ADP
ajlm-2505	128	17	the	the	DET
ajlm-2505	128	18	gap	gap	NOUN
ajlm-2505	128	19	model	model	NOUN
ajlm-2505	128	20	,	,	PUNCT
ajlm-2505	128	21	and	and	CCONJ
ajlm-2505	128	22	6655	6655	NUM
ajlm-2505	128	23	for	for	ADP
ajlm-2505	128	24	the	the	DET
ajlm-2505	128	25	agr	agr	PROPN
ajlm-2505	128	26	model	model	PROPN
ajlm-2505	128	27	)	)	PUNCT
ajlm-2505	128	28	,	,	PUNCT
ajlm-2505	128	29	indicating	indicate	VERB
ajlm-2505	128	30	that	that	SCONJ
ajlm-2505	128	31	the	the	DET
ajlm-2505	128	32	multivariable	multivariable	ADJ
ajlm-2505	128	33	models	model	NOUN
ajlm-2505	128	34	offered	offer	VERB
ajlm-2505	128	35	superior	superior	ADJ
ajlm-2505	128	36	performance	performance	NOUN
ajlm-2505	128	37	despite	despite	SCONJ
ajlm-2505	128	38	their	their	PRON
ajlm-2505	128	39	complexity	complexity	NOUN
ajlm-2505	128	40	.	.	PUNCT
ajlm-2505	129	1	confusion	confusion	NOUN
ajlm-2505	129	2	matrices	matrix	NOUN
ajlm-2505	129	3	and	and	CCONJ
ajlm-2505	129	4	classification	classification	NOUN
ajlm-2505	129	5	reports	report	NOUN
ajlm-2505	129	6	showed	show	VERB
ajlm-2505	129	7	that	that	SCONJ
ajlm-2505	129	8	multivariable	multivariable	ADJ
ajlm-2505	129	9	models	model	NOUN
ajlm-2505	129	10	achieved	achieve	VERB
ajlm-2505	129	11	higher	high	ADJ
ajlm-2505	129	12	accuracy	accuracy	NOUN
ajlm-2505	129	13	,	,	PUNCT
ajlm-2505	129	14	with	with	ADP
ajlm-2505	129	15	gap	gap	NOUN
ajlm-2505	129	16	and	and	CCONJ
ajlm-2505	129	17	agr	agr	NOUN
ajlm-2505	129	18	models	model	NOUN
ajlm-2505	129	19	achieving	achieve	VERB
ajlm-2505	129	20	75	75	NUM
ajlm-2505	129	21	%	%	NOUN
ajlm-2505	129	22	and	and	CCONJ
ajlm-2505	129	23	78	78	NUM
ajlm-2505	129	24	%	%	NOUN
ajlm-2505	129	25	accuracy	accuracy	NOUN
ajlm-2505	129	26	,	,	PUNCT
ajlm-2505	129	27	compared	compare	VERB
ajlm-2505	129	28	to	to	ADP
ajlm-2505	129	29	69	69	NUM
ajlm-2505	129	30	%	%	NOUN
ajlm-2505	129	31	and	and	CCONJ
ajlm-2505	129	32	75	75	NUM
ajlm-2505	129	33	%	%	NOUN
ajlm-2505	129	34	for	for	ADP
ajlm-2505	129	35	the	the	DET
ajlm-2505	129	36	univariable	univariable	ADJ
ajlm-2505	129	37	models	model	NOUN
ajlm-2505	129	38	,	,	PUNCT
ajlm-2505	129	39	respectively	respectively	ADV
ajlm-2505	129	40	(	(	PUNCT
ajlm-2505	129	41	online	online	ADJ
ajlm-2505	129	42	supplementary	supplementary	ADJ
ajlm-2505	129	43	figure	figure	NOUN
ajlm-2505	129	44	3	3	NUM
ajlm-2505	129	45	;	;	PUNCT
ajlm-2505	129	46	online	online	ADJ
ajlm-2505	129	47	supplementary	supplementary	ADJ
ajlm-2505	129	48	table	table	NOUN
ajlm-2505	129	49	5	5	NUM
ajlm-2505	129	50	)	)	PUNCT
ajlm-2505	129	51	.	.	PUNCT
ajlm-2505	130	1	discussion	discussion	NOUN
ajlm-2505	130	2	our	our	PRON
ajlm-2505	130	3	findings	finding	NOUN
ajlm-2505	130	4	highlight	highlight	VERB
ajlm-2505	130	5	that	that	SCONJ
ajlm-2505	130	6	the	the	DET
ajlm-2505	130	7	gamma	gamma	NOUN
ajlm-2505	130	8	gap	gap	NOUN
ajlm-2505	130	9	and	and	CCONJ
ajlm-2505	130	10	agr	agr	NOUN
ajlm-2505	130	11	provide	provide	VERB
ajlm-2505	130	12	limited	limited	ADJ
ajlm-2505	130	13	diagnostic	diagnostic	ADJ
ajlm-2505	130	14	accuracy	accuracy	NOUN
ajlm-2505	130	15	for	for	ADP
ajlm-2505	130	16	identifying	identify	VERB
ajlm-2505	130	17	monoclonal	monoclonal	NOUN
ajlm-2505	130	18	gammopathies	gammopathy	NOUN
ajlm-2505	130	19	in	in	ADP
ajlm-2505	130	20	real	real	ADJ
ajlm-2505	130	21	-	-	PUNCT
ajlm-2505	130	22	world	world	NOUN
ajlm-2505	130	23	clinical	clinical	ADJ
ajlm-2505	130	24	settings	setting	NOUN
ajlm-2505	130	25	with	with	ADP
ajlm-2505	130	26	a	a	DET
ajlm-2505	130	27	high	high	ADJ
ajlm-2505	130	28	burden	burden	NOUN
ajlm-2505	130	29	of	of	ADP
ajlm-2505	130	30	inflammatory	inflammatory	ADJ
ajlm-2505	130	31	and	and	CCONJ
ajlm-2505	130	32	infectious	infectious	ADJ
ajlm-2505	130	33	diseases	disease	NOUN
ajlm-2505	130	34	,	,	PUNCT
ajlm-2505	130	35	such	such	ADJ
ajlm-2505	130	36	as	as	ADP
ajlm-2505	130	37	in	in	ADP
ajlm-2505	130	38	south	south	PROPN
ajlm-2505	130	39	africa	africa	PROPN
ajlm-2505	130	40	.	.	PUNCT
ajlm-2505	131	1	the	the	DET
ajlm-2505	131	2	low	low	ADJ
ajlm-2505	131	3	sensitivity	sensitivity	NOUN
ajlm-2505	131	4	of	of	ADP
ajlm-2505	131	5	these	these	DET
ajlm-2505	131	6	tests	test	NOUN
ajlm-2505	131	7	indicates	indicate	VERB
ajlm-2505	131	8	a	a	DET
ajlm-2505	131	9	significant	significant	ADJ
ajlm-2505	131	10	number	number	NOUN
ajlm-2505	131	11	of	of	ADP
ajlm-2505	131	12	positive	positive	ADJ
ajlm-2505	131	13	cases	case	NOUN
ajlm-2505	131	14	may	may	AUX
ajlm-2505	131	15	go	go	VERB
ajlm-2505	131	16	undetected	undetected	ADJ
ajlm-2505	131	17	,	,	PUNCT
ajlm-2505	131	18	delaying	delay	VERB
ajlm-2505	131	19	diagnosis	diagnosis	NOUN
ajlm-2505	131	20	and	and	CCONJ
ajlm-2505	131	21	treatment	treatment	NOUN
ajlm-2505	131	22	.	.	PUNCT
ajlm-2505	132	1	however	however	ADV
ajlm-2505	132	2	,	,	PUNCT
ajlm-2505	132	3	their	their	PRON
ajlm-2505	132	4	high	high	ADJ
ajlm-2505	132	5	specificity	specificity	NOUN
ajlm-2505	132	6	ensures	ensure	VERB
ajlm-2505	132	7	accurate	accurate	ADJ
ajlm-2505	132	8	identification	identification	NOUN
ajlm-2505	132	9	of	of	ADP
ajlm-2505	132	10	most	most	ADJ
ajlm-2505	132	11	patients	patient	NOUN
ajlm-2505	132	12	without	without	ADP
ajlm-2505	132	13	the	the	DET
ajlm-2505	132	14	condition	condition	NOUN
ajlm-2505	132	15	,	,	PUNCT
ajlm-2505	132	16	reducing	reduce	VERB
ajlm-2505	132	17	false	false	ADJ
ajlm-2505	132	18	positives	positive	NOUN
ajlm-2505	132	19	and	and	CCONJ
ajlm-2505	132	20	unnecessary	unnecessary	ADJ
ajlm-2505	132	21	further	further	ADJ
ajlm-2505	132	22	investigations	investigation	NOUN
ajlm-2505	132	23	.	.	PUNCT
ajlm-2505	133	1	while	while	SCONJ
ajlm-2505	133	2	this	this	PRON
ajlm-2505	133	3	enhances	enhance	VERB
ajlm-2505	133	4	their	their	PRON
ajlm-2505	133	5	utility	utility	NOUN
ajlm-2505	133	6	for	for	ADP
ajlm-2505	133	7	ruling	rule	VERB
ajlm-2505	133	8	out	out	ADP
ajlm-2505	133	9	cases	case	NOUN
ajlm-2505	133	10	,	,	PUNCT
ajlm-2505	133	11	sensitivity	sensitivity	NOUN
ajlm-2505	133	12	should	should	AUX
ajlm-2505	133	13	be	be	AUX
ajlm-2505	133	14	prioritised	prioritise	VERB
ajlm-2505	133	15	for	for	ADP
ajlm-2505	133	16	screening	screen	VERB
ajlm-2505	133	17	purposes	purpose	NOUN
ajlm-2505	133	18	to	to	PART
ajlm-2505	133	19	ensure	ensure	VERB
ajlm-2505	133	20	all	all	DET
ajlm-2505	133	21	cases	case	NOUN
ajlm-2505	133	22	are	be	AUX
ajlm-2505	133	23	captured	capture	VERB
ajlm-2505	133	24	.	.	PUNCT
ajlm-2505	134	1	the	the	DET
ajlm-2505	134	2	sub	sub	NOUN
ajlm-2505	134	3	-	-	NOUN
ajlm-2505	134	4	group	group	NOUN
ajlm-2505	134	5	analyses	analysis	NOUN
ajlm-2505	134	6	we	we	PRON
ajlm-2505	134	7	performed	perform	VERB
ajlm-2505	134	8	offer	offer	VERB
ajlm-2505	134	9	further	further	ADJ
ajlm-2505	134	10	insights	insight	NOUN
ajlm-2505	134	11	.	.	PUNCT
ajlm-2505	135	1	the	the	DET
ajlm-2505	135	2	diagnostic	diagnostic	ADJ
ajlm-2505	135	3	performance	performance	NOUN
ajlm-2505	135	4	of	of	ADP
ajlm-2505	135	5	the	the	DET
ajlm-2505	135	6	gamma	gamma	NOUN
ajlm-2505	135	7	gap	gap	NOUN
ajlm-2505	135	8	and	and	CCONJ
ajlm-2505	135	9	agr	agr	NOUN
ajlm-2505	135	10	improved	improve	VERB
ajlm-2505	135	11	when	when	SCONJ
ajlm-2505	135	12	albumin	albumin	NOUN
ajlm-2505	135	13	and	and	CCONJ
ajlm-2505	135	14	total	total	ADJ
ajlm-2505	135	15	protein	protein	NOUN
ajlm-2505	135	16	concentration	concentration	NOUN
ajlm-2505	135	17	categories	category	NOUN
ajlm-2505	135	18	were	be	AUX
ajlm-2505	135	19	considered	consider	VERB
ajlm-2505	135	20	.	.	PUNCT
ajlm-2505	136	1	including	include	VERB
ajlm-2505	136	2	hypogammaglobulinaemic	hypogammaglobulinaemic	ADJ
ajlm-2505	136	3	patients	patient	NOUN
ajlm-2505	136	4	in	in	ADP
ajlm-2505	136	5	the	the	DET
ajlm-2505	136	6	analysis	analysis	NOUN
ajlm-2505	136	7	confounded	confound	VERB
ajlm-2505	136	8	the	the	DET
ajlm-2505	136	9	results	result	NOUN
ajlm-2505	136	10	,	,	PUNCT
ajlm-2505	136	11	as	as	SCONJ
ajlm-2505	136	12	41	41	NUM
ajlm-2505	136	13	%	%	NOUN
ajlm-2505	136	14	of	of	ADP
ajlm-2505	136	15	these	these	DET
ajlm-2505	136	16	patients	patient	NOUN
ajlm-2505	136	17	had	have	VERB
ajlm-2505	136	18	monoclonal	monoclonal	NOUN
ajlm-2505	136	19	proteins	protein	NOUN
ajlm-2505	136	20	despite	despite	SCONJ
ajlm-2505	136	21	significantly	significantly	ADV
ajlm-2505	136	22	lower	low	ADJ
ajlm-2505	136	23	total	total	ADJ
ajlm-2505	136	24	protein	protein	NOUN
ajlm-2505	136	25	and	and	CCONJ
ajlm-2505	136	26	gamma	gamma	NOUN
ajlm-2505	136	27	gap	gap	NOUN
ajlm-2505	136	28	values	value	NOUN
ajlm-2505	136	29	.	.	PUNCT
ajlm-2505	137	1	notably	notably	ADV
ajlm-2505	137	2	,	,	PUNCT
ajlm-2505	137	3	a	a	DET
ajlm-2505	137	4	low	low	ADJ
ajlm-2505	137	5	gamma	gamma	NOUN
ajlm-2505	137	6	gap	gap	NOUN
ajlm-2505	137	7	(	(	PUNCT
ajlm-2505	137	8	<	<	X
ajlm-2505	137	9	27	27	NUM
ajlm-2505	137	10	g	g	NOUN
ajlm-2505	137	11	/	/	SYM
ajlm-2505	137	12	l	l	NOUN
ajlm-2505	137	13	)	)	PUNCT
ajlm-2505	137	14	was	be	AUX
ajlm-2505	137	15	predictive	predictive	ADJ
ajlm-2505	137	16	of	of	ADP
ajlm-2505	137	17	hypogammaglobulinaemia	hypogammaglobulinaemia	NOUN
ajlm-2505	137	18	,	,	PUNCT
ajlm-2505	137	19	indicating	indicate	VERB
ajlm-2505	137	20	that	that	SCONJ
ajlm-2505	137	21	both	both	CCONJ
ajlm-2505	137	22	high	high	ADJ
ajlm-2505	137	23	and	and	CCONJ
ajlm-2505	137	24	low	low	ADJ
ajlm-2505	137	25	gamma	gamma	NOUN
ajlm-2505	137	26	gap	gap	NOUN
ajlm-2505	137	27	values	value	NOUN
ajlm-2505	137	28	should	should	AUX
ajlm-2505	137	29	raise	raise	VERB
ajlm-2505	137	30	suspicion	suspicion	NOUN
ajlm-2505	137	31	for	for	ADP
ajlm-2505	137	32	monoclonality	monoclonality	NOUN
ajlm-2505	137	33	in	in	ADP
ajlm-2505	137	34	appropriate	appropriate	ADJ
ajlm-2505	137	35	clinical	clinical	ADJ
ajlm-2505	137	36	contexts	contexts	NOUN
ajlm-2505	137	37	.	.	PUNCT
ajlm-2505	138	1	previous	previous	ADJ
ajlm-2505	138	2	studies	study	NOUN
ajlm-2505	138	3	have	have	AUX
ajlm-2505	138	4	shown	show	VERB
ajlm-2505	138	5	disparities	disparity	NOUN
ajlm-2505	138	6	in	in	ADP
ajlm-2505	138	7	diagnostic	diagnostic	ADJ
ajlm-2505	138	8	performance	performance	NOUN
ajlm-2505	138	9	across	across	ADP
ajlm-2505	138	10	different	different	ADJ
ajlm-2505	138	11	contexts	contexts	NOUN
ajlm-2505	138	12	.	.	PUNCT
ajlm-2505	139	1	in	in	ADP
ajlm-2505	139	2	an	an	DET
ajlm-2505	139	3	australian	australian	ADJ
ajlm-2505	139	4	study	study	NOUN
ajlm-2505	139	5	,	,	PUNCT
ajlm-2505	139	6	thakkinstian	thakkinstian	PROPN
ajlm-2505	139	7	et	et	PROPN
ajlm-2505	139	8	al	al	PROPN
ajlm-2505	139	9	.	.	PROPN
ajlm-2505	139	10	reported	report	VERB
ajlm-2505	139	11	higher	high	ADJ
ajlm-2505	139	12	accuracy	accuracy	NOUN
ajlm-2505	139	13	for	for	ADP
ajlm-2505	139	14	the	the	DET
ajlm-2505	139	15	gamma	gamma	NOUN
ajlm-2505	139	16	gap	gap	NOUN
ajlm-2505	139	17	,	,	PUNCT
ajlm-2505	139	18	with	with	ADP
ajlm-2505	139	19	an	an	DET
ajlm-2505	139	20	odds	odd	NOUN
ajlm-2505	139	21	ratio	ratio	NOUN
ajlm-2505	139	22	of	of	ADP
ajlm-2505	139	23	4.5	4.5	NUM
ajlm-2505	139	24	(	(	PUNCT
ajlm-2505	139	25	95	95	NUM
ajlm-2505	139	26	%	%	NOUN
ajlm-2505	139	27	ci	ci	NOUN
ajlm-2505	139	28	:	:	PUNCT
ajlm-2505	139	29	3.8–5.4	3.8–5.4	NUM
ajlm-2505	139	30	)	)	PUNCT
ajlm-2505	139	31	at	at	ADP
ajlm-2505	139	32	a	a	DET
ajlm-2505	139	33	threshold	threshold	NOUN
ajlm-2505	139	34	of	of	ADP
ajlm-2505	139	35	41	41	NUM
ajlm-2505	139	36	g	g	NOUN
ajlm-2505	139	37	/	/	SYM
ajlm-2505	139	38	l.10	l.10	NOUN
ajlm-2505	139	39	similarly	similarly	ADV
ajlm-2505	139	40	,	,	PUNCT
ajlm-2505	139	41	in	in	ADP
ajlm-2505	139	42	a	a	DET
ajlm-2505	139	43	study	study	NOUN
ajlm-2505	139	44	performed	perform	VERB
ajlm-2505	139	45	at	at	ADP
ajlm-2505	139	46	duke	duke	PROPN
ajlm-2505	139	47	university	university	PROPN
ajlm-2505	139	48	medical	medical	ADJ
ajlm-2505	139	49	center	center	NOUN
ajlm-2505	139	50	in	in	ADP
ajlm-2505	139	51	the	the	DET
ajlm-2505	139	52	united	united	PROPN
ajlm-2505	139	53	states	states	PROPN
ajlm-2505	139	54	,	,	PUNCT
ajlm-2505	139	55	dupuis	dupuis	PROPN
ajlm-2505	139	56	et	et	PROPN
ajlm-2505	139	57	al	al	PROPN
ajlm-2505	139	58	.	.	PROPN
ajlm-2505	139	59	demonstrated	demonstrate	VERB
ajlm-2505	139	60	a	a	DET
ajlm-2505	139	61	strong	strong	ADJ
ajlm-2505	139	62	correlation	correlation	NOUN
ajlm-2505	139	63	between	between	ADP
ajlm-2505	139	64	the	the	DET
ajlm-2505	139	65	gamma	gamma	NOUN
ajlm-2505	139	66	gap	gap	NOUN
ajlm-2505	139	67	and	and	CCONJ
ajlm-2505	139	68	monoclonal	monoclonal	NOUN
ajlm-2505	139	69	protein	protein	NOUN
ajlm-2505	139	70	concentrations	concentration	NOUN
ajlm-2505	139	71	,	,	PUNCT
ajlm-2505	139	72	emphasising	emphasise	VERB
ajlm-2505	139	73	its	its	PRON
ajlm-2505	139	74	potential	potential	NOUN
ajlm-2505	139	75	as	as	ADP
ajlm-2505	139	76	a	a	DET
ajlm-2505	139	77	rapid	rapid	ADJ
ajlm-2505	139	78	,	,	PUNCT
ajlm-2505	139	79	simple	simple	ADJ
ajlm-2505	139	80	test	test	NOUN
ajlm-2505	139	81	in	in	ADP
ajlm-2505	139	82	resource	resource	NOUN
ajlm-2505	139	83	-	-	PUNCT
ajlm-2505	139	84	limited	limit	VERB
ajlm-2505	139	85	settings.11	settings.11	NOUN
ajlm-2505	139	86	unlike	unlike	ADP
ajlm-2505	139	87	this	this	DET
ajlm-2505	139	88	present	present	ADJ
ajlm-2505	139	89	study	study	NOUN
ajlm-2505	139	90	,	,	PUNCT
ajlm-2505	139	91	both	both	DET
ajlm-2505	139	92	studies	study	NOUN
ajlm-2505	139	93	were	be	AUX
ajlm-2505	139	94	conducted	conduct	VERB
ajlm-2505	139	95	in	in	ADP
ajlm-2505	139	96	well	well	ADV
ajlm-2505	139	97	-	-	PUNCT
ajlm-2505	139	98	resourced	resource	VERB
ajlm-2505	139	99	settings	setting	NOUN
ajlm-2505	139	100	and	and	CCONJ
ajlm-2505	139	101	did	do	AUX
ajlm-2505	139	102	not	not	PART
ajlm-2505	139	103	address	address	VERB
ajlm-2505	139	104	the	the	DET
ajlm-2505	139	105	influence	influence	NOUN
ajlm-2505	139	106	of	of	ADP
ajlm-2505	139	107	inflammatory	inflammatory	ADJ
ajlm-2505	139	108	and	and	CCONJ
ajlm-2505	139	109	infectious	infectious	ADJ
ajlm-2505	139	110	diseases	disease	NOUN
ajlm-2505	139	111	on	on	ADP
ajlm-2505	139	112	test	test	NOUN
ajlm-2505	139	113	performance	performance	NOUN
ajlm-2505	139	114	.	.	PUNCT
ajlm-2505	140	1	in	in	ADP
ajlm-2505	140	2	contrast	contrast	NOUN
ajlm-2505	140	3	,	,	PUNCT
ajlm-2505	140	4	liu	liu	PROPN
ajlm-2505	140	5	et	et	PROPN
ajlm-2505	140	6	al.13	al.13	PROPN
ajlm-2505	140	7	observed	observe	VERB
ajlm-2505	140	8	limited	limited	ADJ
ajlm-2505	140	9	sensitivity	sensitivity	NOUN
ajlm-2505	140	10	but	but	CCONJ
ajlm-2505	140	11	high	high	ADJ
ajlm-2505	140	12	specificity	specificity	NOUN
ajlm-2505	140	13	for	for	ADP
ajlm-2505	140	14	the	the	DET
ajlm-2505	140	15	gamma	gamma	NOUN
ajlm-2505	140	16	gap	gap	NOUN
ajlm-2505	140	17	(	(	PUNCT
ajlm-2505	140	18	auc	auc	NOUN
ajlm-2505	140	19	of	of	ADP
ajlm-2505	140	20	0.64	0.64	NUM
ajlm-2505	140	21	[	[	SYM
ajlm-2505	140	22	95	95	NUM
ajlm-2505	140	23	%	%	NOUN
ajlm-2505	140	24	ci	ci	NOUN
ajlm-2505	140	25	:	:	PUNCT
ajlm-2505	140	26	0.60–0.69	0.60–0.69	NOUN
ajlm-2505	140	27	]	]	X
ajlm-2505	140	28	,	,	PUNCT
ajlm-2505	140	29	sensitivity	sensitivity	NOUN
ajlm-2505	140	30	of	of	ADP
ajlm-2505	140	31	15.4	15.4	NUM
ajlm-2505	140	32	%	%	NOUN
ajlm-2505	140	33	,	,	PUNCT
ajlm-2505	140	34	specificity	specificity	NOUN
ajlm-2505	140	35	of	of	ADP
ajlm-2505	140	36	95.4	95.4	NUM
ajlm-2505	140	37	%	%	NOUN
ajlm-2505	140	38	,	,	PUNCT
ajlm-2505	140	39	threshold	threshold	NOUN
ajlm-2505	140	40	of	of	ADP
ajlm-2505	140	41	40	40	NUM
ajlm-2505	140	42	g	g	NOUN
ajlm-2505	140	43	/	/	SYM
ajlm-2505	140	44	l	l	NOUN
ajlm-2505	140	45	)	)	PUNCT
ajlm-2505	140	46	in	in	ADP
ajlm-2505	140	47	a	a	DET
ajlm-2505	140	48	united	united	PROPN
ajlm-2505	140	49	states	states	PROPN
ajlm-2505	140	50	community	community	NOUN
ajlm-2505	140	51	-	-	PUNCT
ajlm-2505	140	52	based	base	VERB
ajlm-2505	140	53	study	study	NOUN
ajlm-2505	140	54	that	that	PRON
ajlm-2505	140	55	included	include	VERB
ajlm-2505	140	56	patients	patient	NOUN
ajlm-2505	140	57	with	with	ADP
ajlm-2505	140	58	mgus	mgus	ADJ
ajlm-2505	140	59	,	,	PUNCT
ajlm-2505	140	60	hiv	hiv	PROPN
ajlm-2505	140	61	,	,	PUNCT
ajlm-2505	140	62	and	and	CCONJ
ajlm-2505	140	63	hepatitis	hepatitis	PROPN
ajlm-2505	140	64	c.	c.	PROPN
ajlm-2505	140	65	these	these	DET
ajlm-2505	140	66	findings	finding	NOUN
ajlm-2505	140	67	align	align	VERB
ajlm-2505	140	68	with	with	ADP
ajlm-2505	140	69	our	our	PRON
ajlm-2505	140	70	results	result	NOUN
ajlm-2505	140	71	,	,	PUNCT
ajlm-2505	140	72	suggesting	suggest	VERB
ajlm-2505	140	73	that	that	SCONJ
ajlm-2505	140	74	diagnostic	diagnostic	ADJ
ajlm-2505	140	75	performance	performance	NOUN
ajlm-2505	140	76	is	be	AUX
ajlm-2505	140	77	compromised	compromise	VERB
ajlm-2505	140	78	in	in	ADP
ajlm-2505	140	79	settings	setting	NOUN
ajlm-2505	140	80	with	with	ADP
ajlm-2505	140	81	a	a	DET
ajlm-2505	140	82	high	high	ADJ
ajlm-2505	140	83	burden	burden	NOUN
ajlm-2505	140	84	of	of	ADP
ajlm-2505	140	85	infectious	infectious	ADJ
ajlm-2505	140	86	and	and	CCONJ
ajlm-2505	140	87	inflammatory	inflammatory	ADJ
ajlm-2505	140	88	conditions	condition	NOUN
ajlm-2505	140	89	.	.	PUNCT
ajlm-2505	141	1	while	while	SCONJ
ajlm-2505	141	2	we	we	PRON
ajlm-2505	141	3	found	find	VERB
ajlm-2505	141	4	that	that	SCONJ
ajlm-2505	141	5	the	the	DET
ajlm-2505	141	6	gamma	gamma	NOUN
ajlm-2505	141	7	gap	gap	NOUN
ajlm-2505	141	8	and	and	CCONJ
ajlm-2505	141	9	agr	agr	NOUN
ajlm-2505	141	10	perform	perform	NOUN
ajlm-2505	141	11	similarly	similarly	ADV
ajlm-2505	141	12	,	,	PUNCT
ajlm-2505	141	13	few	few	ADJ
ajlm-2505	141	14	studies	study	NOUN
ajlm-2505	141	15	have	have	AUX
ajlm-2505	141	16	specifically	specifically	ADV
ajlm-2505	141	17	evaluated	evaluate	VERB
ajlm-2505	141	18	the	the	DET
ajlm-2505	141	19	agr	agr	NOUN
ajlm-2505	141	20	in	in	ADP
ajlm-2505	141	21	this	this	DET
ajlm-2505	141	22	context	context	NOUN
ajlm-2505	141	23	.	.	PUNCT
ajlm-2505	142	1	a	a	DET
ajlm-2505	142	2	study	study	NOUN
ajlm-2505	142	3	by	by	ADP
ajlm-2505	142	4	tarín	tarín	NOUN
ajlm-2505	142	5	-	-	PUNCT
ajlm-2505	142	6	arzaga	arzaga	NOUN
ajlm-2505	142	7	et	et	NOUN
ajlm-2505	142	8	al.18	al.18	VERB
ajlm-2505	142	9	in	in	ADP
ajlm-2505	142	10	mexico	mexico	PROPN
ajlm-2505	142	11	included	include	VERB
ajlm-2505	142	12	all	all	DET
ajlm-2505	142	13	spe	spe	PROPN
ajlm-2505	142	14	results	result	NOUN
ajlm-2505	142	15	(	(	PUNCT
ajlm-2505	142	16	n	n	NOUN
ajlm-2505	142	17	=	=	SYM
ajlm-2505	142	18	1578	1578	NUM
ajlm-2505	142	19	)	)	PUNCT
ajlm-2505	142	20	from	from	ADP
ajlm-2505	142	21	255	255	NUM
ajlm-2505	142	22	individuals	individual	NOUN
ajlm-2505	142	23	and	and	CCONJ
ajlm-2505	142	24	found	find	VERB
ajlm-2505	142	25	that	that	SCONJ
ajlm-2505	142	26	the	the	DET
ajlm-2505	142	27	agr	agr	NOUN
ajlm-2505	142	28	(	(	PUNCT
ajlm-2505	142	29	auc	auc	NOUN
ajlm-2505	142	30	=	=	SYM
ajlm-2505	142	31	0.74	0.74	NUM
ajlm-2505	142	32	,	,	PUNCT
ajlm-2505	142	33	sensitivity	sensitivity	NOUN
ajlm-2505	142	34	=	=	SYM
ajlm-2505	142	35	59	59	NUM
ajlm-2505	142	36	%	%	NOUN
ajlm-2505	142	37	,	,	PUNCT
ajlm-2505	142	38	specificity	specificity	NOUN
ajlm-2505	142	39	=	=	SYM
ajlm-2505	142	40	79	79	NUM
ajlm-2505	142	41	%	%	NOUN
ajlm-2505	142	42	)	)	PUNCT
ajlm-2505	142	43	performed	perform	VERB
ajlm-2505	142	44	better	well	ADV
ajlm-2505	142	45	than	than	ADP
ajlm-2505	142	46	the	the	DET
ajlm-2505	142	47	gamma	gamma	NOUN
ajlm-2505	142	48	gap	gap	NOUN
ajlm-2505	142	49	(	(	PUNCT
ajlm-2505	142	50	auc	auc	NOUN
ajlm-2505	142	51	=	=	SYM
ajlm-2505	142	52	0.71	0.71	NUM
ajlm-2505	142	53	,	,	PUNCT
ajlm-2505	142	54	sensitivity	sensitivity	NOUN
ajlm-2505	142	55	=	=	SYM
ajlm-2505	142	56	52	52	NUM
ajlm-2505	142	57	%	%	NOUN
ajlm-2505	142	58	,	,	PUNCT
ajlm-2505	142	59	specificity	specificity	NOUN
ajlm-2505	142	60	=	=	SYM
ajlm-2505	142	61	80	80	NUM
ajlm-2505	142	62	%	%	NOUN
ajlm-2505	142	63	)	)	PUNCT
ajlm-2505	142	64	overall.18	overall.18	VERB
ajlm-2505	142	65	however	however	ADV
ajlm-2505	142	66	,	,	PUNCT
ajlm-2505	142	67	when	when	SCONJ
ajlm-2505	142	68	predicting	predict	VERB
ajlm-2505	142	69	a	a	DET
ajlm-2505	142	70	monoclonal	monoclonal	NOUN
ajlm-2505	142	71	protein	protein	NOUN
ajlm-2505	142	72	≥	≥	NOUN
ajlm-2505	142	73	10	10	NUM
ajlm-2505	142	74	g	g	NOUN
ajlm-2505	142	75	/	/	SYM
ajlm-2505	142	76	l	l	NOUN
ajlm-2505	142	77	,	,	PUNCT
ajlm-2505	142	78	both	both	DET
ajlm-2505	142	79	metrics	metric	NOUN
ajlm-2505	142	80	showed	show	VERB
ajlm-2505	142	81	excellent	excellent	ADJ
ajlm-2505	142	82	diagnostic	diagnostic	ADJ
ajlm-2505	142	83	performance	performance	NOUN
ajlm-2505	142	84	,	,	PUNCT
ajlm-2505	142	85	with	with	ADP
ajlm-2505	142	86	an	an	DET
ajlm-2505	142	87	auc	auc	NOUN
ajlm-2505	142	88	of	of	ADP
ajlm-2505	142	89	0.94	0.94	NUM
ajlm-2505	142	90	,	,	PUNCT
ajlm-2505	142	91	and	and	CCONJ
ajlm-2505	142	92	comparable	comparable	ADJ
ajlm-2505	142	93	sensitivity	sensitivity	NOUN
ajlm-2505	142	94	(	(	PUNCT
ajlm-2505	142	95	84	84	NUM
ajlm-2505	142	96	%	%	NOUN
ajlm-2505	142	97	vs	vs	ADP
ajlm-2505	142	98	87	87	NUM
ajlm-2505	142	99	%	%	NOUN
ajlm-2505	142	100	)	)	PUNCT
ajlm-2505	142	101	and	and	CCONJ
ajlm-2505	142	102	specificity	specificity	NOUN
ajlm-2505	142	103	(	(	PUNCT
ajlm-2505	142	104	87	87	NUM
ajlm-2505	142	105	%	%	NOUN
ajlm-2505	142	106	vs	vs	ADP
ajlm-2505	142	107	84	84	NUM
ajlm-2505	142	108	%	%	NOUN
ajlm-2505	142	109	)	)	PUNCT
ajlm-2505	142	110	values	value	NOUN
ajlm-2505	142	111	,	,	PUNCT
ajlm-2505	142	112	respectively	respectively	ADV
ajlm-2505	142	113	.	.	PUNCT
ajlm-2505	143	1	in	in	ADP
ajlm-2505	143	2	south	south	PROPN
ajlm-2505	143	3	africa	africa	PROPN
ajlm-2505	143	4	,	,	PUNCT
ajlm-2505	143	5	where	where	SCONJ
ajlm-2505	143	6	infectious	infectious	ADJ
ajlm-2505	143	7	and	and	CCONJ
ajlm-2505	143	8	inflammatory	inflammatory	ADJ
ajlm-2505	143	9	diseases	disease	NOUN
ajlm-2505	143	10	are	be	AUX
ajlm-2505	143	11	prevalent,15,16	prevalent,15,16	NOUN
ajlm-2505	143	12	conditions	condition	NOUN
ajlm-2505	143	13	such	such	ADJ
ajlm-2505	143	14	as	as	ADP
ajlm-2505	143	15	hiv	hiv	PROPN
ajlm-2505	143	16	,	,	PUNCT
ajlm-2505	143	17	tuberculosis	tuberculosis	NOUN
ajlm-2505	143	18	,	,	PUNCT
ajlm-2505	143	19	chronic	chronic	ADJ
ajlm-2505	143	20	hepatitis	hepatitis	NOUN
ajlm-2505	143	21	(	(	PUNCT
ajlm-2505	143	22	b	b	PROPN
ajlm-2505	143	23	and	and	CCONJ
ajlm-2505	143	24	c	c	NOUN
ajlm-2505	143	25	)	)	PUNCT
ajlm-2505	143	26	,	,	PUNCT
ajlm-2505	143	27	rheumatoid	rheumatoid	NOUN
ajlm-2505	143	28	arthritis	arthritis	NOUN
ajlm-2505	143	29	,	,	PUNCT
ajlm-2505	143	30	and	and	CCONJ
ajlm-2505	143	31	systemic	systemic	ADJ
ajlm-2505	143	32	lupus	lupus	PROPN
ajlm-2505	143	33	erythematosus	erythematosus	PROPN
ajlm-2505	143	34	compete	compete	VERB
ajlm-2505	143	35	for	for	ADP
ajlm-2505	143	36	attention	attention	NOUN
ajlm-2505	143	37	in	in	ADP
ajlm-2505	143	38	the	the	DET
ajlm-2505	143	39	differential	differential	ADJ
ajlm-2505	143	40	diagnosis	diagnosis	NOUN
ajlm-2505	143	41	of	of	ADP
ajlm-2505	143	42	monoclonal	monoclonal	NOUN
ajlm-2505	143	43	gammopathy	gammopathy	ADJ
ajlm-2505	143	44	.	.	PUNCT
ajlm-2505	144	1	these	these	DET
ajlm-2505	144	2	conditions	condition	NOUN
ajlm-2505	144	3	are	be	AUX
ajlm-2505	144	4	often	often	ADV
ajlm-2505	144	5	associated	associate	VERB
ajlm-2505	144	6	with	with	ADP
ajlm-2505	144	7	abnormal	abnormal	ADJ
ajlm-2505	144	8	protein	protein	NOUN
ajlm-2505	144	9	levels	level	NOUN
ajlm-2505	144	10	and	and	CCONJ
ajlm-2505	144	11	polyclonal	polyclonal	ADJ
ajlm-2505	144	12	hypergammaglobulinaemia	hypergammaglobulinaemia	NOUN
ajlm-2505	144	13	.	.	PUNCT
ajlm-2505	145	1	these	these	DET
ajlm-2505	145	2	changes	change	NOUN
ajlm-2505	145	3	increase	increase	VERB
ajlm-2505	145	4	the	the	DET
ajlm-2505	145	5	gamma	gamma	NOUN
ajlm-2505	145	6	gap	gap	NOUN
ajlm-2505	145	7	and	and	CCONJ
ajlm-2505	145	8	lower	low	ADJ
ajlm-2505	145	9	the	the	DET
ajlm-2505	145	10	agr	agr	NOUN
ajlm-2505	145	11	,	,	PUNCT
ajlm-2505	145	12	complicating	complicate	VERB
ajlm-2505	145	13	clinical	clinical	ADJ
ajlm-2505	145	14	decisions	decision	NOUN
ajlm-2505	145	15	on	on	ADP
ajlm-2505	145	16	diagnostic	diagnostic	ADJ
ajlm-2505	145	17	pathways	pathway	NOUN
ajlm-2505	145	18	and	and	CCONJ
ajlm-2505	145	19	additional	additional	ADJ
ajlm-2505	145	20	testing	testing	NOUN
ajlm-2505	145	21	,	,	PUNCT
ajlm-2505	145	22	in	in	ADP
ajlm-2505	145	23	resource	resource	NOUN
ajlm-2505	145	24	-	-	PUNCT
ajlm-2505	145	25	limited	limit	VERB
ajlm-2505	145	26	settings	setting	NOUN
ajlm-2505	145	27	.	.	PUNCT
ajlm-2505	146	1	careful	careful	ADJ
ajlm-2505	146	2	clinical	clinical	ADJ
ajlm-2505	146	3	evaluation	evaluation	NOUN
ajlm-2505	146	4	is	be	AUX
ajlm-2505	146	5	essential	essential	ADJ
ajlm-2505	146	6	to	to	PART
ajlm-2505	146	7	differentiate	differentiate	VERB
ajlm-2505	146	8	monoclonal	monoclonal	NOUN
ajlm-2505	146	9	gammopathy	gammopathy	ADJ
ajlm-2505	146	10	from	from	ADP
ajlm-2505	146	11	these	these	DET
ajlm-2505	146	12	prevalent	prevalent	ADJ
ajlm-2505	146	13	conditions	condition	NOUN
ajlm-2505	146	14	.	.	PUNCT
ajlm-2505	147	1	studies	study	NOUN
ajlm-2505	147	2	have	have	AUX
ajlm-2505	147	3	reported	report	VERB
ajlm-2505	147	4	inconsistent	inconsistent	ADJ
ajlm-2505	147	5	gamma	gamma	NOUN
ajlm-2505	147	6	gap	gap	NOUN
ajlm-2505	147	7	thresholds	threshold	NOUN
ajlm-2505	147	8	.	.	PUNCT
ajlm-2505	148	1	similar	similar	ADJ
ajlm-2505	148	2	to	to	ADP
ajlm-2505	148	3	our	our	PRON
ajlm-2505	148	4	findings	finding	NOUN
ajlm-2505	148	5	,	,	PUNCT
ajlm-2505	148	6	a	a	DET
ajlm-2505	148	7	canadian	canadian	ADJ
ajlm-2505	148	8	study	study	NOUN
ajlm-2505	148	9	by	by	ADP
ajlm-2505	148	10	suleman	suleman	PROPN
ajlm-2505	148	11	et	et	PROPN
ajlm-2505	148	12	al	al	PROPN
ajlm-2505	148	13	.	.	PROPN
ajlm-2505	148	14	found	find	VERB
ajlm-2505	148	15	a	a	DET
ajlm-2505	148	16	low	low	ADJ
ajlm-2505	148	17	sensitivity	sensitivity	NOUN
ajlm-2505	148	18	(	(	PUNCT
ajlm-2505	148	19	47.7	47.7	NUM
ajlm-2505	148	20	%	%	NOUN
ajlm-2505	148	21	)	)	PUNCT
ajlm-2505	148	22	but	but	CCONJ
ajlm-2505	148	23	moderate	moderate	ADJ
ajlm-2505	148	24	specificity	specificity	NOUN
ajlm-2505	148	25	(	(	PUNCT
ajlm-2505	148	26	77.1	77.1	NUM
ajlm-2505	148	27	%	%	NOUN
ajlm-2505	148	28	)	)	PUNCT
ajlm-2505	148	29	at	at	ADP
ajlm-2505	148	30	a	a	DET
ajlm-2505	148	31	threshold	threshold	NOUN
ajlm-2505	148	32	of	of	ADP
ajlm-2505	148	33	40	40	NUM
ajlm-2505	148	34	g	g	NOUN
ajlm-2505	148	35	/	/	SYM
ajlm-2505	148	36	l.19	l.19	NOUN
ajlm-2505	148	37	when	when	SCONJ
ajlm-2505	148	38	they	they	PRON
ajlm-2505	148	39	evaluated	evaluate	VERB
ajlm-2505	148	40	the	the	DET
ajlm-2505	148	41	threshold	threshold	NOUN
ajlm-2505	148	42	of	of	ADP
ajlm-2505	148	43	44	44	NUM
ajlm-2505	148	44	g	g	NOUN
ajlm-2505	148	45	/	/	SYM
ajlm-2505	148	46	l	l	NOUN
ajlm-2505	148	47	,	,	PUNCT
ajlm-2505	148	48	the	the	DET
ajlm-2505	148	49	specificity	specificity	NOUN
ajlm-2505	148	50	improved	improve	VERB
ajlm-2505	148	51	to	to	ADP
ajlm-2505	148	52	89.2	89.2	NUM
ajlm-2505	148	53	%	%	NOUN
ajlm-2505	148	54	,	,	PUNCT
ajlm-2505	148	55	at	at	ADP
ajlm-2505	148	56	the	the	DET
ajlm-2505	148	57	expense	expense	NOUN
ajlm-2505	148	58	of	of	ADP
ajlm-2505	148	59	sensitivity	sensitivity	NOUN
ajlm-2505	148	60	(	(	PUNCT
ajlm-2505	148	61	33.7%).19	33.7%).19	NUM
ajlm-2505	148	62	in	in	ADP
ajlm-2505	148	63	contrast	contrast	NOUN
ajlm-2505	148	64	,	,	PUNCT
ajlm-2505	148	65	pawar	pawar	NOUN
ajlm-2505	148	66	and	and	CCONJ
ajlm-2505	148	67	hedge	hedge	PROPN
ajlm-2505	148	68	in	in	ADP
ajlm-2505	148	69	india	india	PROPN
ajlm-2505	148	70	observed	observe	VERB
ajlm-2505	148	71	high	high	ADJ
ajlm-2505	148	72	sensitivity	sensitivity	NOUN
ajlm-2505	148	73	(	(	PUNCT
ajlm-2505	148	74	82.1	82.1	NUM
ajlm-2505	148	75	%	%	NOUN
ajlm-2505	148	76	)	)	PUNCT
ajlm-2505	148	77	and	and	CCONJ
ajlm-2505	148	78	specificity	specificity	NOUN
ajlm-2505	148	79	(	(	PUNCT
ajlm-2505	148	80	85.4	85.4	NUM
ajlm-2505	148	81	%	%	NOUN
ajlm-2505	148	82	)	)	PUNCT
ajlm-2505	148	83	at	at	ADP
ajlm-2505	148	84	a	a	DET
ajlm-2505	148	85	lower	low	ADJ
ajlm-2505	148	86	threshold	threshold	NOUN
ajlm-2505	148	87	of	of	ADP
ajlm-2505	148	88	32.5	32.5	NUM
ajlm-2505	148	89	g	g	NOUN
ajlm-2505	148	90	/	/	SYM
ajlm-2505	148	91	l	l	NOUN
ajlm-2505	148	92	,	,	PUNCT
ajlm-2505	148	93	concluding	conclude	VERB
ajlm-2505	148	94	that	that	SCONJ
ajlm-2505	148	95	the	the	DET
ajlm-2505	148	96	gamma	gamma	NOUN
ajlm-2505	148	97	gap	gap	NOUN
ajlm-2505	148	98	reliably	reliably	ADV
ajlm-2505	148	99	distinguishes	distinguish	VERB
ajlm-2505	148	100	monoclonality.20	monoclonality.20	PROPN
ajlm-2505	148	101	however	however	ADV
ajlm-2505	148	102	,	,	PUNCT
ajlm-2505	148	103	their	their	PRON
ajlm-2505	148	104	findings	finding	NOUN
ajlm-2505	148	105	are	be	AUX
ajlm-2505	148	106	limited	limit	VERB
ajlm-2505	148	107	by	by	ADP
ajlm-2505	148	108	a	a	DET
ajlm-2505	148	109	small	small	ADJ
ajlm-2505	148	110	sample	sample	NOUN
ajlm-2505	148	111	size	size	NOUN
ajlm-2505	148	112	(	(	PUNCT
ajlm-2505	148	113	n	n	NOUN
ajlm-2505	148	114	=	=	SYM
ajlm-2505	148	115	147	147	NUM
ajlm-2505	148	116	)	)	PUNCT
ajlm-2505	148	117	,	,	PUNCT
ajlm-2505	148	118	despite	despite	SCONJ
ajlm-2505	148	119	being	be	AUX
ajlm-2505	148	120	conducted	conduct	VERB
ajlm-2505	148	121	in	in	ADP
ajlm-2505	148	122	a	a	DET
ajlm-2505	148	123	similar	similar	ADJ
ajlm-2505	148	124	low	low	NOUN
ajlm-2505	148	125	-	-	PUNCT
ajlm-2505	148	126	to	to	ADP
ajlm-2505	148	127	middle	middle	ADJ
ajlm-2505	148	128	-	-	PUNCT
ajlm-2505	148	129	income	income	NOUN
ajlm-2505	148	130	country	country	NOUN
ajlm-2505	148	131	setting	set	VERB
ajlm-2505	148	132	with	with	ADP
ajlm-2505	148	133	a	a	DET
ajlm-2505	148	134	high	high	ADJ
ajlm-2505	148	135	burden	burden	NOUN
ajlm-2505	148	136	of	of	ADP
ajlm-2505	148	137	infectious	infectious	ADJ
ajlm-2505	148	138	and	and	CCONJ
ajlm-2505	148	139	inflammatory	inflammatory	ADJ
ajlm-2505	148	140	diseases	disease	NOUN
ajlm-2505	148	141	(	(	PUNCT
ajlm-2505	148	142	n	n	NOUN
ajlm-2505	148	143	=	=	NUM
ajlm-2505	148	144	147	147	NUM
ajlm-2505	148	145	)	)	PUNCT
ajlm-2505	148	146	.	.	PUNCT
ajlm-2505	149	1	furthermore	furthermore	ADV
ajlm-2505	149	2	,	,	PUNCT
ajlm-2505	149	3	hassan	hassan	PROPN
ajlm-2505	149	4	and	and	CCONJ
ajlm-2505	149	5	hameed	hameed	PROPN
ajlm-2505	149	6	in	in	ADP
ajlm-2505	149	7	iraq	iraq	PROPN
ajlm-2505	149	8	found	find	VERB
ajlm-2505	149	9	that	that	SCONJ
ajlm-2505	149	10	,	,	PUNCT
ajlm-2505	149	11	at	at	ADP
ajlm-2505	149	12	a	a	DET
ajlm-2505	149	13	threshold	threshold	NOUN
ajlm-2505	149	14	of	of	ADP
ajlm-2505	149	15	29.1	29.1	NUM
ajlm-2505	149	16	g	g	NOUN
ajlm-2505	149	17	/	/	SYM
ajlm-2505	149	18	l	l	NOUN
ajlm-2505	149	19	,	,	PUNCT
ajlm-2505	149	20	the	the	DET
ajlm-2505	149	21	gamma	gamma	NOUN
ajlm-2505	149	22	gap	gap	NOUN
ajlm-2505	149	23	distinguished	distinguish	VERB
ajlm-2505	149	24	treated	treat	VERB
ajlm-2505	149	25	from	from	ADP
ajlm-2505	149	26	untreated	untreated	ADJ
ajlm-2505	149	27	multiple	multiple	ADJ
ajlm-2505	149	28	myeloma	myeloma	NOUN
ajlm-2505	149	29	patients	patient	NOUN
ajlm-2505	149	30	with	with	ADP
ajlm-2505	149	31	an	an	DET
ajlm-2505	149	32	auc	auc	NOUN
ajlm-2505	149	33	of	of	ADP
ajlm-2505	149	34	0.735	0.735	NUM
ajlm-2505	149	35	(	(	PUNCT
ajlm-2505	149	36	95	95	NUM
ajlm-2505	149	37	%	%	NOUN
ajlm-2505	149	38	ci	ci	NOUN
ajlm-2505	149	39	:	:	PUNCT
ajlm-2505	149	40	0.66–0.904	0.66–0.904	NUM
ajlm-2505	149	41	,	,	PUNCT
ajlm-2505	149	42	p	p	X
ajlm-2505	149	43	<	<	X
ajlm-2505	149	44	0.001	0.001	NUM
ajlm-2505	149	45	)	)	PUNCT
ajlm-2505	149	46	,	,	PUNCT
ajlm-2505	149	47	achieving	achieve	VERB
ajlm-2505	149	48	76.5	76.5	NUM
ajlm-2505	149	49	%	%	NOUN
ajlm-2505	149	50	sensitivity	sensitivity	NOUN
ajlm-2505	149	51	and	and	CCONJ
ajlm-2505	149	52	70.6	70.6	NUM
ajlm-2505	149	53	%	%	NOUN
ajlm-2505	149	54	specificity.21	specificity.21	NOUN
ajlm-2505	149	55	in	in	ADP
ajlm-2505	149	56	our	our	PRON
ajlm-2505	149	57	study	study	NOUN
ajlm-2505	149	58	,	,	PUNCT
ajlm-2505	149	59	multivariable	multivariable	ADJ
ajlm-2505	149	60	models	model	NOUN
ajlm-2505	149	61	outperformed	outperform	VERB
ajlm-2505	149	62	univariable	univariable	ADJ
ajlm-2505	149	63	models	model	NOUN
ajlm-2505	149	64	,	,	PUNCT
ajlm-2505	149	65	although	although	SCONJ
ajlm-2505	149	66	both	both	PRON
ajlm-2505	149	67	demonstrated	demonstrate	VERB
ajlm-2505	149	68	low	low	ADJ
ajlm-2505	149	69	precision	precision	NOUN
ajlm-2505	149	70	and	and	CCONJ
ajlm-2505	149	71	recall	recall	NOUN
ajlm-2505	149	72	in	in	ADP
ajlm-2505	149	73	detecting	detect	VERB
ajlm-2505	149	74	monoclonal	monoclonal	NOUN
ajlm-2505	149	75	cases	case	NOUN
ajlm-2505	149	76	,	,	PUNCT
ajlm-2505	149	77	with	with	ADP
ajlm-2505	149	78	the	the	DET
ajlm-2505	149	79	agr	agr	NOUN
ajlm-2505	149	80	model	model	NOUN
ajlm-2505	149	81	performing	perform	VERB
ajlm-2505	149	82	slightly	slightly	ADV
ajlm-2505	149	83	better	well	ADJ
ajlm-2505	149	84	.	.	PUNCT
ajlm-2505	150	1	the	the	DET
ajlm-2505	150	2	gap	gap	NOUN
ajlm-2505	150	3	model	model	NOUN
ajlm-2505	150	4	,	,	PUNCT
ajlm-2505	150	5	however	however	ADV
ajlm-2505	150	6	,	,	PUNCT
ajlm-2505	150	7	showed	show	VERB
ajlm-2505	150	8	a	a	DET
ajlm-2505	150	9	significantly	significantly	ADV
ajlm-2505	150	10	lower	low	ADJ
ajlm-2505	150	11	aic	aic	PROPN
ajlm-2505	150	12	value	value	NOUN
ajlm-2505	150	13	,	,	PUNCT
ajlm-2505	150	14	indicating	indicate	VERB
ajlm-2505	150	15	a	a	DET
ajlm-2505	150	16	better	well	ADJ
ajlm-2505	150	17	balance	balance	NOUN
ajlm-2505	150	18	between	between	ADP
ajlm-2505	150	19	model	model	NOUN
ajlm-2505	150	20	fit	fit	ADJ
ajlm-2505	150	21	and	and	CCONJ
ajlm-2505	150	22	simplicity	simplicity	NOUN
ajlm-2505	150	23	.	.	PUNCT
ajlm-2505	151	1	despite	despite	SCONJ
ajlm-2505	151	2	this	this	PRON
ajlm-2505	151	3	,	,	PUNCT
ajlm-2505	151	4	both	both	DET
ajlm-2505	151	5	models	model	NOUN
ajlm-2505	151	6	have	have	AUX
ajlm-2505	151	7	limited	limit	VERB
ajlm-2505	151	8	diagnostic	diagnostic	ADJ
ajlm-2505	151	9	utility	utility	NOUN
ajlm-2505	151	10	in	in	ADP
ajlm-2505	151	11	isolation	isolation	NOUN
ajlm-2505	151	12	and	and	CCONJ
ajlm-2505	151	13	would	would	AUX
ajlm-2505	151	14	benefit	benefit	VERB
ajlm-2505	151	15	from	from	ADP
ajlm-2505	151	16	further	further	ADJ
ajlm-2505	151	17	optimisation	optimisation	NOUN
ajlm-2505	151	18	by	by	ADP
ajlm-2505	151	19	incorporating	incorporate	VERB
ajlm-2505	151	20	additional	additional	ADJ
ajlm-2505	151	21	predictive	predictive	ADJ
ajlm-2505	151	22	factors	factor	NOUN
ajlm-2505	151	23	.	.	PUNCT
ajlm-2505	152	1	this	this	PRON
ajlm-2505	152	2	highlights	highlight	VERB
ajlm-2505	152	3	the	the	DET
ajlm-2505	152	4	importance	importance	NOUN
ajlm-2505	152	5	of	of	ADP
ajlm-2505	152	6	a	a	DET
ajlm-2505	152	7	comprehensive	comprehensive	ADJ
ajlm-2505	152	8	approach	approach	NOUN
ajlm-2505	152	9	to	to	PART
ajlm-2505	152	10	accurately	accurately	ADV
ajlm-2505	152	11	predict	predict	VERB
ajlm-2505	152	12	monoclonal	monoclonal	NOUN
ajlm-2505	152	13	gammopathies,13	gammopathies,13	NOUN
ajlm-2505	152	14	as	as	SCONJ
ajlm-2505	152	15	demonstrated	demonstrate	VERB
ajlm-2505	152	16	by	by	ADP
ajlm-2505	152	17	thakkinstian	thakkinstian	PROPN
ajlm-2505	152	18	et	et	PROPN
ajlm-2505	152	19	al	al	PROPN
ajlm-2505	152	20	.	.	PROPN
ajlm-2505	152	21	,	,	PUNCT
ajlm-2505	152	22	who	who	PRON
ajlm-2505	152	23	used	use	VERB
ajlm-2505	152	24	five	five	NUM
ajlm-2505	152	25	variables	variable	NOUN
ajlm-2505	152	26	(	(	PUNCT
ajlm-2505	152	27	gamma	gamma	NOUN
ajlm-2505	152	28	gap	gap	NOUN
ajlm-2505	152	29	,	,	PUNCT
ajlm-2505	152	30	age	age	NOUN
ajlm-2505	152	31	,	,	PUNCT
ajlm-2505	152	32	sex	sex	NOUN
ajlm-2505	152	33	,	,	PUNCT
ajlm-2505	152	34	haemoglobin	haemoglobin	NOUN
ajlm-2505	152	35	,	,	PUNCT
ajlm-2505	152	36	and	and	CCONJ
ajlm-2505	152	37	egfr	egfr	X
ajlm-2505	152	38	)	)	PUNCT
ajlm-2505	152	39	in	in	ADP
ajlm-2505	152	40	their	their	PRON
ajlm-2505	152	41	optimised	optimise	VERB
ajlm-2505	152	42	model	model	NOUN
ajlm-2505	152	43	,	,	PUNCT
ajlm-2505	152	44	achieving	achieve	VERB
ajlm-2505	152	45	an	an	DET
ajlm-2505	152	46	auc	auc	NOUN
ajlm-2505	152	47	of	of	ADP
ajlm-2505	152	48	0.80.10	0.80.10	NOUN
ajlm-2505	152	49	this	this	DET
ajlm-2505	152	50	study	study	NOUN
ajlm-2505	152	51	was	be	AUX
ajlm-2505	152	52	strengthened	strengthen	VERB
ajlm-2505	152	53	by	by	ADP
ajlm-2505	152	54	confirmation	confirmation	NOUN
ajlm-2505	152	55	of	of	ADP
ajlm-2505	152	56	their	their	PRON
ajlm-2505	152	57	findings	finding	NOUN
ajlm-2505	152	58	in	in	ADP
ajlm-2505	152	59	a	a	DET
ajlm-2505	152	60	validation	validation	NOUN
ajlm-2505	152	61	data	datum	NOUN
ajlm-2505	152	62	set	set	NOUN
ajlm-2505	152	63	(	(	PUNCT
ajlm-2505	152	64	n	n	NOUN
ajlm-2505	152	65	=	=	SYM
ajlm-2505	152	66	4312	4312	NUM
ajlm-2505	152	67	)	)	PUNCT
ajlm-2505	152	68	.	.	PUNCT
ajlm-2505	153	1	recommendations	recommendation	NOUN
ajlm-2505	153	2	universal	universal	ADJ
ajlm-2505	153	3	screening	screen	VERB
ajlm-2505	153	4	for	for	ADP
ajlm-2505	153	5	monoclonal	monoclonal	NOUN
ajlm-2505	153	6	gammopathy	gammopathy	ADJ
ajlm-2505	153	7	in	in	ADP
ajlm-2505	153	8	asymptomatic	asymptomatic	ADJ
ajlm-2505	153	9	individuals	individual	NOUN
ajlm-2505	153	10	is	be	AUX
ajlm-2505	153	11	not	not	PART
ajlm-2505	153	12	recommended.20	recommended.20	NOUN
ajlm-2505	153	13	this	this	DET
ajlm-2505	153	14	study	study	NOUN
ajlm-2505	153	15	aimed	aim	VERB
ajlm-2505	153	16	to	to	PART
ajlm-2505	153	17	evaluate	evaluate	VERB
ajlm-2505	153	18	the	the	DET
ajlm-2505	153	19	gamma	gamma	NOUN
ajlm-2505	153	20	gap	gap	NOUN
ajlm-2505	153	21	and	and	CCONJ
ajlm-2505	153	22	agr	agr	NOUN
ajlm-2505	153	23	as	as	SCONJ
ajlm-2505	153	24	supplementary	supplementary	ADJ
ajlm-2505	153	25	tools	tool	NOUN
ajlm-2505	153	26	to	to	PART
ajlm-2505	153	27	identify	identify	VERB
ajlm-2505	153	28	patients	patient	NOUN
ajlm-2505	153	29	at	at	ADP
ajlm-2505	153	30	risk	risk	NOUN
ajlm-2505	153	31	of	of	ADP
ajlm-2505	153	32	monoclonal	monoclonal	NOUN
ajlm-2505	153	33	gammopathy	gammopathy	ADJ
ajlm-2505	153	34	,	,	PUNCT
ajlm-2505	153	35	rather	rather	ADV
ajlm-2505	153	36	than	than	ADP
ajlm-2505	153	37	replacing	replace	VERB
ajlm-2505	153	38	specialised	specialised	ADJ
ajlm-2505	153	39	tests	test	NOUN
ajlm-2505	153	40	such	such	ADJ
ajlm-2505	153	41	as	as	ADP
ajlm-2505	153	42	spe	spe	NOUN
ajlm-2505	153	43	,	,	PUNCT
ajlm-2505	153	44	immunofixation	immunofixation	NOUN
ajlm-2505	153	45	,	,	PUNCT
ajlm-2505	153	46	sflc	sflc	NOUN
ajlm-2505	153	47	,	,	PUNCT
ajlm-2505	153	48	or	or	CCONJ
ajlm-2505	153	49	urine	urine	NOUN
ajlm-2505	153	50	protein	protein	NOUN
ajlm-2505	153	51	electrophoresis	electrophoresis	NOUN
ajlm-2505	153	52	.	.	PUNCT
ajlm-2505	154	1	these	these	DET
ajlm-2505	154	2	commonly	commonly	ADV
ajlm-2505	154	3	requested	request	VERB
ajlm-2505	154	4	and	and	CCONJ
ajlm-2505	154	5	cost	cost	NOUN
ajlm-2505	154	6	-	-	PUNCT
ajlm-2505	154	7	effective	effective	ADJ
ajlm-2505	154	8	tests	test	NOUN
ajlm-2505	154	9	may	may	AUX
ajlm-2505	154	10	aid	aid	VERB
ajlm-2505	154	11	in	in	ADP
ajlm-2505	154	12	risk	risk	NOUN
ajlm-2505	154	13	stratification	stratification	NOUN
ajlm-2505	154	14	.	.	PUNCT
ajlm-2505	155	1	evidence	evidence	NOUN
ajlm-2505	155	2	has	have	AUX
ajlm-2505	155	3	consistently	consistently	ADV
ajlm-2505	155	4	shown	show	VERB
ajlm-2505	155	5	that	that	SCONJ
ajlm-2505	155	6	combining	combine	VERB
ajlm-2505	155	7	tests	test	NOUN
ajlm-2505	155	8	enhances	enhance	VERB
ajlm-2505	155	9	diagnostic	diagnostic	ADJ
ajlm-2505	155	10	sensitivity	sensitivity	NOUN
ajlm-2505	155	11	in	in	ADP
ajlm-2505	155	12	monoclonal	monoclonal	NOUN
ajlm-2505	155	13	detection	detection	NOUN
ajlm-2505	155	14	,	,	PUNCT
ajlm-2505	155	15	with	with	ADP
ajlm-2505	155	16	a	a	DET
ajlm-2505	155	17	combination	combination	NOUN
ajlm-2505	155	18	of	of	ADP
ajlm-2505	155	19	spe	spe	NOUN
ajlm-2505	155	20	,	,	PUNCT
ajlm-2505	155	21	immunofixation	immunofixation	NOUN
ajlm-2505	155	22	,	,	PUNCT
ajlm-2505	155	23	and	and	CCONJ
ajlm-2505	155	24	sflc	sflc	ADP
ajlm-2505	155	25	providing	provide	VERB
ajlm-2505	155	26	the	the	DET
ajlm-2505	155	27	most	most	ADV
ajlm-2505	155	28	accurate	accurate	ADJ
ajlm-2505	155	29	diagnostic	diagnostic	ADJ
ajlm-2505	155	30	outcomes.21,22,23,24,25	outcomes.21,22,23,24,25	PROPN
ajlm-2505	155	31	strengths	strength	NOUN
ajlm-2505	155	32	this	this	DET
ajlm-2505	155	33	study	study	NOUN
ajlm-2505	155	34	leveraged	leverage	VERB
ajlm-2505	155	35	a	a	DET
ajlm-2505	155	36	large	large	ADJ
ajlm-2505	155	37	real	real	ADJ
ajlm-2505	155	38	-	-	PUNCT
ajlm-2505	155	39	world	world	NOUN
ajlm-2505	155	40	sample	sample	NOUN
ajlm-2505	155	41	from	from	ADP
ajlm-2505	155	42	a	a	DET
ajlm-2505	155	43	high	high	ADJ
ajlm-2505	155	44	-	-	PUNCT
ajlm-2505	155	45	burden	burden	NOUN
ajlm-2505	155	46	setting	setting	NOUN
ajlm-2505	155	47	,	,	PUNCT
ajlm-2505	155	48	with	with	ADP
ajlm-2505	155	49	tests	test	NOUN
ajlm-2505	155	50	conducted	conduct	VERB
ajlm-2505	155	51	on	on	ADP
ajlm-2505	155	52	standard	standard	ADJ
ajlm-2505	155	53	equipment	equipment	NOUN
ajlm-2505	155	54	and	and	CCONJ
ajlm-2505	155	55	reviewed	review	VERB
ajlm-2505	155	56	by	by	ADP
ajlm-2505	155	57	pathologists	pathologist	NOUN
ajlm-2505	155	58	,	,	PUNCT
ajlm-2505	155	59	ensuring	ensure	VERB
ajlm-2505	155	60	high	high	ADJ
ajlm-2505	155	61	-	-	PUNCT
ajlm-2505	155	62	quality	quality	NOUN
ajlm-2505	155	63	data	datum	NOUN
ajlm-2505	155	64	.	.	PUNCT
ajlm-2505	156	1	limitations	limitation	NOUN
ajlm-2505	156	2	several	several	ADJ
ajlm-2505	156	3	limitations	limitation	NOUN
ajlm-2505	156	4	may	may	AUX
ajlm-2505	156	5	affect	affect	VERB
ajlm-2505	156	6	the	the	DET
ajlm-2505	156	7	generalisability	generalisability	NOUN
ajlm-2505	156	8	of	of	ADP
ajlm-2505	156	9	the	the	DET
ajlm-2505	156	10	findings	finding	NOUN
ajlm-2505	156	11	,	,	PUNCT
ajlm-2505	156	12	including	include	VERB
ajlm-2505	156	13	the	the	DET
ajlm-2505	156	14	focus	focus	NOUN
ajlm-2505	156	15	on	on	ADP
ajlm-2505	156	16	patients	patient	NOUN
ajlm-2505	156	17	already	already	ADV
ajlm-2505	156	18	under	under	ADP
ajlm-2505	156	19	investigation	investigation	NOUN
ajlm-2505	156	20	for	for	ADP
ajlm-2505	156	21	monoclonal	monoclonal	NOUN
ajlm-2505	156	22	gammopathy	gammopathy	ADJ
ajlm-2505	156	23	,	,	PUNCT
ajlm-2505	156	24	retrospective	retrospective	ADJ
ajlm-2505	156	25	design	design	NOUN
ajlm-2505	156	26	,	,	PUNCT
ajlm-2505	156	27	and	and	CCONJ
ajlm-2505	156	28	absence	absence	NOUN
ajlm-2505	156	29	of	of	ADP
ajlm-2505	156	30	clinical	clinical	ADJ
ajlm-2505	156	31	details	detail	NOUN
ajlm-2505	156	32	like	like	ADP
ajlm-2505	156	33	comorbidities	comorbiditie	NOUN
ajlm-2505	156	34	or	or	CCONJ
ajlm-2505	156	35	medication	medication	NOUN
ajlm-2505	156	36	use	use	NOUN
ajlm-2505	156	37	.	.	PUNCT
ajlm-2505	157	1	excluding	exclude	VERB
ajlm-2505	157	2	patients	patient	NOUN
ajlm-2505	157	3	with	with	ADP
ajlm-2505	157	4	equivocal	equivocal	ADJ
ajlm-2505	157	5	immunofixation	immunofixation	NOUN
ajlm-2505	157	6	results	result	NOUN
ajlm-2505	157	7	,	,	PUNCT
ajlm-2505	157	8	while	while	SCONJ
ajlm-2505	157	9	reducing	reduce	VERB
ajlm-2505	157	10	misclassification	misclassification	NOUN
ajlm-2505	157	11	,	,	PUNCT
ajlm-2505	157	12	further	far	ADV
ajlm-2505	157	13	limits	limit	VERB
ajlm-2505	157	14	applicability	applicability	NOUN
ajlm-2505	157	15	in	in	ADP
ajlm-2505	157	16	cases	case	NOUN
ajlm-2505	157	17	of	of	ADP
ajlm-2505	157	18	inflammation	inflammation	NOUN
ajlm-2505	157	19	or	or	CCONJ
ajlm-2505	157	20	unclear	unclear	ADJ
ajlm-2505	157	21	findings	finding	NOUN
ajlm-2505	157	22	.	.	PUNCT
ajlm-2505	158	1	conclusion	conclusion	NOUN
ajlm-2505	158	2	neither	neither	CCONJ
ajlm-2505	158	3	the	the	DET
ajlm-2505	158	4	gamma	gamma	NOUN
ajlm-2505	158	5	gap	gap	NOUN
ajlm-2505	158	6	nor	nor	CCONJ
ajlm-2505	158	7	the	the	DET
ajlm-2505	158	8	agr	agr	NOUN
ajlm-2505	158	9	demonstrates	demonstrate	VERB
ajlm-2505	158	10	sufficient	sufficient	ADJ
ajlm-2505	158	11	reliability	reliability	NOUN
ajlm-2505	158	12	as	as	ADP
ajlm-2505	158	13	standalone	standalone	NOUN
ajlm-2505	158	14	screening	screening	NOUN
ajlm-2505	158	15	tools	tool	NOUN
ajlm-2505	158	16	for	for	ADP
ajlm-2505	158	17	monoclonal	monoclonal	NOUN
ajlm-2505	158	18	gammopathy	gammopathy	ADJ
ajlm-2505	158	19	in	in	ADP
ajlm-2505	158	20	settings	setting	NOUN
ajlm-2505	158	21	with	with	ADP
ajlm-2505	158	22	a	a	DET
ajlm-2505	158	23	high	high	ADJ
ajlm-2505	158	24	burden	burden	NOUN
ajlm-2505	158	25	of	of	ADP
ajlm-2505	158	26	infectious	infectious	ADJ
ajlm-2505	158	27	and	and	CCONJ
ajlm-2505	158	28	inflammatory	inflammatory	ADJ
ajlm-2505	158	29	diseases	disease	NOUN
ajlm-2505	158	30	.	.	PUNCT
ajlm-2505	159	1	while	while	SCONJ
ajlm-2505	159	2	both	both	DET
ajlm-2505	159	3	metrics	metric	NOUN
ajlm-2505	159	4	showed	show	VERB
ajlm-2505	159	5	moderate	moderate	ADJ
ajlm-2505	159	6	specificity	specificity	NOUN
ajlm-2505	159	7	,	,	PUNCT
ajlm-2505	159	8	their	their	PRON
ajlm-2505	159	9	low	low	ADJ
ajlm-2505	159	10	sensitivity	sensitivity	NOUN
ajlm-2505	159	11	highlights	highlight	VERB
ajlm-2505	159	12	the	the	DET
ajlm-2505	159	13	risk	risk	NOUN
ajlm-2505	159	14	of	of	ADP
ajlm-2505	159	15	missed	miss	VERB
ajlm-2505	159	16	cases	case	NOUN
ajlm-2505	159	17	.	.	PUNCT
ajlm-2505	160	1	these	these	DET
ajlm-2505	160	2	findings	finding	NOUN
ajlm-2505	160	3	emphasise	emphasise	VERB
ajlm-2505	160	4	the	the	DET
ajlm-2505	160	5	need	need	NOUN
ajlm-2505	160	6	for	for	ADP
ajlm-2505	160	7	a	a	DET
ajlm-2505	160	8	more	more	ADV
ajlm-2505	160	9	integrated	integrate	VERB
ajlm-2505	160	10	approach	approach	NOUN
ajlm-2505	160	11	that	that	PRON
ajlm-2505	160	12	combines	combine	VERB
ajlm-2505	160	13	clinical	clinical	ADJ
ajlm-2505	160	14	,	,	PUNCT
ajlm-2505	160	15	demographic	demographic	ADJ
ajlm-2505	160	16	,	,	PUNCT
ajlm-2505	160	17	and	and	CCONJ
ajlm-2505	160	18	laboratory	laboratory	NOUN
ajlm-2505	160	19	data	datum	NOUN
ajlm-2505	160	20	,	,	PUNCT
ajlm-2505	160	21	particularly	particularly	ADV
ajlm-2505	160	22	in	in	ADP
ajlm-2505	160	23	resource	resource	NOUN
ajlm-2505	160	24	-	-	PUNCT
ajlm-2505	160	25	limited	limit	VERB
ajlm-2505	160	26	settings	setting	NOUN
ajlm-2505	160	27	.	.	PUNCT
ajlm-2505	161	1	further	further	ADJ
ajlm-2505	161	2	research	research	NOUN
ajlm-2505	161	3	is	be	AUX
ajlm-2505	161	4	essential	essential	ADJ
ajlm-2505	161	5	to	to	PART
ajlm-2505	161	6	develop	develop	VERB
ajlm-2505	161	7	more	more	ADV
ajlm-2505	161	8	effective	effective	ADJ
ajlm-2505	161	9	screening	screening	NOUN
ajlm-2505	161	10	strategies	strategy	NOUN
ajlm-2505	161	11	and	and	CCONJ
ajlm-2505	161	12	explore	explore	VERB
ajlm-2505	161	13	the	the	DET
ajlm-2505	161	14	potential	potential	NOUN
ajlm-2505	161	15	of	of	ADP
ajlm-2505	161	16	combining	combine	VERB
ajlm-2505	161	17	these	these	DET
ajlm-2505	161	18	markers	marker	NOUN
ajlm-2505	161	19	with	with	ADP
ajlm-2505	161	20	other	other	ADJ
ajlm-2505	161	21	clinical	clinical	ADJ
ajlm-2505	161	22	parameters	parameter	NOUN
ajlm-2505	161	23	to	to	PART
ajlm-2505	161	24	improve	improve	VERB
ajlm-2505	161	25	diagnostic	diagnostic	ADJ
ajlm-2505	161	26	performance	performance	NOUN
ajlm-2505	161	27	.	.	PUNCT
ajlm-2505	162	1	acknowledgements	acknowledgement	NOUN
ajlm-2505	162	2	the	the	DET
ajlm-2505	162	3	authors	author	NOUN
ajlm-2505	162	4	would	would	AUX
ajlm-2505	162	5	like	like	VERB
ajlm-2505	162	6	to	to	PART
ajlm-2505	162	7	extend	extend	VERB
ajlm-2505	162	8	their	their	PRON
ajlm-2505	162	9	gratitude	gratitude	NOUN
ajlm-2505	162	10	to	to	ADP
ajlm-2505	162	11	vida	vida	PROPN
ajlm-2505	162	12	van	van	PROPN
ajlm-2505	162	13	dyk	dyk	PROPN
ajlm-2505	162	14	and	and	CCONJ
ajlm-2505	162	15	all	all	DET
ajlm-2505	162	16	the	the	DET
ajlm-2505	162	17	routine	routine	ADJ
ajlm-2505	162	18	staff	staff	NOUN
ajlm-2505	162	19	at	at	ADP
ajlm-2505	162	20	the	the	DET
ajlm-2505	162	21	c17	c17	NOUN
ajlm-2505	162	22	,	,	PUNCT
ajlm-2505	162	23	chemical	chemical	NOUN
ajlm-2505	162	24	pathology	pathology	NOUN
ajlm-2505	162	25	laboratory	laboratory	NOUN
ajlm-2505	162	26	of	of	ADP
ajlm-2505	162	27	the	the	DET
ajlm-2505	162	28	national	national	PROPN
ajlm-2505	162	29	health	health	PROPN
ajlm-2505	162	30	laboratory	laboratory	PROPN
ajlm-2505	162	31	service	service	NOUN
ajlm-2505	162	32	at	at	ADP
ajlm-2505	162	33	groote	groote	PROPN
ajlm-2505	162	34	schuur	schuur	PROPN
ajlm-2505	162	35	hospital	hospital	PROPN
ajlm-2505	162	36	,	,	PUNCT
ajlm-2505	162	37	cape	cape	NOUN
ajlm-2505	162	38	town	town	NOUN
ajlm-2505	162	39	,	,	PUNCT
ajlm-2505	162	40	south	south	PROPN
ajlm-2505	162	41	africa	africa	PROPN
ajlm-2505	162	42	,	,	PUNCT
ajlm-2505	162	43	for	for	ADP
ajlm-2505	162	44	conducting	conduct	VERB
ajlm-2505	162	45	the	the	DET
ajlm-2505	162	46	laboratory	laboratory	NOUN
ajlm-2505	162	47	tests	test	NOUN
ajlm-2505	162	48	used	use	VERB
ajlm-2505	162	49	in	in	ADP
ajlm-2505	162	50	this	this	DET
ajlm-2505	162	51	study	study	NOUN
ajlm-2505	162	52	.	.	PUNCT
ajlm-2505	163	1	we	we	PRON
ajlm-2505	163	2	would	would	AUX
ajlm-2505	163	3	also	also	ADV
ajlm-2505	163	4	like	like	VERB
ajlm-2505	163	5	to	to	PART
ajlm-2505	163	6	thank	thank	VERB
ajlm-2505	163	7	the	the	DET
ajlm-2505	163	8	chemical	chemical	ADJ
ajlm-2505	163	9	pathologists	pathologist	NOUN
ajlm-2505	163	10	and	and	CCONJ
ajlm-2505	163	11	registrars	registrar	NOUN
ajlm-2505	163	12	for	for	ADP
ajlm-2505	163	13	their	their	PRON
ajlm-2505	163	14	work	work	NOUN
ajlm-2505	163	15	in	in	ADP
ajlm-2505	163	16	reporting	report	VERB
ajlm-2505	163	17	these	these	DET
ajlm-2505	163	18	tests	test	NOUN
ajlm-2505	163	19	.	.	PUNCT
ajlm-2505	164	1	competing	compete	VERB
ajlm-2505	164	2	interests	interest	NOUN
ajlm-2505	164	3	the	the	DET
ajlm-2505	164	4	authors	author	NOUN
ajlm-2505	164	5	declare	declare	VERB
ajlm-2505	164	6	that	that	SCONJ
ajlm-2505	164	7	they	they	PRON
ajlm-2505	164	8	have	have	VERB
ajlm-2505	164	9	no	no	DET
ajlm-2505	164	10	financial	financial	ADJ
ajlm-2505	164	11	or	or	CCONJ
ajlm-2505	164	12	personal	personal	ADJ
ajlm-2505	164	13	relationships	relationship	NOUN
ajlm-2505	164	14	that	that	PRON
ajlm-2505	164	15	may	may	AUX
ajlm-2505	164	16	have	have	AUX
ajlm-2505	164	17	inappropriately	inappropriately	ADV
ajlm-2505	164	18	influenced	influence	VERB
ajlm-2505	164	19	them	they	PRON
ajlm-2505	164	20	in	in	ADP
ajlm-2505	164	21	writing	write	VERB
ajlm-2505	164	22	this	this	DET
ajlm-2505	164	23	article	article	NOUN
ajlm-2505	164	24	.	.	PUNCT
ajlm-2505	165	1	authors	author	NOUN
ajlm-2505	165	2	’	’	PART
ajlm-2505	165	3	contributions	contribution	NOUN
ajlm-2505	165	4	j.a.r	j.a.r	NOUN
ajlm-2505	165	5	.	.	PUNCT
ajlm-2505	166	1	and	and	CCONJ
ajlm-2505	166	2	s.m.b	s.m.b	VERB
ajlm-2505	166	3	.	.	PUNCT
ajlm-2505	166	4	conceived	conceive	VERB
ajlm-2505	166	5	the	the	DET
ajlm-2505	166	6	research	research	NOUN
ajlm-2505	166	7	idea	idea	NOUN
ajlm-2505	166	8	.	.	PUNCT
ajlm-2505	167	1	n.k	n.k	PROPN
ajlm-2505	167	2	.	.	PROPN
ajlm-2505	167	3	,	,	PUNCT
ajlm-2505	167	4	j.a.r	j.a.r	PROPN
ajlm-2505	167	5	.	.	PROPN
ajlm-2505	167	6	,	,	PUNCT
ajlm-2505	167	7	and	and	CCONJ
ajlm-2505	167	8	s.m.b	s.m.b	ADJ
ajlm-2505	167	9	.	.	PROPN
ajlm-2505	167	10	assisted	assist	VERB
ajlm-2505	167	11	in	in	ADP
ajlm-2505	167	12	producing	produce	VERB
ajlm-2505	167	13	the	the	DET
ajlm-2505	167	14	protocol	protocol	NOUN
ajlm-2505	167	15	and	and	CCONJ
ajlm-2505	167	16	applying	apply	VERB
ajlm-2505	167	17	for	for	ADP
ajlm-2505	167	18	ethical	ethical	ADJ
ajlm-2505	167	19	approval	approval	NOUN
ajlm-2505	167	20	.	.	PUNCT
ajlm-2505	168	1	c.a.f	c.a.f	PROPN
ajlm-2505	168	2	.	.	PUNCT
ajlm-2505	169	1	handled	handle	VERB
ajlm-2505	169	2	the	the	DET
ajlm-2505	169	3	data	datum	NOUN
ajlm-2505	169	4	collection	collection	NOUN
ajlm-2505	169	5	and	and	CCONJ
ajlm-2505	169	6	data	datum	NOUN
ajlm-2505	169	7	cleaning	cleaning	NOUN
ajlm-2505	169	8	.	.	PUNCT
ajlm-2505	170	1	j.a.r	j.a.r	PROPN
ajlm-2505	170	2	.	.	PROPN
ajlm-2505	170	3	,	,	PUNCT
ajlm-2505	170	4	c.a.f	c.a.f	PROPN
ajlm-2505	170	5	.	.	PUNCT
ajlm-2505	170	6	,	,	PUNCT
ajlm-2505	170	7	and	and	CCONJ
ajlm-2505	170	8	n.k	n.k	PROPN
ajlm-2505	170	9	.	.	PROPN
ajlm-2505	170	10	performed	perform	VERB
ajlm-2505	170	11	data	datum	NOUN
ajlm-2505	170	12	analysis	analysis	NOUN
ajlm-2505	170	13	.	.	PUNCT
ajlm-2505	171	1	j.a.r	j.a.r	PROPN
ajlm-2505	171	2	.	.	PUNCT
ajlm-2505	171	3	,	,	PUNCT
ajlm-2505	171	4	s.m.b	s.m.b	PROPN
ajlm-2505	171	5	.	.	PROPN
ajlm-2505	171	6	,	,	PUNCT
ajlm-2505	171	7	c.a.f	c.a.f	PROPN
ajlm-2505	171	8	.	.	PUNCT
ajlm-2505	171	9	,	,	PUNCT
ajlm-2505	171	10	and	and	CCONJ
ajlm-2505	171	11	n.k	n.k	PROPN
ajlm-2505	171	12	.	.	PROPN
ajlm-2505	171	13	wrote	write	VERB
ajlm-2505	171	14	and	and	CCONJ
ajlm-2505	171	15	revised	revise	VERB
ajlm-2505	171	16	the	the	DET
ajlm-2505	171	17	article	article	NOUN
ajlm-2505	171	18	.	.	PUNCT
ajlm-2505	172	1	sources	source	NOUN
ajlm-2505	172	2	of	of	ADP
ajlm-2505	172	3	support	support	NOUN
ajlm-2505	172	4	this	this	DET
ajlm-2505	172	5	research	research	NOUN
ajlm-2505	172	6	did	do	AUX
ajlm-2505	172	7	not	not	PART
ajlm-2505	172	8	receive	receive	VERB
ajlm-2505	172	9	any	any	DET
ajlm-2505	172	10	form	form	NOUN
ajlm-2505	172	11	of	of	ADP
ajlm-2505	172	12	grant	grant	NOUN
ajlm-2505	172	13	from	from	ADP
ajlm-2505	172	14	any	any	DET
ajlm-2505	172	15	funding	funding	NOUN
ajlm-2505	172	16	agency	agency	NOUN
ajlm-2505	172	17	,	,	PUNCT
ajlm-2505	172	18	in	in	ADP
ajlm-2505	172	19	the	the	DET
ajlm-2505	172	20	government	government	NOUN
ajlm-2505	172	21	,	,	PUNCT
ajlm-2505	172	22	commercial	commercial	ADJ
ajlm-2505	172	23	or	or	CCONJ
ajlm-2505	172	24	non	non	ADJ
ajlm-2505	172	25	-	-	ADJ
ajlm-2505	172	26	profit	profit	ADJ
ajlm-2505	172	27	sectors	sector	NOUN
ajlm-2505	172	28	.	.	PUNCT
ajlm-2505	173	1	data	datum	NOUN
ajlm-2505	173	2	availability	availability	NOUN
ajlm-2505	173	3	data	datum	NOUN
ajlm-2505	173	4	are	be	AUX
ajlm-2505	173	5	not	not	PART
ajlm-2505	173	6	available	available	ADJ
ajlm-2505	173	7	publicly	publicly	ADV
ajlm-2505	173	8	but	but	CCONJ
ajlm-2505	173	9	may	may	AUX
ajlm-2505	173	10	be	be	AUX
ajlm-2505	173	11	requested	request	VERB
ajlm-2505	173	12	from	from	ADP
ajlm-2505	173	13	the	the	DET
ajlm-2505	173	14	corresponding	corresponding	ADJ
ajlm-2505	173	15	author	author	NOUN
ajlm-2505	173	16	,	,	PUNCT
ajlm-2505	173	17	n.k	n.k	PROPN
ajlm-2505	173	18	.	.	PROPN
ajlm-2505	173	19	,	,	PUNCT
ajlm-2505	173	20	upon	upon	SCONJ
ajlm-2505	173	21	reasonable	reasonable	ADJ
ajlm-2505	173	22	request	request	NOUN
ajlm-2505	173	23	and	and	CCONJ
ajlm-2505	173	24	after	after	ADP
ajlm-2505	173	25	consultation	consultation	NOUN
ajlm-2505	173	26	with	with	ADP
ajlm-2505	173	27	the	the	DET
ajlm-2505	173	28	human	human	ADJ
ajlm-2505	173	29	research	research	PROPN
ajlm-2505	173	30	ethics	ethic	NOUN
ajlm-2505	173	31	committee	committee	PROPN
ajlm-2505	173	32	of	of	ADP
ajlm-2505	173	33	the	the	DET
ajlm-2505	173	34	university	university	PROPN
ajlm-2505	173	35	of	of	ADP
ajlm-2505	173	36	cape	cape	NOUN
ajlm-2505	173	37	town	town	NOUN
ajlm-2505	173	38	.	.	PUNCT
ajlm-2505	174	1	disclaimer	disclaimer	VERB
ajlm-2505	174	2	the	the	DET
ajlm-2505	174	3	views	view	NOUN
ajlm-2505	174	4	and	and	CCONJ
ajlm-2505	174	5	opinions	opinion	NOUN
ajlm-2505	174	6	expressed	express	VERB
ajlm-2505	174	7	in	in	ADP
ajlm-2505	174	8	this	this	DET
ajlm-2505	174	9	article	article	NOUN
ajlm-2505	174	10	are	be	AUX
ajlm-2505	174	11	those	those	PRON
ajlm-2505	174	12	of	of	ADP
ajlm-2505	174	13	the	the	DET
ajlm-2505	174	14	authors	author	NOUN
ajlm-2505	174	15	and	and	CCONJ
ajlm-2505	174	16	are	be	AUX
ajlm-2505	174	17	the	the	DET
ajlm-2505	174	18	product	product	NOUN
ajlm-2505	174	19	of	of	ADP
ajlm-2505	174	20	professional	professional	ADJ
ajlm-2505	174	21	research	research	NOUN
ajlm-2505	174	22	.	.	PUNCT
ajlm-2505	175	1	the	the	DET
ajlm-2505	175	2	article	article	NOUN
ajlm-2505	175	3	does	do	AUX
ajlm-2505	175	4	not	not	PART
ajlm-2505	175	5	necessarily	necessarily	ADV
ajlm-2505	175	6	reflect	reflect	VERB
ajlm-2505	175	7	the	the	DET
ajlm-2505	175	8	official	official	ADJ
ajlm-2505	175	9	policy	policy	NOUN
ajlm-2505	175	10	or	or	CCONJ
ajlm-2505	175	11	position	position	NOUN
ajlm-2505	175	12	of	of	ADP
ajlm-2505	175	13	any	any	DET
ajlm-2505	175	14	affiliated	affiliated	ADJ
ajlm-2505	175	15	institution	institution	NOUN
ajlm-2505	175	16	,	,	PUNCT
ajlm-2505	175	17	funder	funder	NOUN
ajlm-2505	175	18	,	,	PUNCT
ajlm-2505	175	19	agency	agency	NOUN
ajlm-2505	175	20	,	,	PUNCT
ajlm-2505	175	21	or	or	CCONJ
ajlm-2505	175	22	that	that	PRON
ajlm-2505	175	23	of	of	ADP
ajlm-2505	175	24	the	the	DET
ajlm-2505	175	25	publisher	publisher	NOUN
ajlm-2505	175	26	.	.	PUNCT
ajlm-2505	176	1	the	the	DET
ajlm-2505	176	2	authors	author	NOUN
ajlm-2505	176	3	are	be	AUX
ajlm-2505	176	4	responsible	responsible	ADJ
ajlm-2505	176	5	for	for	ADP
ajlm-2505	176	6	this	this	DET
ajlm-2505	176	7	article	article	NOUN
ajlm-2505	176	8	’s	’s	PART
ajlm-2505	176	9	results	result	NOUN
ajlm-2505	176	10	,	,	PUNCT
ajlm-2505	176	11	findings	finding	NOUN
ajlm-2505	176	12	,	,	PUNCT
ajlm-2505	176	13	and	and	CCONJ
ajlm-2505	176	14	content	content	NOUN
ajlm-2505	176	15	.	.	PUNCT
ajlm-2505	177	1	references	reference	NOUN
ajlm-2505	177	2	rajkumar	rajkumar	PROPN
ajlm-2505	177	3	sv	sv	PROPN
ajlm-2505	177	4	,	,	PUNCT
ajlm-2505	177	5	dimopoulos	dimopoulos	PROPN
ajlm-2505	177	6	ma	ma	PROPN
ajlm-2505	177	7	,	,	PUNCT
ajlm-2505	177	8	palumbo	palumbo	PROPN
ajlm-2505	177	9	a	a	X
ajlm-2505	177	10	,	,	PUNCT
ajlm-2505	177	11	et	et	PROPN
ajlm-2505	177	12	al	al	PROPN
ajlm-2505	177	13	.	.	PUNCT
ajlm-2505	178	1	international	international	ADJ
ajlm-2505	178	2	myeloma	myeloma	PROPN
ajlm-2505	178	3	working	working	PROPN
ajlm-2505	178	4	group	group	NOUN
ajlm-2505	178	5	updated	update	VERB
ajlm-2505	178	6	criteria	criterion	NOUN
ajlm-2505	178	7	for	for	ADP
ajlm-2505	178	8	the	the	DET
ajlm-2505	178	9	diagnosis	diagnosis	NOUN
ajlm-2505	178	10	of	of	ADP
ajlm-2505	178	11	multiple	multiple	ADJ
ajlm-2505	178	12	myeloma	myeloma	NOUN
ajlm-2505	178	13	.	.	PUNCT
ajlm-2505	179	1	lancet	lancet	PROPN
ajlm-2505	179	2	oncol	oncol	PROPN
ajlm-2505	179	3	.	.	PUNCT
ajlm-2505	180	1	2014;15(12):e538	2014;15(12):e538	NUM
ajlm-2505	180	2	–	–	PUNCT
ajlm-2505	180	3	e548	e548	NUM
ajlm-2505	180	4	.	.	PUNCT
ajlm-2505	181	1	https://doi.org/10.1016/s1470-2045(14)70442-5	https://doi.org/10.1016/s1470-2045(14)70442-5	NOUN
ajlm-2505	181	2	palumbo	palumbo	PROPN
ajlm-2505	181	3	a	a	PROPN
ajlm-2505	181	4	,	,	PUNCT
ajlm-2505	181	5	anderson	anderson	PROPN
ajlm-2505	181	6	k.	k.	PROPN
ajlm-2505	182	1	multiple	multiple	PROPN
ajlm-2505	182	2	myeloma	myeloma	PROPN
ajlm-2505	182	3	.	.	PUNCT
ajlm-2505	183	1	n	n	PROPN
ajlm-2505	183	2	engl	engl	PROPN
ajlm-2505	183	3	j	j	PROPN
ajlm-2505	183	4	med	med	PROPN
ajlm-2505	183	5	.	.	PUNCT
ajlm-2505	184	1	2011;364(11):1046–1060	2011;364(11):1046–1060	NUM
ajlm-2505	184	2	.	.	PUNCT
ajlm-2505	185	1	https://doi.org/10.1056/nejmra1011442	https://doi.org/10.1056/nejmra1011442	PROPN
ajlm-2505	185	2	cowan	cowan	PROPN
ajlm-2505	185	3	aj	aj	PROPN
ajlm-2505	185	4	,	,	PUNCT
ajlm-2505	185	5	allen	allen	PROPN
ajlm-2505	185	6	c	c	PROPN
ajlm-2505	185	7	,	,	PUNCT
ajlm-2505	185	8	barac	barac	PROPN
ajlm-2505	185	9	a	a	NOUN
ajlm-2505	185	10	,	,	PUNCT
ajlm-2505	185	11	et	et	PROPN
ajlm-2505	185	12	al	al	PROPN
ajlm-2505	185	13	.	.	PUNCT
ajlm-2505	185	14	global	global	ADJ
ajlm-2505	185	15	burden	burden	NOUN
ajlm-2505	185	16	of	of	ADP
ajlm-2505	185	17	multiple	multiple	ADJ
ajlm-2505	185	18	myeloma	myeloma	NOUN
ajlm-2505	185	19	:	:	PUNCT
ajlm-2505	185	20	a	a	DET
ajlm-2505	185	21	systematic	systematic	ADJ
ajlm-2505	185	22	analysis	analysis	NOUN
ajlm-2505	185	23	for	for	ADP
ajlm-2505	185	24	the	the	DET
ajlm-2505	185	25	global	global	ADJ
ajlm-2505	185	26	burden	burden	NOUN
ajlm-2505	185	27	of	of	ADP
ajlm-2505	185	28	disease	disease	NOUN
ajlm-2505	185	29	study	study	NOUN
ajlm-2505	185	30	2016	2016	NUM
ajlm-2505	185	31	.	.	PUNCT
ajlm-2505	186	1	jama	jama	PROPN
ajlm-2505	186	2	oncol	oncol	ADJ
ajlm-2505	186	3	.	.	PUNCT
ajlm-2505	187	1	2018;4(9):1221–1227	2018;4(9):1221–1227	X
ajlm-2505	187	2	.	.	PUNCT
ajlm-2505	188	1	https://doi.org/10.1001/jamaoncol.2018.2128	https://doi.org/10.1001/jamaoncol.2018.2128	PROPN
ajlm-2505	188	2	rebbeck	rebbeck	NOUN
ajlm-2505	188	3	tr	tr	VERB
ajlm-2505	188	4	.	.	NOUN
ajlm-2505	188	5	cancer	cancer	NOUN
ajlm-2505	188	6	in	in	ADP
ajlm-2505	188	7	sub	sub	ADJ
ajlm-2505	188	8	-	-	ADJ
ajlm-2505	188	9	saharan	saharan	ADJ
ajlm-2505	188	10	africa	africa	PROPN
ajlm-2505	188	11	.	.	PUNCT
ajlm-2505	189	1	science	science	NOUN
ajlm-2505	189	2	.	.	PUNCT
ajlm-2505	190	1	2020;367(6473):27–28	2020;367(6473):27–28	NOUN
ajlm-2505	190	2	.	.	PUNCT
ajlm-2505	191	1	https://doi.org/10.1126/science.aay4743	https://doi.org/10.1126/science.aay4743	PROPN
ajlm-2505	191	2	finestone	finestone	PROPN
ajlm-2505	191	3	e	e	PROPN
ajlm-2505	191	4	,	,	PUNCT
ajlm-2505	191	5	wishnia	wishnia	PROPN
ajlm-2505	191	6	j.	j.	PROPN
ajlm-2505	191	7	estimating	estimate	VERB
ajlm-2505	191	8	the	the	DET
ajlm-2505	191	9	burden	burden	NOUN
ajlm-2505	191	10	of	of	ADP
ajlm-2505	191	11	cancer	cancer	NOUN
ajlm-2505	191	12	in	in	ADP
ajlm-2505	191	13	south	south	PROPN
ajlm-2505	191	14	africa	africa	PROPN
ajlm-2505	191	15	.	.	PUNCT
ajlm-2505	192	1	s	s	PROPN
ajlm-2505	192	2	afr	afr	PROPN
ajlm-2505	192	3	j	j	PROPN
ajlm-2505	192	4	oncol	oncol	PROPN
ajlm-2505	192	5	.	.	PUNCT
ajlm-2505	193	1	2022;6:220	2022;6:220	NOUN
ajlm-2505	193	2	.	.	PUNCT
ajlm-2505	194	1	https://doi.org/10.4102/sajo.v6i0.220	https://doi.org/10.4102/sajo.v6i0.220	PROPN
ajlm-2505	194	2	kariyawasan	kariyawasan	PROPN
ajlm-2505	194	3	cc	cc	PROPN
ajlm-2505	194	4	,	,	PUNCT
ajlm-2505	194	5	hughes	hughes	PROPN
ajlm-2505	194	6	da	da	PROPN
ajlm-2505	194	7	,	,	PUNCT
ajlm-2505	194	8	jayatillake	jayatillake	NOUN
ajlm-2505	194	9	mm	mm	PROPN
ajlm-2505	194	10	,	,	PUNCT
ajlm-2505	194	11	mehta	mehta	PROPN
ajlm-2505	194	12	ab	ab	PROPN
ajlm-2505	194	13	.	.	PUNCT
ajlm-2505	194	14	multiple	multiple	ADJ
ajlm-2505	194	15	myeloma	myeloma	PROPN
ajlm-2505	194	16	:	:	PUNCT
ajlm-2505	194	17	causes	cause	NOUN
ajlm-2505	194	18	and	and	CCONJ
ajlm-2505	194	19	consequences	consequence	NOUN
ajlm-2505	194	20	of	of	ADP
ajlm-2505	194	21	delay	delay	NOUN
ajlm-2505	194	22	in	in	ADP
ajlm-2505	194	23	diagnosis	diagnosis	NOUN
ajlm-2505	194	24	.	.	PUNCT
ajlm-2505	195	1	q	q	PUNCT
ajlm-2505	196	1	j	j	PROPN
ajlm-2505	196	2	med	med	PROPN
ajlm-2505	196	3	.	.	PUNCT
ajlm-2505	197	1	2007;100(10):635–640	2007;100(10):635–640	NUM
ajlm-2505	197	2	.	.	PUNCT
ajlm-2505	198	1	https://doi.org/10.1093/qjmed/hcm077	https://doi.org/10.1093/qjmed/hcm077	PROPN
ajlm-2505	198	2	chong	chong	PROPN
ajlm-2505	198	3	yp	yp	PROPN
ajlm-2505	198	4	,	,	PUNCT
ajlm-2505	198	5	lim	lim	PROPN
ajlm-2505	198	6	sm	sm	PROPN
ajlm-2505	198	7	,	,	PUNCT
ajlm-2505	198	8	loh	loh	PROPN
ajlm-2505	198	9	tp	tp	NOUN
ajlm-2505	198	10	,	,	PUNCT
ajlm-2505	198	11	mollee	mollee	PROPN
ajlm-2505	198	12	p	p	NOUN
ajlm-2505	198	13	,	,	PUNCT
ajlm-2505	198	14	wijeratne	wijeratne	PROPN
ajlm-2505	198	15	n	n	SYM
ajlm-2505	198	16	,	,	PUNCT
ajlm-2505	198	17	choy	choy	NOUN
ajlm-2505	198	18	kw	kw	NOUN
ajlm-2505	198	19	.	.	PUNCT
ajlm-2505	199	1	screening	screen	VERB
ajlm-2505	199	2	for	for	ADP
ajlm-2505	199	3	and	and	CCONJ
ajlm-2505	199	4	diagnosis	diagnosis	NOUN
ajlm-2505	199	5	of	of	ADP
ajlm-2505	199	6	monoclonal	monoclonal	NOUN
ajlm-2505	199	7	gammopathy	gammopathy	ADJ
ajlm-2505	199	8	.	.	PUNCT
ajlm-2505	200	1	j	j	PROPN
ajlm-2505	200	2	clin	clin	PROPN
ajlm-2505	200	3	pathol	pathol	PROPN
ajlm-2505	200	4	.	.	PUNCT
ajlm-2505	201	1	2023;76(11):727–733	2023;76(11):727–733	NUM
ajlm-2505	201	2	.	.	PUNCT
ajlm-2505	202	1	https://doi.org/10.1136/jcp-2023-208774	https://doi.org/10.1136/jcp-2023-208774	PROPN
ajlm-2505	202	2	heaton	heaton	PROPN
ajlm-2505	202	3	c	c	PROPN
ajlm-2505	202	4	,	,	PUNCT
ajlm-2505	202	5	vyas	vyas	PROPN
ajlm-2505	202	6	sg	sg	PROPN
ajlm-2505	202	7	,	,	PUNCT
ajlm-2505	202	8	singh	singh	PROPN
ajlm-2505	202	9	g.	g.	PROPN
ajlm-2505	202	10	audit	audit	NOUN
ajlm-2505	202	11	of	of	ADP
ajlm-2505	202	12	use	use	NOUN
ajlm-2505	202	13	and	and	CCONJ
ajlm-2505	202	14	overuse	overuse	NOUN
ajlm-2505	202	15	of	of	ADP
ajlm-2505	202	16	serum	serum	NOUN
ajlm-2505	202	17	protein	protein	NOUN
ajlm-2505	202	18	immunofixation	immunofixation	NOUN
ajlm-2505	202	19	electrophoresis	electrophoresis	NOUN
ajlm-2505	202	20	and	and	CCONJ
ajlm-2505	202	21	serum	serum	NOUN
ajlm-2505	202	22	free	free	ADJ
ajlm-2505	202	23	light	light	NOUN
ajlm-2505	202	24	chain	chain	NOUN
ajlm-2505	202	25	assay	assay	NOUN
ajlm-2505	202	26	in	in	ADP
ajlm-2505	202	27	tertiary	tertiary	ADJ
ajlm-2505	202	28	health	health	NOUN
ajlm-2505	202	29	care	care	NOUN
ajlm-2505	202	30	:	:	PUNCT
ajlm-2505	202	31	a	a	DET
ajlm-2505	202	32	case	case	NOUN
ajlm-2505	202	33	for	for	ADP
ajlm-2505	202	34	algorithmic	algorithmic	ADJ
ajlm-2505	202	35	testing	testing	NOUN
ajlm-2505	202	36	to	to	PART
ajlm-2505	202	37	optimize	optimize	VERB
ajlm-2505	202	38	laboratory	laboratory	NOUN
ajlm-2505	202	39	utilization	utilization	NOUN
ajlm-2505	202	40	.	.	PUNCT
ajlm-2505	203	1	am	be	AUX
ajlm-2505	203	2	j	j	PROPN
ajlm-2505	203	3	clin	clin	PROPN
ajlm-2505	203	4	pathol	pathol	NOUN
ajlm-2505	203	5	.	.	PUNCT
ajlm-2505	204	1	2016;145(4):531–537	2016;145(4):531–537	X
ajlm-2505	204	2	.	.	PUNCT
ajlm-2505	204	3	https://doi.org/10.1093/ajcp/aqw026	https://doi.org/10.1093/ajcp/aqw026	ADJ
ajlm-2505	204	4	salt	salt	NOUN
ajlm-2505	205	1	hb	hb	PROPN
ajlm-2505	205	2	.	.	PUNCT
ajlm-2505	206	1	serum	serum	PROPN
ajlm-2505	206	2	globulin	globulin	NOUN
ajlm-2505	206	3	fractions	fraction	NOUN
ajlm-2505	206	4	in	in	ADP
ajlm-2505	206	5	chronic	chronic	ADJ
ajlm-2505	206	6	rheumatic	rheumatic	ADJ
ajlm-2505	206	7	diseases	disease	NOUN
ajlm-2505	206	8	:	:	PUNCT
ajlm-2505	206	9	an	an	DET
ajlm-2505	206	10	electrophoretic	electrophoretic	ADJ
ajlm-2505	206	11	study	study	NOUN
ajlm-2505	206	12	.	.	PUNCT
ajlm-2505	207	1	clin	clin	PROPN
ajlm-2505	207	2	chem	chem	PROPN
ajlm-2505	207	3	.	.	PUNCT
ajlm-2505	208	1	1956;2(1):35–44	1956;2(1):35–44	NUM
ajlm-2505	208	2	.	.	X
ajlm-2505	209	1	https://doi.org/10.1093/clinchem/2.1.35	https://doi.org/10.1093/clinchem/2.1.35	PROPN
ajlm-2505	209	2	thakkinstian	thakkinstian	PROPN
ajlm-2505	209	3	a	a	X
ajlm-2505	209	4	,	,	PUNCT
ajlm-2505	209	5	tran	tran	PROPN
ajlm-2505	209	6	h	h	PROPN
ajlm-2505	209	7	,	,	PUNCT
ajlm-2505	209	8	reeves	reeves	PROPN
ajlm-2505	209	9	g	g	PROPN
ajlm-2505	209	10	,	,	PUNCT
ajlm-2505	209	11	murch	murch	PROPN
ajlm-2505	209	12	s	s	PROPN
ajlm-2505	209	13	,	,	PUNCT
ajlm-2505	209	14	attia	attia	PROPN
ajlm-2505	209	15	j.	j.	PROPN
ajlm-2505	210	1	a	a	DET
ajlm-2505	210	2	clinical	clinical	ADJ
ajlm-2505	210	3	decision	decision	NOUN
ajlm-2505	210	4	rule	rule	NOUN
ajlm-2505	210	5	to	to	PART
ajlm-2505	210	6	aid	aid	VERB
ajlm-2505	210	7	ordering	ordering	NOUN
ajlm-2505	210	8	of	of	ADP
ajlm-2505	210	9	serum	serum	NOUN
ajlm-2505	210	10	and	and	CCONJ
ajlm-2505	210	11	urine	urine	NOUN
ajlm-2505	210	12	protein	protein	NOUN
ajlm-2505	210	13	electrophoresis	electrophoresis	NOUN
ajlm-2505	210	14	for	for	ADP
ajlm-2505	210	15	case	case	NOUN
ajlm-2505	210	16	-	-	PUNCT
ajlm-2505	210	17	finding	finding	NOUN
ajlm-2505	210	18	of	of	ADP
ajlm-2505	210	19	paraproteins	paraprotein	NOUN
ajlm-2505	210	20	in	in	ADP
ajlm-2505	210	21	hospitalized	hospitalize	VERB
ajlm-2505	210	22	inpatients	inpatient	NOUN
ajlm-2505	210	23	.	.	PUNCT
ajlm-2505	211	1	j	j	PROPN
ajlm-2505	211	2	gen	gen	PROPN
ajlm-2505	211	3	intern	intern	NOUN
ajlm-2505	211	4	med	me	VERB
ajlm-2505	211	5	.	.	PUNCT
ajlm-2505	212	1	2008;23(10):1688–1692	2008;23(10):1688–1692	NUM
ajlm-2505	212	2	.	.	PUNCT
ajlm-2505	213	1	dupuis	dupuis	PROPN
ajlm-2505	213	2	mm	mm	PROPN
ajlm-2505	213	3	,	,	PUNCT
ajlm-2505	213	4	paul	paul	PROPN
ajlm-2505	213	5	b	b	PROPN
ajlm-2505	213	6	,	,	PUNCT
ajlm-2505	213	7	loitsch	loitsch	VERB
ajlm-2505	213	8	g	g	NOUN
ajlm-2505	213	9	,	,	PUNCT
ajlm-2505	213	10	et	et	PROPN
ajlm-2505	213	11	al	al	PROPN
ajlm-2505	213	12	.	.	PROPN
ajlm-2505	213	13	gamma	gamma	PROPN
ajlm-2505	213	14	gap	gap	PROPN
ajlm-2505	213	15	:	:	PUNCT
ajlm-2505	213	16	a	a	DET
ajlm-2505	213	17	point	point	NOUN
ajlm-2505	213	18	-	-	PUNCT
ajlm-2505	213	19	of	of	ADP
ajlm-2505	213	20	-	-	PUNCT
ajlm-2505	213	21	care	care	NOUN
ajlm-2505	213	22	test	test	NOUN
ajlm-2505	213	23	that	that	PRON
ajlm-2505	213	24	correlates	correlate	VERB
ajlm-2505	213	25	with	with	ADP
ajlm-2505	213	26	disease	disease	NOUN
ajlm-2505	213	27	burden	burden	NOUN
ajlm-2505	213	28	and	and	CCONJ
ajlm-2505	213	29	treatment	treatment	NOUN
ajlm-2505	213	30	response	response	NOUN
ajlm-2505	213	31	in	in	ADP
ajlm-2505	213	32	multiple	multiple	ADJ
ajlm-2505	213	33	myeloma	myeloma	NOUN
ajlm-2505	213	34	.	.	PUNCT
ajlm-2505	214	1	jco	jco	PROPN
ajlm-2505	214	2	oncol	oncol	PROPN
ajlm-2505	214	3	pract	pract	PROPN
ajlm-2505	214	4	.	.	PUNCT
ajlm-2505	215	1	2020;16(8):e751	2020;16(8):e751	ADV
ajlm-2505	215	2	–	–	PUNCT
ajlm-2505	215	3	e757	e757	PROPN
ajlm-2505	215	4	.	.	PUNCT
ajlm-2505	216	1	https://doi.org/10.1200/jop.19.00517	https://doi.org/10.1200/jop.19.00517	PROPN
ajlm-2505	216	2	edwards	edwards	PROPN
ajlm-2505	216	3	mk	mk	PROPN
ajlm-2505	216	4	,	,	PUNCT
ajlm-2505	216	5	loprinzi	loprinzi	PROPN
ajlm-2505	216	6	pd	pd	PROPN
ajlm-2505	216	7	.	.	PROPN
ajlm-2505	216	8	atherogenic	atherogenic	ADJ
ajlm-2505	216	9	index	index	NOUN
ajlm-2505	216	10	of	of	ADP
ajlm-2505	216	11	plasma	plasma	NOUN
ajlm-2505	216	12	and	and	CCONJ
ajlm-2505	216	13	the	the	DET
ajlm-2505	216	14	gamma	gamma	NOUN
ajlm-2505	216	15	gap	gap	NOUN
ajlm-2505	216	16	:	:	PUNCT
ajlm-2505	216	17	considerations	consideration	NOUN
ajlm-2505	216	18	by	by	ADP
ajlm-2505	216	19	physical	physical	ADJ
ajlm-2505	216	20	activity	activity	NOUN
ajlm-2505	216	21	.	.	PUNCT
ajlm-2505	217	1	int	int	NOUN
ajlm-2505	217	2	j	j	PROPN
ajlm-2505	217	3	cardiol	cardiol	NOUN
ajlm-2505	217	4	.	.	PUNCT
ajlm-2505	218	1	2016;222:946–948	2016;222:946–948	NOUN
ajlm-2505	218	2	.	.	PUNCT
ajlm-2505	219	1	liu	liu	PROPN
ajlm-2505	219	2	gy	gy	PROPN
ajlm-2505	219	3	,	,	PUNCT
ajlm-2505	219	4	tang	tang	PROPN
ajlm-2505	219	5	o	o	NOUN
ajlm-2505	219	6	,	,	PUNCT
ajlm-2505	219	7	brotman	brotman	NOUN
ajlm-2505	219	8	dj	dj	PROPN
ajlm-2505	219	9	,	,	PUNCT
ajlm-2505	219	10	miller	miller	PROPN
ajlm-2505	219	11	er	er	INTJ
ajlm-2505	219	12	,	,	PUNCT
ajlm-2505	219	13	3rd	3rd	NOUN
ajlm-2505	219	14	,	,	PUNCT
ajlm-2505	219	15	moliterno	moliterno	PROPN
ajlm-2505	219	16	ar	ar	PROPN
ajlm-2505	219	17	,	,	PUNCT
ajlm-2505	219	18	juraschek	juraschek	PROPN
ajlm-2505	219	19	sp	sp	PROPN
ajlm-2505	219	20	.	.	PROPN
ajlm-2505	219	21	gamma	gamma	NOUN
ajlm-2505	219	22	gap	gap	NOUN
ajlm-2505	219	23	thresholds	threshold	NOUN
ajlm-2505	219	24	and	and	CCONJ
ajlm-2505	219	25	hiv	hiv	PROPN
ajlm-2505	219	26	,	,	PUNCT
ajlm-2505	219	27	hepatitis	hepatitis	NOUN
ajlm-2505	219	28	c	c	NOUN
ajlm-2505	219	29	,	,	PUNCT
ajlm-2505	219	30	and	and	CCONJ
ajlm-2505	219	31	monoclonal	monoclonal	NOUN
ajlm-2505	219	32	gammopathy	gammopathy	ADJ
ajlm-2505	219	33	.	.	PUNCT
ajlm-2505	220	1	plos	plos	PROPN
ajlm-2505	220	2	one	one	NUM
ajlm-2505	220	3	.	.	PUNCT
ajlm-2505	221	1	2020;15(1):e0224977	2020;15(1):e0224977	NUM
ajlm-2505	221	2	.	.	PUNCT
ajlm-2505	221	3	https://doi.org/10.1371/journal.pone.0224977	https://doi.org/10.1371/journal.pone.0224977	PROPN
ajlm-2505	222	1	o’connell	o’connell	INTJ
ajlm-2505	222	2	tx	tx	PROPN
ajlm-2505	222	3	ht	ht	PROPN
ajlm-2505	222	4	,	,	PUNCT
ajlm-2505	222	5	kasravi	kasravi	PROPN
ajlm-2505	222	6	b.	b.	PROPN
ajlm-2505	222	7	understanding	understanding	NOUN
ajlm-2505	222	8	and	and	CCONJ
ajlm-2505	222	9	interpreting	interpret	VERB
ajlm-2505	222	10	serum	serum	NOUN
ajlm-2505	222	11	protein	protein	NOUN
ajlm-2505	222	12	electrophoresis	electrophoresis	NOUN
ajlm-2505	222	13	.	.	PUNCT
ajlm-2505	223	1	am	be	AUX
ajlm-2505	223	2	fam	fam	NOUN
ajlm-2505	223	3	phys	phy	NOUN
ajlm-2505	223	4	.	.	PUNCT
ajlm-2505	224	1	2005;71:105–112	2005;71:105–112	NUM
ajlm-2505	224	2	.	.	PUNCT
ajlm-2505	225	1	who	who	PRON
ajlm-2505	225	2	.	.	PUNCT
ajlm-2505	226	1	global	global	ADJ
ajlm-2505	226	2	tuberculosis	tuberculosis	NOUN
ajlm-2505	226	3	report	report	NOUN
ajlm-2505	226	4	.	.	PUNCT
ajlm-2505	227	1	geneva	geneva	PROPN
ajlm-2505	227	2	:	:	PUNCT
ajlm-2505	227	3	world	world	PROPN
ajlm-2505	227	4	health	health	NOUN
ajlm-2505	227	5	organisation	organisation	NOUN
ajlm-2505	227	6	;	;	PUNCT
ajlm-2505	227	7	2023	2023	NUM
ajlm-2505	227	8	.	.	PUNCT
ajlm-2505	227	9	sanac	sanac	NOUN
ajlm-2505	227	10	.	.	PUNCT
ajlm-2505	228	1	south	south	PROPN
ajlm-2505	228	2	africa	africa	PROPN
ajlm-2505	228	3	’s	’s	PART
ajlm-2505	228	4	national	national	ADJ
ajlm-2505	228	5	strategic	strategic	ADJ
ajlm-2505	228	6	plan	plan	NOUN
ajlm-2505	228	7	for	for	ADP
ajlm-2505	228	8	hiv	hiv	PROPN
ajlm-2505	228	9	,	,	PUNCT
ajlm-2505	228	10	tb	tb	NOUN
ajlm-2505	228	11	and	and	CCONJ
ajlm-2505	228	12	stis	stis	PROPN
ajlm-2505	228	13	2017–2022	2017–2022	NOUN
ajlm-2505	228	14	.	.	PUNCT
ajlm-2505	229	1	pretoria	pretoria	PROPN
ajlm-2505	229	2	:	:	PUNCT
ajlm-2505	229	3	south	south	ADJ
ajlm-2505	229	4	african	african	ADJ
ajlm-2505	229	5	national	national	PROPN
ajlm-2505	229	6	aids	aids	PROPN
ajlm-2505	229	7	council	council	PROPN
ajlm-2505	229	8	;	;	PUNCT
ajlm-2505	229	9	2017	2017	NUM
ajlm-2505	229	10	.	.	PUNCT
ajlm-2505	230	1	south	south	ADJ
ajlm-2505	230	2	african	african	PROPN
ajlm-2505	230	3	national	national	PROPN
ajlm-2505	230	4	health	health	PROPN
ajlm-2505	230	5	research	research	PROPN
ajlm-2505	230	6	ethics	ethic	NOUN
ajlm-2505	230	7	council	council	PROPN
ajlm-2505	230	8	.	.	PUNCT
ajlm-2505	231	1	ethics	ethic	NOUN
ajlm-2505	231	2	in	in	ADP
ajlm-2505	231	3	health	health	NOUN
ajlm-2505	231	4	research	research	NOUN
ajlm-2505	231	5	principles	principle	NOUN
ajlm-2505	231	6	,	,	PUNCT
ajlm-2505	231	7	processes	process	NOUN
ajlm-2505	231	8	,	,	PUNCT
ajlm-2505	231	9	and	and	CCONJ
ajlm-2505	231	10	structures	structure	NOUN
ajlm-2505	231	11	.	.	PUNCT
ajlm-2505	232	1	pretoria	pretoria	PROPN
ajlm-2505	232	2	:	:	PUNCT
ajlm-2505	232	3	national	national	PROPN
ajlm-2505	232	4	department	department	PROPN
ajlm-2505	232	5	of	of	ADP
ajlm-2505	232	6	health	health	NOUN
ajlm-2505	232	7	of	of	ADP
ajlm-2505	232	8	the	the	DET
ajlm-2505	232	9	republic	republic	NOUN
ajlm-2505	232	10	of	of	ADP
ajlm-2505	232	11	south	south	PROPN
ajlm-2505	232	12	africa	africa	PROPN
ajlm-2505	232	13	;	;	PUNCT
ajlm-2505	232	14	2015	2015	NUM
ajlm-2505	232	15	.	.	PUNCT
ajlm-2505	233	1	tarín	tarín	NOUN
ajlm-2505	233	2	-	-	PUNCT
ajlm-2505	233	3	arzaga	arzaga	NOUN
ajlm-2505	233	4	l	l	NOUN
ajlm-2505	233	5	,	,	PUNCT
ajlm-2505	233	6	cantu	cantu	PROPN
ajlm-2505	233	7	-	-	PUNCT
ajlm-2505	233	8	martinez	martinez	PROPN
ajlm-2505	233	9	o	o	PROPN
ajlm-2505	233	10	,	,	PUNCT
ajlm-2505	233	11	de	de	X
ajlm-2505	233	12	la	la	PROPN
ajlm-2505	233	13	cruz	cruz	PROPN
ajlm-2505	234	1	c	c	PROPN
ajlm-2505	234	2	,	,	PUNCT
ajlm-2505	234	3	et	et	PROPN
ajlm-2505	234	4	al	al	PROPN
ajlm-2505	234	5	.	.	PUNCT
ajlm-2505	235	1	roc	roc	PROPN
ajlm-2505	235	2	defined	define	VERB
ajlm-2505	235	3	serum	serum	NOUN
ajlm-2505	235	4	globulin	globulin	NOUN
ajlm-2505	235	5	cutoff	cutoff	NOUN
ajlm-2505	235	6	as	as	ADP
ajlm-2505	235	7	a	a	DET
ajlm-2505	235	8	screening	screening	NOUN
ajlm-2505	235	9	tool	tool	NOUN
ajlm-2505	235	10	for	for	ADP
ajlm-2505	235	11	monoclonal	monoclonal	NOUN
ajlm-2505	235	12	gammopathies	gammopathy	NOUN
ajlm-2505	235	13	.	.	PUNCT
ajlm-2505	236	1	rev	rev	PROPN
ajlm-2505	236	2	med	med	PROPN
ajlm-2505	236	3	univ	univ	PROPN
ajlm-2505	236	4	.	.	PUNCT
ajlm-2505	237	1	2022;24(2):47–51	2022;24(2):47–51	X
ajlm-2505	237	2	.	.	PUNCT
ajlm-2505	237	3	https://doi.org/10.24875/rmu.22000004	https://doi.org/10.24875/rmu.22000004	PROPN
ajlm-2505	237	4	suleman	suleman	PROPN
ajlm-2505	237	5	a	a	PROPN
ajlm-2505	237	6	,	,	PUNCT
ajlm-2505	237	7	cameron	cameron	PROPN
ajlm-2505	237	8	dw	dw	PROPN
ajlm-2505	237	9	,	,	PUNCT
ajlm-2505	237	10	corrales	corrales	PROPN
ajlm-2505	237	11	-	-	PUNCT
ajlm-2505	237	12	medina	medina	PROPN
ajlm-2505	237	13	v	v	PROPN
ajlm-2505	237	14	,	,	PUNCT
ajlm-2505	237	15	mccudden	mccudden	ADJ
ajlm-2505	237	16	c	c	NOUN
ajlm-2505	237	17	,	,	PUNCT
ajlm-2505	237	18	cowan	cowan	PROPN
ajlm-2505	237	19	j.	j.	PROPN
ajlm-2505	237	20	evaluation	evaluation	NOUN
ajlm-2505	237	21	of	of	ADP
ajlm-2505	237	22	the	the	DET
ajlm-2505	237	23	protein	protein	NOUN
ajlm-2505	237	24	gap	gap	NOUN
ajlm-2505	237	25	for	for	ADP
ajlm-2505	237	26	detection	detection	NOUN
ajlm-2505	237	27	of	of	ADP
ajlm-2505	237	28	abnormal	abnormal	ADJ
ajlm-2505	237	29	serum	serum	NOUN
ajlm-2505	237	30	gammaglobulin	gammaglobulin	NOUN
ajlm-2505	237	31	level	level	NOUN
ajlm-2505	237	32	:	:	PUNCT
ajlm-2505	237	33	an	an	DET
ajlm-2505	237	34	imperfect	imperfect	ADJ
ajlm-2505	237	35	predictor	predictor	NOUN
ajlm-2505	237	36	.	.	PUNCT
ajlm-2505	238	1	clin	clin	PROPN
ajlm-2505	238	2	chem	chem	NOUN
ajlm-2505	238	3	lab	lab	NOUN
ajlm-2505	238	4	med	me	VERB
ajlm-2505	238	5	.	.	PUNCT
ajlm-2505	239	1	2021;59(5):869–874	2021;59(5):869–874	NUM
ajlm-2505	239	2	.	.	PUNCT
ajlm-2505	240	1	pawar	pawar	PROPN
ajlm-2505	240	2	nm	nm	PROPN
ajlm-2505	240	3	,	,	PUNCT
ajlm-2505	240	4	hegde	hegde	PROPN
ajlm-2505	240	5	a.	a.	NOUN
ajlm-2505	240	6	usefulness	usefulness	NOUN
ajlm-2505	240	7	of	of	ADP
ajlm-2505	240	8	serum	serum	NOUN
ajlm-2505	240	9	globulin	globulin	NOUN
ajlm-2505	240	10	levels	level	NOUN
ajlm-2505	240	11	for	for	ADP
ajlm-2505	240	12	discriminating	discriminate	VERB
ajlm-2505	240	13	patients	patient	NOUN
ajlm-2505	240	14	with	with	ADP
ajlm-2505	240	15	monoclonal	monoclonal	NOUN
ajlm-2505	240	16	gammopathies/	gammopathies/	NUM
ajlm-2505	240	17	paraproteinemias	paraproteinemia	NOUN
ajlm-2505	240	18	.	.	PUNCT
ajlm-2505	241	1	biomedicine	biomedicine	NOUN
ajlm-2505	241	2	.	.	PUNCT
ajlm-2505	242	1	2021;41(1):31–35	2021;41(1):31–35	NUM
ajlm-2505	242	2	.	.	PUNCT
ajlm-2505	243	1	https://doi.org/10.51248/.v41i1.529	https://doi.org/10.51248/.v41i1.529	PROPN
ajlm-2505	243	2	hassan	hassan	PROPN
ajlm-2505	243	3	ea	ea	PROPN
ajlm-2505	243	4	,	,	PUNCT
ajlm-2505	243	5	hameed	hameed	PROPN
ajlm-2505	243	6	ry	ry	PROPN
ajlm-2505	243	7	.	.	PROPN
ajlm-2505	243	8	gamma	gamma	NOUN
ajlm-2505	243	9	gap	gap	NOUN
ajlm-2505	243	10	as	as	ADP
ajlm-2505	243	11	a	a	DET
ajlm-2505	243	12	prognostic	prognostic	ADJ
ajlm-2505	243	13	marker	marker	NOUN
ajlm-2505	243	14	of	of	ADP
ajlm-2505	243	15	treatment	treatment	NOUN
ajlm-2505	243	16	response	response	NOUN
ajlm-2505	243	17	in	in	ADP
ajlm-2505	243	18	patients	patient	NOUN
ajlm-2505	243	19	with	with	ADP
ajlm-2505	243	20	multiple	multiple	ADJ
ajlm-2505	243	21	myeloma	myeloma	NOUN
ajlm-2505	243	22	.	.	PUNCT
ajlm-2505	244	1	ir	ir	PROPN
ajlm-2505	244	2	j	j	PROPN
ajlm-2505	244	3	med	med	PROPN
ajlm-2505	244	4	sci	sci	PROPN
ajlm-2505	244	5	.	.	PUNCT
ajlm-2505	244	6	2024;193:1–7	2024;193:1–7	NUM
ajlm-2505	244	7	.	.	PUNCT
ajlm-2505	245	1	https://doi.org/10.1007/s11845-024-03784-5	https://doi.org/10.1007/s11845-024-03784-5	PROPN
ajlm-2505	245	2	huang	huang	PROPN
ajlm-2505	245	3	ry	ry	PROPN
ajlm-2505	245	4	,	,	PUNCT
ajlm-2505	245	5	x.	x.	NOUN
ajlm-2505	245	6	comparison	comparison	NOUN
ajlm-2505	245	7	of	of	ADP
ajlm-2505	245	8	serum	serum	NOUN
ajlm-2505	245	9	free	free	ADJ
ajlm-2505	245	10	light	light	NOUN
ajlm-2505	245	11	chain	chain	NOUN
ajlm-2505	245	12	assay	assay	NOUN
ajlm-2505	245	13	and	and	CCONJ
ajlm-2505	245	14	urine	urine	NOUN
ajlm-2505	245	15	protein	protein	NOUN
ajlm-2505	245	16	electrophoresis	electrophoresis	NOUN
ajlm-2505	245	17	for	for	ADP
ajlm-2505	245	18	the	the	DET
ajlm-2505	245	19	detection	detection	NOUN
ajlm-2505	245	20	of	of	ADP
ajlm-2505	245	21	monoclonal	monoclonal	NOUN
ajlm-2505	245	22	gammopathies	gammopathy	NOUN
ajlm-2505	245	23	.	.	PUNCT
ajlm-2505	245	24	am	be	AUX
ajlm-2505	245	25	j	j	PROPN
ajlm-2505	245	26	clin	clin	PROPN
ajlm-2505	245	27	pathol	pathol	NOUN
ajlm-2505	245	28	.	.	PUNCT
ajlm-2505	246	1	2019(152):s36	2019(152):s36	NUM
ajlm-2505	246	2	.	.	PUNCT
ajlm-2505	247	1	https://doi.org/10.1093/ajcp/aqz112.020	https://doi.org/10.1093/ajcp/aqz112.020	ADP
ajlm-2505	247	2	mctaggart	mctaggart	PROPN
ajlm-2505	247	3	mp	mp	PROPN
ajlm-2505	247	4	,	,	PUNCT
ajlm-2505	247	5	lindsay	lindsay	PROPN
ajlm-2505	247	6	j	j	PROPN
ajlm-2505	247	7	,	,	PUNCT
ajlm-2505	247	8	kearney	kearney	PROPN
ajlm-2505	247	9	em	em	PRON
ajlm-2505	247	10	.	.	PUNCT
ajlm-2505	248	1	replacing	replace	VERB
ajlm-2505	248	2	urine	urine	NOUN
ajlm-2505	248	3	protein	protein	NOUN
ajlm-2505	248	4	electrophoresis	electrophoresis	NOUN
ajlm-2505	248	5	with	with	ADP
ajlm-2505	248	6	serum	serum	NOUN
ajlm-2505	248	7	free	free	ADJ
ajlm-2505	248	8	light	light	ADJ
ajlm-2505	248	9	chain	chain	NOUN
ajlm-2505	248	10	analysis	analysis	NOUN
ajlm-2505	248	11	as	as	ADP
ajlm-2505	248	12	a	a	DET
ajlm-2505	248	13	first	first	ADJ
ajlm-2505	248	14	-	-	PUNCT
ajlm-2505	248	15	line	line	NOUN
ajlm-2505	248	16	test	test	NOUN
ajlm-2505	248	17	for	for	ADP
ajlm-2505	248	18	detecting	detect	VERB
ajlm-2505	248	19	plasma	plasma	NOUN
ajlm-2505	248	20	cell	cell	NOUN
ajlm-2505	248	21	disorders	disorder	NOUN
ajlm-2505	248	22	offers	offer	VERB
ajlm-2505	248	23	increased	increase	VERB
ajlm-2505	248	24	diagnostic	diagnostic	ADJ
ajlm-2505	248	25	accuracy	accuracy	NOUN
ajlm-2505	248	26	and	and	CCONJ
ajlm-2505	248	27	potential	potential	ADJ
ajlm-2505	248	28	health	health	NOUN
ajlm-2505	248	29	benefit	benefit	NOUN
ajlm-2505	248	30	to	to	ADP
ajlm-2505	248	31	patients	patient	NOUN
ajlm-2505	248	32	.	.	PUNCT
ajlm-2505	249	1	am	be	AUX
ajlm-2505	249	2	j	j	PROPN
ajlm-2505	249	3	clin	clin	PROPN
ajlm-2505	249	4	pathol	pathol	NOUN
ajlm-2505	249	5	.	.	PUNCT
ajlm-2505	250	1	2013;140(6):890–897	2013;140(6):890–897	NUM
ajlm-2505	250	2	.	.	PUNCT
ajlm-2505	250	3	https://doi.org/10.1309/ajcp25ihylewcahj	https://doi.org/10.1309/ajcp25ihylewcahj	PROPN
ajlm-2505	250	4	ansari	ansari	PROPN
ajlm-2505	250	5	aath	aath	PROPN
ajlm-2505	250	6	,	,	PUNCT
ajlm-2505	250	7	ahmed	ahmed	PROPN
ajlm-2505	250	8	d	d	PROPN
ajlm-2505	250	9	,	,	PUNCT
ajlm-2505	250	10	farhan	farhan	PROPN
ajlm-2505	250	11	m.	m.	NOUN
ajlm-2505	250	12	evaluation	evaluation	NOUN
ajlm-2505	250	13	of	of	ADP
ajlm-2505	250	14	serum	serum	NOUN
ajlm-2505	250	15	free	free	ADJ
ajlm-2505	250	16	light	light	NOUN
ajlm-2505	250	17	chain	chain	NOUN
ajlm-2505	250	18	in	in	ADP
ajlm-2505	250	19	diagnosis	diagnosis	NOUN
ajlm-2505	250	20	and	and	CCONJ
ajlm-2505	250	21	monitoring	monitoring	NOUN
ajlm-2505	250	22	of	of	ADP
ajlm-2505	250	23	plasma	plasma	NOUN
ajlm-2505	250	24	cell	cell	NOUN
ajlm-2505	250	25	disorders	disorder	NOUN
ajlm-2505	250	26	.	.	PUNCT
ajlm-2505	251	1	crit	crit	PROPN
ajlm-2505	251	2	rev	rev	PROPN
ajlm-2505	251	3	immunol	immunol	NOUN
ajlm-2505	251	4	.	.	PUNCT
ajlm-2505	252	1	2019;39(3):203–210	2019;39(3):203–210	X
ajlm-2505	252	2	.	.	PUNCT
ajlm-2505	253	1	https://doi.org/10.1615/critrevimmunol.2019032260	https://doi.org/10.1615/critrevimmunol.2019032260	PROPN
ajlm-2505	253	2	sandfeld	sandfeld	PROPN
ajlm-2505	253	3	-	-	PUNCT
ajlm-2505	253	4	paulsen	paulsen	PROPN
ajlm-2505	253	5	b	b	PROPN
ajlm-2505	253	6	,	,	PUNCT
ajlm-2505	253	7	aggerholm	aggerholm	NOUN
ajlm-2505	253	8	-	-	PUNCT
ajlm-2505	253	9	pedersen	pedersen	PROPN
ajlm-2505	253	10	n	n	CCONJ
ajlm-2505	253	11	,	,	PUNCT
ajlm-2505	253	12	samson	samson	PROPN
ajlm-2505	253	13	mh	mh	PROPN
ajlm-2505	253	14	,	,	PUNCT
ajlm-2505	253	15	møller	møller	PROPN
ajlm-2505	253	16	hj	hj	PROPN
ajlm-2505	253	17	.	.	PROPN
ajlm-2505	254	1	a	a	DET
ajlm-2505	254	2	cohort	cohort	NOUN
ajlm-2505	254	3	study	study	NOUN
ajlm-2505	254	4	of	of	ADP
ajlm-2505	254	5	free	free	ADJ
ajlm-2505	254	6	light	light	NOUN
ajlm-2505	254	7	chain	chain	NOUN
ajlm-2505	254	8	ratio	ratio	NOUN
ajlm-2505	254	9	in	in	ADP
ajlm-2505	254	10	combination	combination	NOUN
ajlm-2505	254	11	with	with	ADP
ajlm-2505	254	12	serum	serum	NOUN
ajlm-2505	254	13	protein	protein	NOUN
ajlm-2505	254	14	electrophoresis	electrophoresis	NOUN
ajlm-2505	254	15	as	as	ADP
ajlm-2505	254	16	a	a	DET
ajlm-2505	254	17	first	first	ADJ
ajlm-2505	254	18	-	-	PUNCT
ajlm-2505	254	19	line	line	NOUN
ajlm-2505	254	20	test	test	NOUN
ajlm-2505	254	21	in	in	ADP
ajlm-2505	254	22	general	general	ADJ
ajlm-2505	254	23	practice	practice	NOUN
ajlm-2505	254	24	.	.	PUNCT
ajlm-2505	255	1	cancers	cancer	NOUN
ajlm-2505	255	2	.	.	PUNCT
ajlm-2505	256	1	2022;14(12):1–11	2022;14(12):1–11	X
ajlm-2505	256	2	.	.	PUNCT
ajlm-2505	256	3	https://doi.org/10.3390/cancers14122930	https://doi.org/10.3390/cancers14122930	PROPN